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ABSTRACT

Moser, Sydney E., Ph.D., Purdue University, August 2016. Ability of Dietary
Polyphenols to Modulate Carbohydrate Digestion and Glucose Transport. Major
Professor: Mario Ferruzzi.
Both epidemiological and clinical evidence support the notion that polyphenol
rich foods and beverages may modify glycemic response, glucose homeostasis and
subsequent risk of Type-2 diabetes. In vitro evidence typically derived from experiments
with pure phenolics and phenolic rich extracts have pointed to this benefit being
associated with two potential mechanisms: (1) the ability of specific polyphenolics to
inhibit carbohydrate digestion (amylase and glucosidase) and (2) polyphenolic inhibition
of intestinal glucose transport. While the high potential of these activities is evident, little
is actually known regarding the extent to which these benefits are extendable to the actual
food matrix these phenolics are naturally present in. Further, the extent to which coconsumption of polyphenol rich foods may actually result in decreased glycemic
response from a mixed meal remains mostly unknown. Considering these limitations,
additional insights are required in order to advance knowledge on the benefits of
polyphenolics on glucomodulatory mechanisms and translation of these insights into
meaningful recommendations and products for consumers. With this in mind, the
objectives of these studies were to determine the extent to which phenolic-rich foods
(grapes and potatoes) exert glucomodulatory properties in model food systems using in

xiv
vitro and in vivo assessments. First, mechanisms associated with polyphenol rich extracts
or model foods on carbohydrate intestinal digestion and glucose transport were
investigated in vitro using a three-stage in vitro digestion model coupled to the Caco-2
human intestinal cell model. Components of this model used individually or in
combination allowed for assessment of the two main mechanistic steps in phenolic
modulation of glycemic response (starch digestion and glucose transport) in the context
of interactions with bioaccessible phenolics. Additionally, the ability of the coupled in
vitro digestion/Caco-2 model to predict in vivo outcomes was assessed.
The first study compared the ability of 100% Niagara or Concord grape juice (GJ)
phenolics to modify carbohydrase activity and intestinal glucose transport relative to a
sugar sweetened beverage. While grape juices remain a major dietary source of phenolics,
they are also well recognized to be naturally high in sugar content. Insights into the
ability of natural fruit phenolics to modify glycemic response of grape juice were
investigated in vitro. Also, in consideration that 100% GJ is consumed with meals, the
extent to which modulation of carbohydrate digestion and intestinal absorption by GJ
phenolics can be extended to a carbohydrate rich meal was evaluated. In the first
experiment, inhibition of α-amylase and α-glucosidase by GJ extracts (300 and 500 μM
total phenolics) and ability of GJ extracts (10 to 100 μM total phenolics) to modulate
labelled glucose and fructose transport across Caco-2 intestinal cell monolayers
compared to a phenolic-free control were determined. GJ extracts decreased αglucosidase, but not α-amylase activity at both concentrations tested. Further, glucose and
fructose transport were significantly (p<0.05) decreased in a dose-dependent manner by
Niagara and Concord GJ extracts. In a second experiment, GJs and phenolic-free control

xv
beverages were co-digested in vitro with a starch-rich model meal. Resulting aqueous
digesta (AQ) from both experiments were used to assess impact of bioaccessible GJ
phenolics on carbohydrate digestion and glucose transport. Concord and Niagara GJs
significantly decreased in vitro gastrointestinal digestion of carbohydrate from model
meal compared with a sugar-matched control. Further, d7-glucose transport from AQ
fraction of GJ and co-digested GJ and carbohydrate-rich meal across Caco-2 human
intestinal cell monolayers was significantly decreased compared to phenolic-free sugarsweetened control.
The second study evaluated potential for phenolics from starch rich white, purple,
or red potatoes to modulate carbohydrate digestion or glucose transport in a Caco-2
intestinal cell model. Potato phenolic extracts (300 μM) had no impact on α-amylase
activity, and marginally decreased α-glucosidase activity. However, potato phenolic
extracts (25-100μM) did decrease d7-glucose transport compared to phenolic-free control.
Interestingly, whole potato phenolic extracts reduced glucose transport to a greater extent
compared to those from potato peel. To determine if results from aforementioned in vitro
assays are predictive of effects in vivo, a pilot clinical study (n=11) was completed to
assess differences in acute blood glucose response and gastric emptying following
consumption of phenolic-rich purple and red potato chips compared to white potato chips
(50g available carbohydrate) containing lower level of total phenolics. Blood glucose
levels were measured for up to two hours. Peak blood glucose levels were lower for
pigmented chips, especially purple chips, compared to white chips without any
significant changes in gastric emptying. These results suggest that potato phenolics may
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play a role in modulation of intestinal glucose transport and that these effects are
translatable to consumer products such as potato chips.
Taken together, these data support the notion that phenolics intrinsic to select foods have
the ability to modify glycemic response through alteration of glucose transport and to a
certain extent starch digestion. Therefore, it is likely that observed benefits associated
with consumption of phenolic-rich foods and 100% fruit juices, as a part of an overall
healthy diet, may be associated with the ability of intrinsic and bioaccessible phenolics to
modify glycemic response. Future research that focuses on hypoglycemic effects of
phenolic-rich foods should be larger scale and should evaluate a greater variety of
phenolic-rich foods in order to better understand the extent to which phenolic class and
food matrix impact hypoglycemic effects. Regarding meal-effects, a pilot clinical study
should be completed to validate in vitro results and to provide information as to what
degree various types of meal patterns alter glycemic effects of phenolic-rich foods. Such
information can be leveraged in the development of phenolic-rich food products that have
post-prandial glycemic effects and for making recommendations of dietary choices which
may result in improved glucose homeostasis.

1

CHAPTER 1. REVIEW OF THE RELEVANT LITERATURE

1.1

Introduction

Phenolic phytochemicals are abundant in fruits, vegetables, and select wholegrains. Historically, the U.S. Dietary Guidelines have stressed these phenolic rich food
groups as important components of a healthful diet, providing guidance to increase fruit
and vegetable intake and to consume more than half of grains as whole-grains [1].
Additionally, several epidemiological studies and meta-analyses suggest that increased
consumption of phenolic-rich foods is associated with positive health outcomes such as
cardioprotection, reduced oxidative stress and diabetes prevention [2–5]. About 29.1
million people (9.3% of the U.S. population) have diabetes, with type 2 diabetes
constituting about 90% to 95% of all diagnosed cases of diabetes in adults [6]. Therefore,
prevention of type 2 diabetes, or adult-onset diabetes, through improved diet and exercise
regimen has become an important focus for Americans.
A major risk factor associated with development of diabetes is hyperglycemia, or
the state of excess glucose in the blood stream [6]. Foods with high simple sugar or
rapidly digestible starch content are considered high glycemic index (GI) foods and are
well known stimulate an increased glycemic response[7–9]. Interestingly, whole grains
and many fruits are in fact high in digestible carbohydrate or simple sugars creating a
conflicting message. That being said, these foods have lower glycemic index compared to
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other commonly consumed carbohydrate-rich foods such as white and wheat bread, pasta
and tortillas [10]. Beyond simply avoiding high GI foods, it is unclear what types of
dietary strategies may be used to effectively decrease glycemic response following a meal.
However there is evidence that avoiding spikes in blood glucose levels and maintaining
sustained energy and enhanced satiety is correlated to improved modulation of glycemia
and decreased risk for development of obesity and diabetes [11–15]. Therefore, interest in
development of diet-based strategies aimed to modify high glycemic response has grown
[11–13].
The ability of phenolics to modulate glycemic parameters was first postulated by
Thompson et al. [16] who reported in a systematic study on grains, pulses and other
starch rich foods that the phenolic content was inversely correlated to glycemic index.
Since this study, clinical evidence exist that show that dietary phenolics may result in
reduced post-prandial glucose response or fasting blood glucose levels [17–30].
Specifically, results suggest co-consumption of phenolic-rich fruits, vegetables, whole
grains, or select spices with a meal may lower post-prandial glycemic response and have
sustained impact on markers of glycemia. Similarly to work with extracts and starchy
foods, consumption of phenolic-rich berry fruits and select 100% fruit juices appear to
result in a reduced glycemic effect despite their higher sugar content [22–26,28–30].
While these observations are promising, mechanisms behind these effects have not been
clearly identified. Some evidence suggest that phenolics may impact glucose transport or
modify glucose homeostasis through inhibition of starch digestion by α-amylase and αglucosidase [21,22,31–44] However, there are still gaps in knowledge concerning
mechanisms that may be related to the ability of a phenolic-rich foods to modulate
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glucose homeostasis. Furthermore, despite the promising observations, the extent to
which these effects can be translated to more complex products or to meals and dietary
patterns is unknown. This review focuses on providing an overview of studies that have
investigated hypoglycemic effects exerted by phenolics and the mechanisms involved as
a background for the specific objectives investigated in this research.

1.2

Dietary Flavonoids

Flavonoids are one of four main classes of polyphenols, the remaining classes
being phenolic acids, stilbenes, and lignans [45]. Flavonoids are complex polyphenols
having a C6–C3–C6 backbone in which the two C6 units are of phenolic nature [46].
Major flavonoid classes include anthocyanins, flavan-3-ols, flavones, flavonols, and
flavanones (Figure 1-1). Select flavonoid-rich foods are outlined in Table 1-1.
Anthocyanidins are flavylium cations and are generally in nature as glycosides
bound at either the 3 or 5 position of the C ring (Anthocyanins- in their conjugated forms).
Key glycosylation sugars include glucose, galactose, rhamnose, and arabinose. These
flavonoids contribute to the hue of plants through a process known as copigmentation
[47]. At low pH, anthocyanins are in their protonated, colored form, but at high pH they
assume a deprotonated colorless form. Anthocyanins are abundant in colored fruits and
vegetables including berries, purple grapes, and red or purple potato, cabbage, and onion.
Flavan-3-ols are the most abundant flavonoid consumed in the western diet [48].
They are present in common foods and beverages including tea, apple, cocoa, grape and
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grape derived products [49,50]. Flavan-3-ols are structurally characterized by a lack in a
double bond between C2 and C3, a C4 carbonyl, and by conjugation to glycosidic moiety
at C3. The unique structure of flavan-3-ols allows for formation of two chiral centers and
four diastereoisomers [46]. The primary flavan-3-ols include (+/-) catechin, epicatechin,
epigallocatechin, epicatechin-gallate, and epigallocatechin-gallate. Further, flavan-3-ols
can be polymerized to form complicated polymers referred to as proanthocyanidins
(PACs) ranging in degree of polymerization from DP2 to about DP30 [51–53]. These
polymers are commonly found in cocoa, cider, and red wine [54,55].
Flavones are characterized by a double bond between positions 2 and 3 and a
ketone in position 4 of the C ring. Flavones are much less common in fruit and vegetables
compared to other flavonoid classes. Luteolin and apigenin glycosides are the primary
flavones present in foods. Parsley, celery, millet and citrus peels contain flavones [54,56].
Compared to flavones, flavonols have a hydroxyl group in position 3 of the C ring,
which may be glycosylated. Flavonols are the most ubiquitous flavonoids in foods, albeit
they are generally present at relatively low concentrations. These compounds are found
naturally in glycosylated form, primarily associated with glucose or rhamnose. The main
representatives of flavonols are quercetin and kaempferol. The richest sources of
flavonols include onions, kale, leeks, broccoli, dill weed, apples and blueberries [54,56].
Flavanones also have similar structure to flavones, except they lack a double bond
between positions 2 and 3 of the C ring and are generally glycosylated by a disaccharide.
Citrus fruit, namely oranges and grapefruit are particularly rich in flavanones. In addition,
tomatoes and aromatic plants such as mint contain flavanones [54,56].
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Figure 1-1: Major Flavonoid Subclasses

6
Table 1-1: Flavonoid content in selected foods from top 100-ranked richest (mg per 100 g
or mg per 100 ml) and primary flavonoid classes in each1.
Food

Flavonoid Content
(mg/100 g or
mg/100 ml)

Rank

Primary flavonoid classes

Cocoa powder

3448

4

Flavan-3-ols, flavonols

Mexican oregano, dried

2319

5

Flavanones, flavones, flavonols

Black chokeberry

1756

7

Anthocyanidins, flavonols

Dark chocolate

1664

8

Flavan-3-ols

Highbush blueberry

295

23

Anthocyanidins, flavan-3-ols

Blackberry

260

30

Anthocyanidins, flavan-3-ols, flavonols

Strawberry

235

33

Anthocyanidins, flavan-3-ols, flavanones,
flavonols

Coffee, filter

214

36

Flavan-3-ols, flavonols

Almond

187

40

Anthocyanidins, flavan-3-ols, flavanones,
flavonols

Black grape

169

41

Flavan-3-ols, flavonols

Red onion

168

42

Anthocyanidins, flavones, flavonols

Apple

136

48

Anthoycyanidins, flavan-3-ols, flavones,
flavonols

Spinach

119

49

Flavones, flavonols

Black tea

102

52

Flavan-3-ols, flavonols

Red wine

101

53

Anthocyanidins, flavan-3-ols, flavones,
flavonols

Green tea

89

54

Flavan-3-ols, flavones, flavonols

Yellow onion

74

56

Flavones, flavonols

Pure apple juice

68

59

Anthocyanidins, flavan-3-ols, flavonols

Broccoli

45

70

Flavones, flavonols

Asparagus

29

78

Flavonols

Potato

28

80

Flavonols

Green grape

15

95

Flavan-3-ols, flavonols

White wine

10

99

Anthocyanidins, flavanones, flavonols
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1.3

Epidemiological associations between flavonoid consumption and health

Flavonoids are one of the main dietary polyphenols forms associated with health
endpoints. Several epidemiological studies have reported the associations between
flavonoid intake and select markers of disease risk. Importantly, studies have focused on
common preventable chronic diseases such as cardiovascular disease and diabetes.

1.3.1

Cardiovascular disease risk

There is high consensus among prospective cohort studies that consuming diets
rich in flavonoids is protective against cardiovascular disease (CVD). Studies have shown
that consumption of foods rich in flavonoids are inversely associated with the incidence
of coronary heart disease (CHD) and, more specifically, quercetin intake decreases risk
for ischemic heart disease [57,58]. Similarly, results from a prospective study in
postmenopausal women showed consumption of anthocyanins and anthocyanin-rich
foods, specifically red wine and strawberries, was significantly inversely associated with
risk of CHD and CVD [59]. In addition, flavanones, flavanone-rich grape fruit, and
flavanol-rich apples and chocolate were associated with decreased risk of CHD or CVD.
Conversely, an earlier study by Sesso et al. [60] suggested that flavonoids were not
associated with CVD risk. Similarly, flavonols and flavones were not associated with risk
for CHD and isoflavones were not associated with decreased CVD risk [61,62].
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1.3.2

Diabetes.

As diabetes has recently become a primary health concern for Americans,
epidemiological studies and meta-analyses have been focusing on investigating the
potential for flavonoids to decrease risk for or to mitigate symptoms of diabetes [58,63–
65]. In a meta-analysis completed by Mahoney & Loprinzi [65], the relationship between
flavonoid-rich diet and diabetes-related markers was determined. Data was taken from
381 participants with diabetes from NHANES 2003-2006. The study found that increased
flavonoid consumption was associated with improved glycemic control as indicated by
lower levels of blood glucose and glycosylated hemoglobin (HbA1c). Similarly, results
from additional meta-analyses and prospective cohort studies suggest diets high in
anthocyanins, quercetin and myricetin, as well as increased consumption of anthocyaninrich foods, apples and tea were associated with decreased risk of type 2 diabetes
[58,63,64]. Conversely, a prospective cohort study by Nettleton et al. [66] observed that
no glycemic effect was associated with consumption of flavonoid rich foods in
postmenopausal women. Similar to epidemiological and cohort studies, results from
clinical trials directly studying effects of flavonoids on diabetes risk have been mixed,
suggesting more information is needed. In vivo and in vitro investigations that have
elucidated some potential mechanisms of actions related to the effects will be discussed
in the subsequent sections.
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1.4

Relationship between Flavonoid Intake and Glucose Homeostasis: Pre-clinical
Evidence

1.4.1

Animal studies

Animal models for disease are critical screening tools to determine efficacy of
health-promoting compounds prior to clinical investigation. A number of studies have
used streptozotocin-induced (STZ) diabetic rats to determine if inclusion of phenolic
extracts from flavonoid-rich fruits and vegetables or individual flavonoids into the
experimental diets may impact blood glucose levels compared to STZ-free control (Table
1-2). Overall, acute effects of flavonoid extracts from fruit and select spices on glycemia
have been observed with a general trend to reduction of glucose response. In a study by
Hogan et al. [67], red grape pomace extract (22.1mg/g total flavonoids) was administered
to STZ rats by gavage (400mg/kg bw) followed by a potato starch challenge (2g/kg bw).
Glycemic AUC response two hours following starch challenge was 35% lower for
treatment group compared to STZ control group receiving water. Similarly, ingestion of
flavonoid and tannin-rich cinnamon bark extract (300 and 600mg/kg bw) by STZ rats
before consumption of maltose/sucrose (2g/kg bw) decreased two hour post-prandial
glycemic response by 78-86% compared to STZ control group receiving maltose/sucrose
solution without cinnamon bark extract [68]. Overall, results suggest that flavonoid-rich
extracts decrease acute post-prandial hyperglycemic response for up to 2 hours following
a carbohydrate challenge.
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Table 1-2: Impact of flavonoid consumption on postprandial or resting blood glucose
concentration in streptozotocin-induced (STZ) rats
Postprandial
Resting
Blood Glucose
Blood Glucose
Reference
Compared to STZ Compared to STZ
Control
Control

Flavonoid Extract or
Individual Flavonoid

Polyphenol
Concentration/Dose

Starch
Challenge

Study
Length

Red grape pomace
extract

22.1mg/g total flavonoids;
400mg/kg bw

Potato starch
(2g/kg bw)

2hr

↓35%

NA

Hogan et al.
2010

Maltose/sucrose
(2g/kg bw)

2hr

↓78-86%

NA

Shihabudeen
et al. 2011

Cinnamon bark extract 300 and 600 mg/kg bw
Chokeberry fruit
extract

714mg/g total
polyphenols; 0.2% in diet

NA

4wks

NA

↓17%

Jurganski et
al. 2008

Red cabbage extract

1g/kg bw daily

NA

8.5wks

NA

↓~35%

Kataya et al.
2007

Bilberry extract

27g/kg bw daily

NA

5wks

NA

↓~25%

Takikawa et
al. 2010

Kaempferetin

100mg/kg bw

Glucose
(4g/kg bw)

3-4hrs

↓20%

NA

Epicatechin

30mg/kg 2x/day

NA

6 days

NA

↓~70%

Kim et al.
2003

Quercetin

100mg/kg bw

Soluble starch
(1g/kg bw)

3-4hrs

↓50%

NA

Kim et al.
2011

Quercetin

0.08% in diet

NA

7wks

NA

↓14%

Kim et al.
2011

Isoquercetin

5 and 15mg/kg bw

NA

11d

NA

No effect

Hunyadi et al.
2012

Rutin

5 and 15mg/kg bw

NA

11d

NA

↓32%

Hunyadi et al.
2012

Fisetin

10mg/kg bw

NA

30d

NA

↓~60%

Prasath et al.
2011

Quercetin

0.05mg/kg bw

NA

8wks

NA

No effect

Dias et al.
2005

Hesperedin or Naringin

50g/kg bw

NA

4wks

NA

↓54-58%

Mahmoud et
al. 2012

Diosmin

100mg/kg bw

NA

6.5wks

NA

↓~70%

Srinivasan et
al. 2011

Pelargonidin

3mg/kg bw

NA

3wks

NA

↓60%

1

Controls for each study are STZ rats receiving matching phenolic-free treatment or diet.
NC = not calculated

2

deSousa et al.
2004

Roy et al.
2008
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In addition to acute effects, many studies have investigated chronic effects of
flavonoid consumption on hyperglycemia with positive results. Fasting blood glucose
levels of STZ rats treated with 0.2% PAC rich chokeberry extract (714 mg polyphenols/g
extract) for 4 weeks was decreased by 17% compared to STZ rats consuming matched
extract-free diets [69]. More moderate effects were observed for addition of anthocyanin
rich red cabbage and bilberry extracts (1g/kg bw daily, 8.5 wks and 27g/kg bw, 5 wks,
respectively) to diet of STZ rodents, with treatments resulting in 25% decrease of fasting
blood glucose levels compared to STZ rats receiving vehicle control [70,71].
Hypoglycemic effect of individual flavonoids has also been investigated.
Flavonols and flavan-3-ols, in particular, have been subject of many investigations as
they are ubiquitous in many foods. Addition of specific flavonols to the diet of STZ rats
has been shown to mitigate acute glycemia compared to control STZ rats consuming
matching diets free of the specific flavonol. Specifically, kaempferetin (100mg/kg bw)
and quercetin (100mg/kg bw) administered to STZ rats decreased postprandial glucose
levels (3 to 4 hours post-consumption) by 20% and 50%, respectively, compared to STZ
rats receiving vehicle control [72,73].
Chronic hypoglycemic effects of flavonols have also been reported. Addition of
the flavan-3-ol epicatechin (EC) (30mg/kg bw, 2x/day) to diets mitigated effects of STZ,
resulting in significantly decreased fasting blood glucose levels compared to STZ control
rats [74]. Further, blood glucose levels in EC-treated STZ rats were similar to normal
control rats. Chronic exposure to quercetin (0.08% in diet, 7 weeks), and rutin and fisetin
(15mg/kg bw, 11 days and 10mg/kg bw, 30 days, respectively) decreased fasting blood
glucose by 14, 32, and 60%, respectively, in STZ rats compared to STZ rats consuming
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matching diets containing vehicle control [73,75,76]. However, addition of quercetin
(0.05g/kg, 8 wks) to diet had no apparent effect on fasting blood glucose levels in STZ
rats compared to STZ control rats [77]. Regarding other flavonoid classes, flavonoid
glycosides hesperidin and naringin (50mg/kg, 4 wks), the flavone diosmin (100mg/kg,
6.5 wks), and the anthocyanin pelargonidin (3mg/kg, 3 wks) were all reported to decrease
fasting blood glucose levels in STZ rats by 60 to 70% compared to STZ control rats [78–
80]. Although studies have shown that addition of flavonoid-rich extracts from foods or
individual flavonoids to diet have the ability to decrease blood glucose levels in models
for hyperglycemia, there is little information on hypoglycemic effect by flavonoid
treatment in normoglycemic models.

1.4.2

Evidence from human studies

Results from population based studies, meta-analyses and preclinical models
examining the association between flavonoid-rich diet with glycemic modulation or risk
of diabetes do suggest that diets rich in phenolics or, more specifically, flavonoid-rich
foods are associated with lower fasting blood glucose levels and can potentially influence
the risk of type 2 diabetes [58,63–65]. Clinical intervention studies have in fact been
completed to obtain direct evidence of these effects in human participants using more
controlled conditions in order to support observations made using epidemiological studies
(Table 1-3). More recently, an acute hypoglycemic effect following consumption of black
tea with sugar compared to sugar sweetened control beverage (water) was reported in
humans [17]. The phenolic profile of black tea is interesting because in addition to
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Table 1-3: Results from clinical interventions observing impact of flavonoid-rich food
consumption on postprandial or resting blood glucose concentration in humans 1.
Polyphenol
Flavonoid-Rich
Concentration/
Food
Dose

Black Tea

350mg total
phenolics, 39mg Glucose (75g)
flavanols; 1.0g

2hr

↓1.3mmol/L%

NA

Bryans et
al. 2013

Rice pudding
(300g)

2hr

↓50% (1545min)

NA

Hlebowicz
et al.
2007,2009

Cinnamon

Dark Chocolate

Pigmented
(Purple/Red)
Potatoes
Pigmented
(Purple)
Potatoes

Orange Juice

1

Starch
Challenge

Postprandial Resting
Blood
Blood
Study
Glucose
Glucose Reference
Length
Compared Compared
to Control to Control

1, 3, or 6g

500mg total
polyphenols/day

NA

120-145mg total
phenolics and
Potato
15mg
(50g CHO)
anthocyanins
10mg/g dw total
phenolics and
Potato
6.5mg/g dw (138g 2x/day)
anthocyanins
Muffin
sandwiches
350mL
and
hashbrowns
(81g CHO)

↓0.59-0.68
mM
(overweight, Almoosawi
et al. 2012
but not
normal
weight)

4wks

NA

2hr

↓25% (15 min)

NA

4wks

NA

No effect

1hr

↓20%

NA

Ghanim a et
al. 2010

Ramdath et
al. 2014

Vinson et
al. 2012

Berry Pureé

300mL

35g Sucrose

3-4hrs

↓14% at 15
min

NA

Torronen et
al. 2012a

Blackcurrant
juice fortified
with crowberry
powder

300mL

15g Sucrose

2hrs

↑10% at 90
min

NA

Torronen et
al. 2012b

Raspberries or
blueberries

100g

Pancakes
(50g CHO)

2hrs

No effect

NA

Clegg et al.
2011

Concord grape
juice

7mL/kg bw/d

NA

8wks

NA

↓3mg/dL

Dohadwala
et al. 2010

NC = not calculate
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native flavan-3-ols such as those found in green tea (catechins), black tea is rich in
oxidized flavonoid polymers, including theaflavins and thearubigins. Following ingestion
of instant black tea beverages (1.0g, 350mg phenolics, 39mg flavan-3-ols/g; 75g glucose),
postprandial plasma glucose concentrations was similar relative to consumption of
control (75g glucose) for up to 60min, but was significantly reduced at 120 min by
1.3mmol/L. Although results suggest that black tea may elicit a latent hypoglycemic
response to carbohydrate from a sugar matched phenolic-free beverage, the extent to
which this effect can be translated to a more complex meal is unknown. Considering that
tea is typically consumed with food this remains a critical question to consider.
In that regard, a few studies have observed effects from co-ingestion of flavonoidrich plant materials with starchy foods related to subsequent glycemic response. Herbs
and spices are commonly used as seasonings to enhance the flavor of foods. As they are
low in energy and contain high levels of phenolics, spices are an appropriate vehicle for
flavonoids to determine effects of seasoning a carbohydrate-rich food on post-prandial
glycemic response. Hlebowicz et al. [18,19] investigated glycemic effects due to addition
of proanthocyanidin-rich cinnamon (1, 3, or 6g) to rice pudding (300g). Addition of a
high load (6g) of cinnamon to the pudding resulted in reduction of incremental
postprandial blood glucose concentration (mmol/L) at 15, 30, and 45 minutes compared
to control. However, this effect was not observed for pudding containing lower levels of
cinnamon. Therefore, it appears that cinnamon added at very high concentrations to a
starchy food may have an acute effect on post-prandial glycemic response.
Overweight individuals (body mass index (BMI) >25kg/m2) are more susceptible
to development of diabetes compared to individuals of normal weight (BMI <25kg/m2).

15
A study by Almoosawi et al. [20] completed a 4 wk study in which obese and non-obese
participants consumed 20g polyphenol-rich dark chocolate (500mg polyphenols/day) to
determine if chronic dark chocolate consumption may have a positive impact on glucose
homeostasis. Consumption of dark chocolate significantly decreased fasting blood
glucose levels by 0.59 mM compared to phenolic-free control in overweight subjects, but
not in subjects with normal weight. At the beginning of the study, overweight individuals
had higher fasting blood glucose levels compared to normal weight individuals.
Therefore, the flavan-3-ols and other polyphenols from dark chocolate may have a
beneficial effect only for those consumers who have impaired glycemic control. The
extent to which this effect is related to differences in glycemic control or in flavonoid
bioavailability or metabolism is unknown.

1.4.3 Studies on Potatoes
Potatoes are common staple foods that provide a good source of both
carbohydrate and phenolics in the form of phenolic acids and chlorogenic acids (Figure
1-2). Per 100g, potatoes provide 93 kcals, 2.2g of fiber, 535mg potassium, and 9.6mg
vitamin C [81]. Additionally potatoes are rich in phenolics. Notably, studies have found
chlorogenic acid accounts for the majority of potato phenolic content, with levels
reaching 1833 mg chlorogenic acid per 100g [82–85]. Pigmented potatoes contain
anthocyanins, with purple and red potatoes characteristically containing high levels of
petunidin and pelargonidin, respectively [86]. Although being a rich source of phenolics
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Figure 1-2: Major phenolic acid subclasses, including those found in potatoes
(chlorogenic acid and caffeic acid).

and micronutrients (potassium, iron, vitamin B6, and vitamin C) and lower in
carbohydrate and energy per 100g compared to other carbohydrate-rich staples such as
macaroni and long grain brown rice [81], potatoes have been classified with medium to
high GI and are often cited as a contributor to diabetes risk [87–89]. Therefore, interest in
determining their true contribution to post prandial glycemia has grown.
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Clinical trials have been completed to determine if select consumption of
anthocyanin and phenolic-rich potatoes with pigmented flesh and skin may result in
decreased glycemic response compared to the commonly consumed white fleshed potato.
Ramdath et al. [21] reported an inverse correlation between polyphenol content of
microwaved potato cubes and GI. Specifically, purple and red pigmented potatoes, high
in total phenolics (120-145mg gallic acid equivalents (GAE)/50g available carbohydrate
(CHO)) and specifically rich in anthocyanins (15mg cyanidin-3-glucoside
equivalents/50g CHO), tended to have reduced acute (15min) glucose responses and GI
values compared to white or yellow varieties (50-70mg GAE/50g CHO), decreasing
blood glucose concentration (mmol/L) by ~15%. However, consumption of 6-8 small
anthocyanin rich purple potatoes (~138g total; 6.5mg/g dw anthocyanins; 10mg/g dw
total phenolics) 2 times per day for 4 weeks did not impact fasting blood glucose
compared to a comparable amount of refined starch as cooked biscuits [90]. These results
suggest that although potatoes may exert hypoglycemic effects, the phenolic profile may
be a factor in determining the extent to which they deliver glucose to the GI tract.
Further these effects may be acute rather than more sustained effects.

1.4.4

Studies with Fruits and Juices

Fruits have historically been recommended as part of a balanced diet by the
USDA Dietary Guidelines for Americans. However, fresh fruits and fruit juices are also
known to high natural sugar content. That being said, fruits are rich sources of phenolics,
including flavonoids [91]. Therefore, it can be postulated that fruits or their products
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consumed as an alternative to other low or non-flavonoid sugar sweetened beverages or
snacks may result in lowered glycemic response. However, the extent to which fruit may
contribute GI active phenolics that can modulate carbohydrate digestion and absorption
remains a question. That being said, recent research does suggest that consumption of
fruits and fruit juices in the context of a meal reduces acute postprandial glucose response.
Orange juice (rich in flavanones and flavones) and apple juice (rich in flavan-3ols and flavonols) are the ranked 1st and 2nd, respectively, for per capita consumption in
the US [92]. According to results from previous studies, both orange and apple juice have
been shown to reduce acute glycemic response relative to sugar matched controls.
Specifically, consumption of orange juice (300kcal) in place of a beverage matched for
calorie content along with a high-fat, high-carbohydrate meal reduced 1 hr postprandial
blood glucose levels by ~20% [26]. Additionally, apple juices (400mL; cloudy or clear;
containing 1567µM and 463µM total phenolics, respectively) significantly delayed
glucose absorption over 30 minutes as indicated by incremental glucose area under the
curve (AUC) [22]. Results suggest that consumption of orange juice or apple juice with a
meal results in lower post-prandial glycemic response compared to a phenolic-free sweet
beverage with comparable sugar content.
In addition to juices, berry fruits including raspberries, blueberries, and
crowberries, have been strongly associated with anti-obesity and diabetes benefits. Berry
fruits are well established as a rich source of flavonoids and are especially known for
their high anthocyanin content, which ranges from 83 – 615 mg/100g for blueberries,
blackberries and grapes [91][28]. Co-consumption of anthocyanin, flavonol, and flavan3-ol-rich berry purée or blackcurrant juice fortified with crowberry powder (300mL) with
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a standard meal both resulted in significantly decreased postprandial blood glucose levels
compared to control (sugar matched beverage). With regards to berry purée consumption,
blood glucose levels were significantly decreased compared to control 15 minutes
following consumption, but significantly increased after 90 minutes [29]. Between 15 and
90 minutes, there were no significant differences between treatments. On the other hand,
following consumption of blackcurrant juice fortified with crowberry powder, plasma
glucose levels were initially not different compared to control, but increased compared to
control 90 minutes post-consumption [30]. These results suggest that although berries
processed into a purée or juice may decrease immediate glycemic response compared to
sugar-sweetened beverages, a rise in blood glucose may eventually occur.
Another acute study was completed in which blood glucose was tested following
participants’ consumption of pancakes supplemented with either raspberries or
blueberries (100g in meal) or control pancakes containing similar amounts of fructose
and glucose [27]. Unlike aforementioned berry studies, results showed that addition of
flavonoid-rich raspberries or blueberries to a starch rich meal did not result in lowered
blood glucose response. Null effects may have been observed be due to the lower dose of
flavonoid-rich berries compared to aforementioned studies (100g vs. 300g). Although
flavonoid content was not measured in these studies, the amount of berry served from the
first two studies mentioned was higher compared to the third study by at least 150%.
Although there are many acute studies investigating effects of fruit and fruit
beverages on glycemic response, there have been limited studies addressing long term
benefits to fasting or postprandial blood glucose response. Although little data exists,
there have been some interesting clinical results. For example in a double-blind crossover
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study, Concord grape juice (7 mL/kg/d) rich in flavan-3-ols, flavonols, and procyanidins
or matched placebo beverage was consumed for 8 wks and blood glucose levels were
measured [23]. Interestingly, fasting blood glucose decreased 2 mg/dL following
consumption of grape juice and increased 1 mg/dL following consumption of the placebo
beverage suggesting that addition of 100% grape juice to the diet may result in improved
glucose homeostasis in the long term.

1.5

Mechanisms involved in Flavonoid Modulation of Glucose-Homeostasis during
Gastrointestinal Digestion

Increasing interest in the hypoglycemic effects of polyphenol rich foods has
stimulated the investigation of mechanisms associated with such effects. Central
hypotheses in regards to the hypoglycemic effects of flavonoids specifically revolve
around the potential for flavonoids to modulate carbohydrate digestion and intestinal
glucose transport. Additionally, modulation of insulin response through stimulation of
insulin secretion by β-cells in the pancreas and activation of insulin receptors; stimulation
of glucose uptake by insulin-sensitive tissues such as adipose and muscle cells; and
suppression of hepatic glucose output have all been postulated (reviewed by Hanhineva et
al. [93]). Ample studies have investigated mechanisms central to the gastrointestinal tract,
associated with the ability of specific flavonoids and plant-derived flavonoid-rich extracts
to modulate intestinal carbohydrate digestion and glucose transport (Figure 1-3). Both are
somewhat predicated on the polyphenols’ ability to interact non-specifically with
macromolecules including starch and protein (reviewed by Bordenave et al. [56] and
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Figure 1-3: Schematic of flavonoid modulation of carbohydrate digestion and glucose transport.
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Ferruzzi et al. [94]). The result of such interactions may in fact be the inhibition of
carbohydrate digestion through modest inhibition of α-amylase and glucoamylase
[21,31–40]. Additionally, flavonoids have been reported to interact directly with glucose
transporters SGLT1 and GLUT2, potentially reducing the rate at which glucose is
translocated from the lumen into the enterocyte [22,41–44]. Combined these effects may
serve to decrease the rate of both glucogenesis and glucose transport from digested foods
in the gut.

1.5.1

Flavonoid-Macronutrient Interactions.

Flavonoid-protein interactions have been extensively investigated with a primary
focus on food quality and digestive impacts [95–102]. The dominant forces associated
with these non-specific interactions are hydrophobic stacking generated by π-π
interactions and London forces between dipoles within polyphenols and aromatic amino
acid side chains within protein [103–105]. In addition to these primary forces, proteinflavonoid binding can be further stabilized by hydrogen bonds between hydroxyl groups
of polyphenols with those of protein chains.
Research suggests that flavonoid structure can greatly influence the nature and
strength of their interaction with proteins (Table 1-4). In most cases, large molecular
weight flavonoids with greater extent of aromatic rings (such as polymeric flavan-3-ols)
appear to have increased binding with proteins. For example, galloylation of flavonoids
has been shown to increase binding interactions due to increased availability of aromatic
rings and hydroxyl groups. However in some cases, low conformational mobility of large
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flavonoids may serve to decrease binding affinity [99,106–109]. Binding is also
improved with increased hydroxylation on A and B rings of a flavonoid or presence of
ortho phenolic hydroxyl groups [106,108,109]. On the other hand, binding affinity tends
to decrease by flavonoid methoxylation, glycosylation, and hydrogenation of C2=C3
double bond [108–110].
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Table 1-4: Influence of flavonoid structural characteristics on binding with protein or
carbohydrate.1
Structural
Characteristic on
Flavonoid

1

Impact on Extent of Preferred Binding
Binding with
Site on
Binding Mechanism
Protein/Carbohydate Protein/Carbohydate

Increased molecular
weight

↑

Increased
hydrophobicity

↑

Increased degree of
polypmerization

↑

Aromatic Rings

↑

Galloylation

↑

Aromatic side chains
on protein;
π-stacking; London
hydrophobic areas (ie.
dipole forces
center of helices, βsheet) of carbohydrate

Hydroxylation

↑

Hydroxyl groups on
protein or
carbohydrate

Increased Charge

↑

Charged carbohydrate
(pectin and lignin)

Ionic interaction

Methoxylation

↓

Glycosylation

↓

NA

NA

Hydrogenation of
C2=C3 double bond

↓

Hydrogen bonding

NA = not applicable

Impacts of flavonoid-protein interactions within food matrices on beverage
stability and protein digestion have been extensively investigated. An example of this is
that of beverage haze. Beverage haze is a phenomena characteristic of beverages that
contain naturally occurring polyphenols and haze-active proteins, for example juice, wine,
and beer. Haze active proteins contain proline groups that form complexes with
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polyphenols through hydrophobic and electrostatic interactions, thereby causing the
beverage to appear cloudy [111].

Milk proteins are popular models for flavonoid interaction with dietary protein. A
study by Xiao et al. investigated the extent of binding between various flavonoids with
proteins from diluted bovine milk. Hydroxylation and galloylation of flavonoids
enhanced flavonoid-protein interaction whereas glycosylation and hydrogenation of
flavonoids weakened their affinity to protein [108]. Structural analysis has also been
used to show that catechins bind β-LG and α- and β-caseins via both hydrophilic and
hydrophobic interactions, with gallated catechins having lower binding constants [97,98].
Ultimately, such interactions between flavonoids with dietary proteins may alter protein
digestion.
Polyphenols have also been shown to interact with carbohydrate. One study
showed incorporation of tea polyphenols to 10% w/w in a high amylose (0.1% w/w)
maize starch solution increased hydrodynamic radius of amylose, suggesting the tea
polyphenols interact with amylose units, bridging them together [112]. In a study by
Takahama et al. [113], phenolics were extracted from buckwheat flour and were then
individually re-incorporated into the flour to determine extent of phenolic interaction
with starch. Individual phenolics (epicatechin-dimethylgallate and rutin) extracted from
buckwheat flour bound with amylose and amylopectin. It was suggested that the
hydrophobic helical structures present in amylose and amylopectin interacted with
hydrophobic areas on the phenolics. Similarly, a study by Barros et al. [114] showed
addition of sorghum extracts (monomeric phenolic-rich and proanthocyanidin-rich
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varieties) at 5 to 10% w/w in corn starches (normal or high amylose content) resulted in
3x increased formation of resistant starch compared to phenolic-free control. Results
from subsequent analyses indicated polymeric proanthocyanidins interacted more
strongly with amylose and linear fragments of amylopectin compared to branched
amylopectin, suggesting hydrophobic interaction dominated.
Research studying flavonoid interaction with fiber has elucidated further possible
mechanisms behind flavonoid-polysaccharide interactions. In general, flavonoid
molecular size, conformational flexibility and extent of galloylation and hydroxylation
favored flavonoid-β-glucan or β-cyclodextrin interaction [102,115,116]. However,
flavonoid-β-glucan adsorption deteriorated with flavonoids bearing more than three
hydroxyl groups [102]. In addition to galloylation, flavonoid degree of polymerization
has been shown to increase binding between procyanidins and apple cell wall material.
Interestingly, binding was also shown to increase with proportion of (+)-catechin as
opposed to (-)-catechin, indicating a stereochemical specificity for flavan-3-ols [117]. In
another study anthocyanins, due to their charged nature, were reported to preferentially
interact with pectin and lignin, likely due to their negatively charged nature [114,118].
These results highlight the importance of both flavonoid and polysaccharide structure to
their interaction with each other. With regards to characteristics of flavonoid structure
that decrease binding, results from a recent study indicate that similar to protein
interaction, phenolic methylation and methoxylation decreased their ability to interact
with β-glucan [102].
Overall, it appears that flavonoid structure is important to flavonoid-protein and
flavonoid-carbohydrate interactions. Specifically, increased extent of flavonoid molecular
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size, galloylation, and hydroxylation typically increases interactions, whereas
methylation and methoxylation tend to decrease interactions. The relationship between
flavonoid structure and binding affinity for protein and carbohydrate are important to
consider when investigating carbohydrate digestion. However, it is important to note that
little is known in regards to polyphenol-starch interactions and the impact that these
interactions in foods may have on glucose release in the GI tract.

1.5.2

Inhibition of starch digestive enzymes by flavonoids

In vitro gastrointestinal digestion models have been used to determine
digestibility of carbohydrate from specific foods (reviewed by Woolnough et al. [119]).
The simplest of these models is the Englyst method, which focuses on classifying
carbohydrates based on how quickly they are digested to glucose units that are ready to
be absorbed by the intestine. In this method, HPLC is used to measure amount of glucose
released from a test food during incubation with digestive enzymes [120]. More complex
models that encompass broader digestive interactions occurring within model foods or
meals rich in carbohydrate have been applied to investigate the impact of flavonoids on
starch digestion and glucose release [33,121,122]. In combination with in vitro
experiments focused on measuring specific enzyme inhibitory and structure-function
effects related to binding with α-amylase or glucoamylase by specific flavonoids,
extensive knowledge can be gained relative to the impact of co-digested flavonoids and
starch using in vitro digestion models that more closely mimic in vivo digestion processes.
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Using such methods, it has been reported that formulation of phenolic rich
buckwheat flour into a wheat flour bread resulted in lower glycemic inedex (GI)
compared to wheat flour bread without added buckwheat flour [123]. A study by
Takahama & Hirota [123] aimed to determine which constituents of buckwheat flour may
be responsible for the effect. After fractionation of buckwheat flour into its fatty acid,
rutin, proanthocyanins, and flavan-3-ols constituents, release of sugars from in vitro
digestion of starch suspensions was determined using the individual fractions or native
buckwheat flour. Release of reducing sugars was faster and reached higher levels by
digestion of extracted buckwheat starch compared to non-extracted buckwheat starch.
Flavonoids extracted from buckwheat flour, specifically rutin (a flavonol) and
epicatechin-dimethylgallate (a flavan-3-ol), were found to bind both amylose and
amylopectin. Therefore, lower GI from bread fortified with buckwheat may be attributed,
in part, to inhibitory activity of flavonoids against starch digestion through their
interaction with amylose and amylopectin.
Similar results were observed in a study by Shen et al. [37] investigating the
impact of citrus flavonoids on starch digestion. Citrus flavanones neohesperidin and
naringin (0.8 and 1.0mM, respectively) significantly inhibited amylase-catalyzed
digestion of soluble potato starch (0.6mg/mL). Interestingly, naringin and neohesperidin
mainly inhibited amylose digestion, whereas hesperidin and nobiletin inhibited both
amylose and amylopectin digestion. In agreement, results from binding studies suggest
that naringin and neohesperidin bind to amylose, whereas hesperidin and nobiletin bind
to both amylose and amylopectin. On the other hand, these flavonoids showed weak
inhibitory activities against digestive enzymes [37]. These results suggest that citrus
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flavonoids decrease digestion of amylose and amylopectin from starch by binding with
starch rather than by decreasing activity of specific digestive enzymes such as amylase or
glucoamylase. Further, it appears that each flavanone has preferential and differential
binding capacities with specific starch structures providing evidence for structure
function relationships that can be leveraged.
Similarly, the flavonol kaempferol inhibited α-amylase-catalyzed starch digestion
as a function of kaempferol concentration in the presence of 0.1 mg/mL starch [38].
Specifically amylose, soluble starch, and amylopectin digestion were inhibited by 40 to
75%, 20 to 60%, and 10 to 40%, respectively by kaempferol (10 to 100µM). IC50 was
observed at concentrations of about 12, 50, and 100 µM kaempferol for amylose, soluble
starch, and amylopectin, respectively. Further, results from binding studies indicated that
kaempferol binds directly to amylose and amylopectin indicating kaempferol activity is at
least partly due to its ability to shield starch from digestion by carbohydrases.
In addition to their ability to interact with macronutrients, flavonoids have been
shown to directly inhibit activity of several digestive enzymes including lipase
[31,124,125], protease [31,126,127] and starch digestive enzymes including amylase and
glucoamylase [21,22,31–44]. With regards to starch digestive enzymes, theaflavin-rich
black tea (2.8mL; 2.3 and 3.3 mg GAE/mL) was able to moderately retard pancreatincatalyzed digestion of rice noodle (120mg), ultimately reducing glucose liberation by up
to 28% [35]. Supplementary data from enzyme inhibition studies revealed that black tea
extract (0.1mg GAE/mg tea leaves primarily as complex oxidized flavan-3-ols) inhibited
α-amylase and α-glucosidase with IC50 of 0.42 to 0.67 and 0.56 to 0.58mg tea extract/mL,
respectively. Additionally, the black tea flavan-3-ol oxidized dimer, theaflavin, had IC50
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of 2.9µM and 165µM against α-amylase and α-glucosidase, respectively. Outcomes from
this study suggest that theaflavin specifically decreases digestion of starch at least in part
by inhibition of α-amylase and α-glucosidase activity. However, it is not clear to what
extent black tea flavonoids may be binding to rice noodle starch.
Similar results were observed in a study by Goto et al. [34] who investigated the
mechanisms behind reported anti-diabetic activity of tiliroside (kaempferol
glucopyranoside), a flavonol present in medicinal herbs. Tiliroside (0.1 to 1mM)
significantly inhibited pancreatic α-amylase activity compared to phenolic-free control in
vitro in a dose dependent manner (30 to 96% inhibition), as indicated by decreased
release of p-nitrophenol from 4-nitrophenyl-a-D-glucopyranoside. However it inhibited
activity of maltase and sucrase minimally, decreasing activity by 25 and 33%,
respectively, at 1mM dose. These results are contradictory to those from several other
studies showing increased inhibition of glucoamylase compared to α-amylase by
flavonoids. Specifically, recent studies show grape tannins and grape pomace and skin
extracts rich in anthocyanins, flavonols and flavan-3-ols can inhibit glucoamylase activity
by ~20 to 85%, but do not inhibit α-amylase activity [39,67,128]. This selective
inhibition is one that has been previously reported for various plant-derived phenolic
extracts by Garza et al. [129], Links et al. [130], and Lordan et al. [131]. Interestingly, it
appears that phenolic compounds with differing structures (catechin, chlorogenic acid,
and EGCG) selectively inhibit individual C- and N-terminal units of maltaseglucoamylase and sucrose-isomaltase to various extents through noncompetitive type
inhibition. Chlorogenic acid and EGCG exhibited strong inhibitory activity to C-terminal
subunits of both glucosidases [132].
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Contradictory enzyme inhibition results are likely due to structural differences
between flavonoids of interest and/or models used to assess activity. Results from a study
by McDougall et al. [133] suggest that tannin-rich fractions from fruits have high αamylase activity and low glucoamylase activity, whereas the opposite trend is found for
anthocyanin-rich fractions, suggesting inhibitory activity of large polymers may be more
specific to α-amylase whereas inhibitory activity of monomeric flavonoids may be more
specific to glucoamylase. In agreement, a study by Yilmazer-Musa et al. [40] showed that
procyanidin-rich grape seed extract strongly inhibited both α-amylase and α-glucosidase
activity while tea extracts and individual catechins were less effective inhibitors of αamylase, but strong inhibitors of α-glucosidase. Further, nongallated catechins had no
inhibitory activity toward digestive enzymes. Galloylation was also important to
theaflavin derivatives’ ability to inhibit α-amylase [36]. Specifically, results suggested
that inhibitory effects were greatest for theaflavin-3,3’-di-O-gallate followed by
theaflavin-3’-O-gallate, theaflavin-3-O-gallate, and finally theaflavin. In addition to
galloylation, inhibitory activity was dependent on presence of hydroxyl groups as they
promote hydrogen bonding between theaflavin aromatic groups with the catalytic
residues within the active site of α-amylase.
Overall, results suggest that flavonoids influence starch digestion by noncovalently binding to starch, shielding starch from digestion by α-amylase and
glucoamylase, and through direct interaction with α-amylase and glucoamylase, thereby
decreasing their activity. The combined effect of these activities is a general delay of
starch digestion and release of starch digestive products including glucose in the GI
lumen and at the brush boarder. The extent to which a specific flavonoid is involved in
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either mechanism is dependent on the structure of both the flavonoid and carbohydrate or
enzyme involved in the reaction. Further leveraging of this activity by delay of glucose
uptake is discussed next.

1.5.3

Mechanisms involved in inhibition of glucose transport by flavonoids

Although in vitro digestion and enzyme inhibition assays provide some
information about possible mechanisms behind hypoglycemic effects of flavonoid-rich
foods, there are additional mechanisms likely responsible for these effects that require
further analyses. Following gastrointestinal digestion of starch to glucose, small intestinal
epithelial cells are responsible for absorbing glucose from the lumen and transporting it
to the blood. The primary intestinal glucose transporters involved include sodiumdependent glucose transporter 1 (SGLT1) and glucose transporter 2 (GLUT2). SGLT1 is
located on the apical membrane of small intestinal cells. At low glucose concentrations,
SGLT1 co-transports glucose with sodium against the glucose concentration gradient. At
low glucose concentrations, GLUT2 is primarily located on the basolateral membrane of
intestinal cells. At higher luminal concentrations, such as that characteristic of the postprandial state, GLUT2 is translocated to the apical membrane in order to transport
glucose into the cell. Flavonoids have been shown in cell-based mechanistic studies to
decrease glucose transport by competitive inhibition of SGLT1 and by inhibition of
GLUT2 [134].
Investigation of flavonoid impacts on glucose transport started using SGLT1containing brush-border-membrane vesicles (BBMV) from pig jejunum. In a study by
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Cermak et al. [135], the flavonols quercetin-3-O-glucoside (Q3G) and -4-O-glucoside
(Q4G) significantly decreased sodium-dependent uptake of radio-labelled D-glucose into
BBMV for up to 1 minute. Specifically, Q3G (0.4 to 0.8mM) inhibited sodium-dependent
uptake of radio-labelled D-glucose into BBMV after 5 sec in a dose-dependent manner,
with IC50 achieved using 0.8mM dose. Also, the constant for half-maximal glucose
uptake in presence of Q3G was increased, suggesting competitive inhibition of glucose
uptake by Q3G. Q4G also inhibited sodium-dependent glucose uptake, whereas the 3-Ogalactoside, 3-O-glucorhamnoside, and aglycone forms of quercetin were ineffective.
Further, naringenin-7-O-glucoside, genistein-7-O-glucoside and cyanidin-3,5-Odiglucoside were also ineffective. Although results suggest specific quercetin derivatives
may decrease glucose transport, the model utilized is not closely related to human
intestinal cells. Further, incubation times were very short (5 seconds to 5 minutes)
compared to what is physiologically relevant with regards to postprandial hyperglycemia
in humans (15 mins to 2 hrs). Also, the activity of GLUT2 could not be investigated with
this model.
In a subsequent study, GLUT2 transport was modeled in Xenopus laevis oocytes
and Caco-2E human intestinal cells [42]. Robust inhibition of glucose and fructose
transport by GLUT2 was achieved by the flavonols myricetin (IC50 17.2 and 11.9µM),
fisetin (IC50 47.2 and 42.2µM), and quercetin (IC50 12.7 and 15.9 µM). However, there
was only moderate inhibition by flavones, and inhibition by flavanones, isoflavones,
catechin, and anthocyanidins was low to undetectable above 300µM dose. Further, results
from this study showed GLUT5 and SGLT1 were unaffected by flavonoids; fructose was
transported only by GLUT2 and GLUT5; and quercetin selectively inhibited GLUT2.

34
Therefore, subsequent assays were completed utilizing Caco-2E human intestinal cells to
study GLUT2 transport of fructose as affected by quercetin. Quercetin (200 µM)
inhibited fructose transport at 5 min by ~30 to 60% compared to flavonoid-free control
over a wide fructose concentration range (1 to 100 mM). Over 45 minutes, quercetin (200
µM) inhibited transport of 50 mM fructose by up to ~75% compared with flavonoid-free
control. This work filled in gaps from the previous GLUT2 study that was completed
using BBMV by utilizing a more relevant human intestinal cell model to demonstrate
GLUT2 and SGLT1 activity. However, glucose transport was not examined using the
model.
In response, intestinal transport of radiolabeled glucose across Caco-2 human
intestinal cells treated with strawberry or apple extracts or individual flavonoids was
studied [43]. Further, inhibitory activity of flavonoids in the context of sodiumcontaining conditions in which both SGLT1 and GLUT2 are active and sodium-free
conditions in which just GLUT2 is active was assessed. Both strawberry and apple
extracts contained anthocyanins, flavonols, flavan-3-ols, and flavanones, however
strawberry contained more species of each flavonoid class. Strawberry and apple extracts
(100 to 400mg/mL) decreased intracellular glucose concentration and glucose transport
over 30 minutes compared to flavonoid-free control. Using sodium-containing and
sodium-free conditions, IC50 for strawberry and apple extracts were 324 and 66mg/mL
extract and 121 and 52 mg/mL extract, respectively, suggesting apple extract was a more
potent inhibitor of glucose transport compared to strawberry extract and inhibition of
GLUT2 was greater than that of SGLT1. The ability of derivatives of pelargonidin (an
anthocyanidin), quercetin (a flavonol), and epicatechin (a flavan-3-ol) on glucose
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transport was also studied. Results showed the quercetin derivative was a potent inhibitor
of glucose transport (IC50=31µM) and the anthocyanidin derivative exerted moderate
inhibitory activity (IC50=802µM), however the epicatechin derivative had no effect. In a
similar study by Johnston et al. [136], the effect of flavonoid glycosidation and
galloylation on inhibition of glucose uptake by Caco-2 cells was examined. Under
sodium-dependent conditions, dietary glycosylated flavonoids, but not aglycones nor
flavan-3-ols, inhibited glucose uptake. Conversely under sodium-free conditions,
flavonoid aglycones and flavan-3-ols inhibited glucose uptake while flavonoid glycosides
had no effect. Therefore, results showed that aglycones selectively inhibit facilitated
glucose uptake and glycosides preferentially inhibit active glucose uptake whereas
gallated and galloylated flavan-3-ols were inhibitors of both transporters. Results from
both glucose transport studies indicate that similarly to enzyme inhibition by flavonoids,
molecular structure is an important factor in the efficacy of flavonoids to impact glucose
transport activity.
In addition to deciphering glucose transport effects by flavonoids in sodiumdependent and sodium-independent conditions, acute (15min) and chronic (16hr) effects
of flavonoid-rich berry extract and berry anthocyanins on glucose transport were
determined [41]. Treatment of Caco-2 cells with berry extract (0.125% w/v) decreased
glucose transport by about 40% using both sodium-dependent and sodium-independent
conditions. Similar to the study by Manzano & Williamson et al. [43], it was shown that
berry extracts decreased acute glucose transport compared to flavonoid-free control under
both conditions, with inhibition being greatest under sodium-free conditions. Results also
showed that individual anthocyanins (100µM) decreased glucose transport, but the effect
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was more subtle compared to that of the berry extract. However, chronic treatment of
cells with berry extract (16hr) did not significantly decrease total glucose transport,
although sodium independent glucose transport was significantly decreased. Interestingly,
both GLUT2 and SGLT1 mRNA expression were significantly decreased compared to
baseline by up to 85 and 70%, respectively, following treatment of cells with berry
extract for over 12 hours. However, although GLUT2 protein was significantly reduced
compared to control by treatment of blueberry extract for 16 hours, SGLT1 protein levels
were not affected. Results show that both short-term and long-term glucose transport
effects by berry flavonoids are governed by reduction of glucose transport by GLUT2 in
part due to reduction of GLUT2 expression. Further, acute effects are likely due to
physical interaction of flavonoids with glucose transporters, whereas chronic effects are
likely a function of changes in genome that translate to altered transporter expression.
There is a consensus between studies that certain flavonoids have the ability to
mitigate glucose transport across Caco-2 intestinal epithelial cells. In addition, flavonoids
have greater impact on GLUT2 compared to SGLT1 activity and expression. Similarly to
carbohydrate binding and digestive enzyme inhibitory activity by flavonoids, glucose
transport inhibitory activity by flavonoids is dependent on flavonoid structure. Further,
results from limited studies on structure-function relationship between flavonoids and
their ability to inhibit glucose transport indicate that increased hydrophobicity, gallation
and galloylation increase flavonoid inhibitory activity toward both transporters. Further,
glycosylation appears to promote flavonoid ability to mitigate sodium dependent glucose
transport, but not sodium independent glucose transport whereas the opposite is true for
flavonoid aglycones.
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1.6

Conclusions, Research Gaps & Objectives

Results from epidemiological studies indicate that increased consumption of
flavonoid-rich foods promote health due to ability of flavonoids to exert cardioprotective
effects, reduce oxidative stress and prevent diabetes [2–5]. As diabetes has become a
principal health concern, development of diet-related strategies targeted at decreasing
development of health-related risk factors associated with the disease has been
increasingly important. Therefore, many clinical studies have been completed to
determine efficacy of specific flavonoid-rich foods or flavonoids to decrease postprandial glycemic effect.
Overall, results have consistently shown consumption of flavonoid-rich foods or
meals results in reduced glycemic response or improved glucose homeostasis. Therefore,
it appears that it may be beneficial to recommend those at risk of developing diabetes to
regularly consume flavonoid-rich snacks or meals in replacement of those low in
flavonoids as a diet-based approach to promote glucohomeostasis. In vitro studies suggest
that the primary mechanisms behind hypoglycemic effect of flavonoids include
decreasing carbohydrate digestion by interaction with carbohydrate or carbohydrate
digestion enzymes, and decreasing intestinal glucose transport by physically inhibiting
glucose transporters or by decreasing expression of glucose transporters on a genomic
level. Importantly, each mechanism has generally been screened with extracts or
individual phenolics and appear to be dependent on flavonoid structure. Therefore, it is
important to consider flavonoid profile of a food when determining its efficacy in
blunting postprandial hyperglycemic response.
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Furthermore, most mechanistic insight has been gathered using in vitro assays
relating to impacts of flavonoids on glucose transport across intestinal epithelial cells and
have been completed using extracts from flavonoid-rich foods or individual flavonoids,
but not the food itself. Therefore, there is a lack of information about how the food matrix
and digestion environment may impact observed effects. Insight into the extent to which
these effects may translate to whole food systems or whole meals is critical to
development of appropriate guidance and products for consumers.

1.7

Proposed Objectives

To translate what is known about impact of flavonoids on glucose transport to
possible in vivo glycemic effects following consumption of flavonoid-rich foods,
additional insight into the ability of flavonoids from specific foods to survive
gastrointestinal conditions and modulate glucose transport by intestinal epithelial cells
needs to be obtained. Further, similar information for flavonoid-rich foods consumed
with a carbohydrate and protein-rich meal should be acquired. The specific objectives of
this group of studies were therefore to (1) examine the potential for flavonoids intrinsic to
carbohydrate rich foods (juices and potatoes) to modulate carbohydrate digestion and
glucose uptake/transport in a coupled in vitro digestion/Caco-2 human intestinal cell
model and (2) assess the ability of a co-consumed flavonoid-rich foods such as juices
with a model starch rich meal to modulate starch digestion, glucose transport, and SGLT1
and GLUT2 gene expression using a coupled in vitro digestion/Caco-2 model.
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CHAPTER 2. CONCORD AND NIAGARA GRAPE JUICE AND THEIR PHENOLICS
MODIFY INTESTINAL GLUCOSE TRANSPORT IN A COUPLED IN VITRO
DIGESTION/CACO-2 HUMAN INTESTINAL MODEL

2.1

Abstract

While the potential of dietary phenolics to mitigate glycemic response has been
proposed, the translation of these effects to phenolic rich foods such as 100% grape juice
(GJ) remains unclear. Initial in vitro screening of GJ phenolic extracts from American
grape varieties (V. labrusca; Niagara and Concord) suggested limited inhibitory capacity
for α-amylase and α-glucosidase (6.2-11.5% inhibition; p<0.05). Separately, all GJ
extracts (10 to 100 µM total phenolics) did reduce intestinal trans-epithelial transport of
deuterated glucose (d7-glu) and fructose (d7-fru) by Caco-2 monolayers in a dosedependent fashion, with 60 min d7-glu/d7-fru transport reduced 10-38% by GJ extracts
compared to control. To expand on these findings by assessing the ability of 100% GJ to
modify starch digestion and glucose transport from a model starch-rich meal, 100%
Niagara and Concord GJ samples were combined with a starch rich model meal (1:1 and
1:2 wt:wt) and glucose release and transport were assessed in a coupled in vitro
digestion/Caco-2 cell model. Digestive release of glucose from the starch model meal
was decreased when digested in the presence of GJs (5.9 to 15% relative to sugar
matched control). Furthermore, transport of d7-glu was reduced 10-38% by digesta
containing bioaccessible phenolics from Concord and Niagara GJ compared to control.
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These data suggest that phenolics present in 100% GJ may alter absorption of
monosaccharides naturally present in 100% GJ and may potentially alter glycemic
response if consumed with a starch rich meal.

2.2

Introduction

On average, Americans consume 0.43 gallons per capita of grape juice (GJ)
annually, making GJ the third most commonly consumed juice in the US [1]. Native
American Concord and Niagara grape cultivars are sources for production of purple and
white juice, respectively. Both grapes and their corresponding juices are well established
sources of nutrients and bioactive phenolic compounds, including flavan-3-ols, flavonols,
stilbenes, phenolic acids and, for Concord grapes, anthocyanins [2–5]. With total
phenolic and anthocyanin levels reported as high as 2900 mg/L and 880 mg/L,
respectively, for 100% Concord GJ and similarly high levels of phenolics in 100%
Niagara GJ, these products can be significant contributors to health promoting
phytochemicals [4].
Phenolic rich 100% Concord GJ consumption has been reported to have health
promoting activities including improved cardiovascular and cognitive function [6-8].
Primary outcomes mediated by Concord GJ include increased flow mediated dilation,
decreased platelet aggregation, modulation of LDL oxidation lag time, and improved
memory function and brain signaling (reviewed by Blumberg et al. [6]; Krikorian et al.
[7,8]). While promising, these benefits have been observed with consumption of between
~12 and 20 oz of 100% GJ, which contains ~36g sugar per 240mL serving [9]. While
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fruit juices have been reported to have similar glycemic response to whole fruits when
matched for sugar load [10], realization of these benefits remains challenged by
consumer concern related to the higher sugar content and risk for obesity and diabetes.
Therefore, while evidence for the benefits of GJ and GJ phenolics continues to expand,
there remains a hesitation in recommending 100% GJ consumption to certain populations
due to its natural high sugar content.
Over the past decade, the potential of phenolics to modulate glucose homeostasis
has emerged (reviewed by Hanhineva et al. [11] and Williamson et al. [12]). Specifically,
phenolics derived from foods including berries, juices, tea and coffee have demonstrated
the ability to modulate intestinal digestion of starch by inhibition of α-amylase and αglucosidase enzymes as well as intestinal glucose absorption through inhibition of
glucose transporters such as GLUT2 [13–20]. While primarily based on experiments with
purified phenolics and phenolic extracts, these data would suggest that sugar in the
context of a phenolic rich food or beverage may be processed differently in the intestine
resulting in a modified glycemic response. Interestingly, while similar glycemic
responses have been observed between grape juice and fruit, juice resulted in lower
insulin response [21]. Johnston et al. [22] previously reported that 3hr glycemic response
from both clear and cloudy 100% apple juice was in fact lower in healthy volunteers
compared to a phenolic-free, sugar-matched placebo beverage. While no mechanistic
tests were performed, the authors postulated that phenolics in apple juices, including
phloridzin or other polyphenols, may be responsible, in part, for the observed delay in
intestinal absorption of glucose. In a related fashion, chronic consumption of 100%
Concord GJ (8wks) decreased fasting blood glucose levels compared to placebo beverage
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[23]. These results do in fact suggest that specific 100% juice components might modify
glucose absorption and/or homeostasis in humans. In a related fashion, chronic
consumption of 100% Concord GJ (8wks) decreased fasting blood glucose levels
compared to placebo beverage [23]. These results do in fact suggest that specific 100%
juice components might modify glucose absorption and/or homeostasis in humans.
While these data are promising, additional insight into the ability and mechanisms
by which GJ phenolics may modulate glucose absorption is required. Also, considering
the potential mechanism of phenolic inhibition of starch digestive enzyme and glucose
transport it is important to consider the potential impact of a complex meal on these
effects. Although clinical studies remain the gold standard for investigating healthrelated outcomes, in vitro models provide an effective screening tool to investigate
mechanistic steps and screen a broader set of food matrix factors that impact nutrient and
phytonutrient bioavailability prior to refining designs for clinical evaluation [24–28].
Leveraging a similar approach, the specific objectives of this study were to (1) examine
the potential for 100% GJ phenolics to modulate carbohydrate digestion and intestinal
glucose transport in vitro, and (2) determine if bioaccessible phenolics from 100% GJ can
alter carbohydrate digestion and intestinal glucose transport in the presence of a starch
rich meal using a coupled in vitro digestion/Caco-2 model.
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2.3

2.3.1

Materials and Methods

Chemicals, Solutions and Standards

Chromatography solvents, acids and salts including acetonitrile, methanol and water,
formic acid and ammonium formate in addition to analytical standards (gallic acid,
caffeic acid, epicatechin, quercetin-3-O-β-D-glucoside, quercetin-3-glucuronide,
quercetin, resveratrol, and cyanidin-3-O-glucoside) were purchased from Sigma-Aldrich,
(St. Louis, MO). Material for test meal including nonfat dry milk (NFDM; Maple Island,
North St. Paul, MN) and corn starch (Tate and Lyle) were purchased at a local market.
Materials for in vitro digestion including urea (U5378), uric acid (U2625), porcine mucin
(M2378), α-amylase (A3176), pepsin (P7125), lipase (L3126), pancreatin (P1750) bile
salt extract (B8631), KH2PO4 (VWR), K2SO4 (Riedel-de Haën), potassium citrate,
sodium citrate, KCl, CaCO3, MgCO3 and Tris-HCl were also purchased from SigmaAldrich. NaCl, HCl, and NaHCO3 were purchased from Mallinckrodt (Phillipsburg, NJ).
Reagents for enzyme inhibition assays including dimethylsulfoxide (DMSO), acarbose,
phosphoric acid, α-amylase (A3176), rat intestinal α-glucosidase, NaCl, glucose oxidaseperoxidase, maltose, maltotriose, maltotetrose and maltopentose, were obtained from
Sigma-Aldrich. Cell culture reagents including Dulbecco’s Modified Eagles Medium
(DMEM), non-essential amino acids (NEAA), penicillin/streptomycin (pen/strep), and
phosphate buffered saline (PBS) were purchased from Lonza (Walkersville, MD). Cell
culture reagents including 4-(2-hydroxylethyl)-1-piperazineethanes (HEPES), bovine
serum albumin (free fatty acid free) (FFA) and glucose-free DMEM were purchased from
Sigma-Aldrich. NaHCO3, monosodium phosphate, and disodium phosphate were
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obtained from J.T. Baker (Center Valley, PA). Fetal bovine serum (FBS) (Atlanta
Biologicals), gentamycin (J.R. Scientific), trypsin (Thermo Scientific, Waltham MA),
glucose and fructose (Research Products International Corps, Mt. Prospect IL), and Dglucose-1,2,3,4,5,6,6-d7 (d7-glu) and D-Fructose-1,1,3,4,5,6,6-d7 (d7-fru) (Aldrich) were
used in glucose transport experiments.

2.3.2

Grape Juice Samples

100% Niagara and Concord GJ were provided by Welch Foods Inc. (Concord MA)
(Table 2-1). 100% juices were produced from two harvest years (2013 and 2014) and
were pasteurized and maintained refrigerated at 4°C until used in experiments. The
Niagara GJs were processed with and without the addition of sulfur dioxide.

Table 2-1: Description of 100% grape juice samples assessed.1
Grape juice description

Form of juice

SO2 Niagara, 2014 harvest

Reconstituted from
concentrate
Reconstituted from
concentrate
Not from concentrate
Reconstituted from
concentrate
Not from concentrate

Concord, 2014 harvest

Not from concentrate

Niagara, 2013 harvest
SO2 Niagara, 2013 harvest
Concord, 2013 harvest
Niagara, 2014 harvest

1

All samples received from Welch’s Foods Inc (Concord, MA, USA)

Sugar content
16.0°Brix
16.0°Brix
16.5°Brix
16.0°Brix
13.3°Brix
15.9°Brix
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2.3.3

Phenolic Extraction

Phenolics were extracted from aliquots (5 mL) of GJ by solid phase extraction
(Oasis® HLB 6cc (150mg) extraction cartridges) using the method of Song et al. [29].
Briefly, 5mL of juice were loaded onto the SPE cartridges (Milford, MA, USA) and
rinsed with 2% formic acid in water. Elution of phenolics was completed with 2% formic
acid in methanol. Eluates were dried down under nitrogen and kept frozen (-20°C) until
analysis. Total phenolic content of extracts was measured using a modified FolinCiocalteau assay as described by Waterhouse et al. [30].

2.3.4

Analysis of Polyphenol and Anthocyanin-Rich Fractions by LC-MS

Dried GJ extracts were resolubilized in 2.0% formic acid in water and
characterized by LC-MS using methods outlined by Song et al. [29] with modification.
Single ion responses (SIRs) were used to quantify individual GJ phenolics. Phenolic
acids, flavonoids and stilbenoids were quantified using multi-level response curves
constructed with authentic standards of each phenolic species identified by cochromatography with limited exception. Piceid concentration (a resveratrol glucoside)
was estimated using a resveratrol calibration curve. Concentration of all quercetin-O- β glucosides were estimated using quercetin-3-O-β-D-glucoside. Finally, concentrations of
anthocyanins were determined using a calibration curve constructed from cyanidin-3-Oglucoside.
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2.3.5

Impact of GJ Phenolic Extracts on Starch Digestive Enzymes In Vitro

Impact of GJ phenolic extracts on starch digestion by α-amylase and αglucosidase was determined as described by Lee et al. [31]. Briefly, GJ phenolic extracts
were dissolved in DMSO (5 mM). A waxy maize starch solution (1g/50 mL) was
prepared in 20 mM sodium phosphate buffer and boiled to achieve gelatinization (20
min). Starch solutions (50 µL) were then combined with GJ phenolic extract (15 µL,
delivering 10-500 μM of total phenols), pancreatic α-amylase (37°C, 10 U/37.5 µL) and
phosphate buffer (20 mM, pH 6.8). Samples were incubated for 10 minutes after which
the reaction was terminated by boiling. Samples were diluted 10x in water prior to
quantification of maltose and maltotriose by HPAEC-ECD. Percent inhibition of αamylase by GJ phenolics was calculated relative to vehicle control (DMSO with no GJ
extract) and compared to positive control acarbose.
Inhibition of α-glucosidase by GJ phenolics was assessed using a Megazyme
glucose assay kit. Briefly, rat intestinal α-glucosidase solution (1 g/10 mL, 10 µL) was
mixed with inhibitor (10 µL, 100-5000 µM total polyphenols). Sodium phosphate (0.1 M,
pH 6.8, 70 µL) was added to the enzyme-inhibitor solution and the mixture was vortexed
well. Maltose solution (10 µL, 100 mg/mL) was then added. The reaction mixture was
incubated at 37°C for 90 minutes. Enzymes were inactivated by placing the samples in
boiling water. Samples were then centrifuged. The supernatant was collected and diluted
10x. Glucose content was determined by addition of glucose oxidase-peroxidase reagent
and measuring absorbance at 510 nm. Percent inhibition of α-glucosidase by phenolic
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extracts and acarbose was determined by comparing the difference in absorbance
between control and extract relative to absorbance of the control.

2.3.6

Inhibition of Glucose/Fructose Transport through Caco-2 Human Intestinal Cell
Monolayers by GJ Phenolic Extracts
Potential for inhibition of glucose and fructose intestinal transport by GJ phenolic

extract was assessed using a three-compartment Caco-2 human intestinal cell culture
model. Caco-2 (TC7 clone) cells were maintained in DMEM supplemented with 10%
v/v FBS, 1% v/v NEAA, 1% v/v HEPES, 1% v/v pen/strep and 0.1% v/v gentamicin.
Cells were seeded (2.12x105 cells/cm2), grown and differentiated in 6 well insert plates
(Corning® Transwell® polyester membrane, 24mm diameter, pore size 0.4μm) under a
humidified atmosphere of air/CO2 (95:5) at 37°C. All experiments used differentiated
monolayers (electrical resistance > 250 Ω) at passages 90-95, with transport studies
conducted 21-24 days post-confluency. Cells were incubated in glucose-free DMEM for
2 hours preceding treatment. Test media for initial experiments was prepared by
solubilizing glucose and fructose (9mM each), d7-glu and d7-fru (3mM each), and GJ
phenolic extracts in PBS pH 5.5 (delivering 10-100 µM total phenolics, respectively).
Cellular viability was assessed using the MTT assay (Biotium, Hayward, CA). Cells
treated with phenolic extracts and digesta (at concentrations >100 µM) for 4 h were
found to have >95% viability. Test media was applied to the apical surface of cell
monolayers. After 60 min incubation, basolateral and apical media were collected and
cells were washed twice with 0.1% fatty acid free PBS. Membranes were then washed
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with ice cold PBS to terminate glucose transport, and cells were collected by scraping
and frozen until analysis. Treatments were replicated in quadruplicate.

2.3.7

Analysis of d7-Glucose and d7-Fructose Concentration in Basolateral Media by
LC-MS
Basolateral media (100 µL) was extracted using acetone (0.5 mL), dried down

under nitrogen, resolubilized in mobile phase (0.6 mL), and centrifuged (14,000 rpm, 5
min) prior to analysis for the chlorine adduct of d7-glu and d7-fru by LC-TOF-MS [32].
10μL of sample was injected on a Waters ACQUITY UPLC H-Class system equipped
with an ACQUITY QDa mass detector. Separation was achieved according to a method
by Liu et al. [33] with minor modification. A Waters BEH-amide column (2.1 mm id x
150 mm, 2.5 μM particle size) was heated to 30°C under isocratic conditions with flow
rate of 0.65 mL/min for 6 min and mobile phase 87:13 acetonitrile:water with 8 mM
ammonium formate, pH 9.8. Conditions were as follows: ionization mode: ESI (-); mass:
222 m/z; capillary voltage: 0.8 kV; cone voltage: 20 V; probe temp: 350°C; desolvation
temp: 600°C. Glucose, fructose, d7-glu and d7-fru concentrations were calculated using
calibration curves made from authentic standards.

2.3.8

Impact of 100% GJ on Glucose Release/Transport in a Coupled In Vitro
Digestion/Caco-2 Model

To extend beyond GJ extracts, a coupled three-stage in vitro digestion/Caco-2
model was used to determine if bioaccessible GJ phenolics could inhibit starch digestion
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and/or glucose transport with or without a co-consumed starch rich meal. Initially 100%
GJ or sugar matched phenolic free control (~10 mL) was introduced to a three-stage in
vitro digestion with oral, gastric and small intestinal phase as described by Moser et al.
[34] and modified according to conditions described by Vermeirssen et al. [35] to
include rat intestinal powder (0.15g/reaction) as a source of α-glucosidase. Aliquots of
undigested beverage starting material (SM), and centrifuged aqueous intestinal digesta
(AQ) containing bioaccessible GJ phenolics were collected and acidified with aqueous
acetic acid (1% total in sample) and stored frozen at -80°C until phenolic analysis by
HPLC-MS (outlined above). A separate aliquot of AQ digesta was then diluted 2:7 with
PBS (pH 5.5) (delivering ~21-56 µM total bioaccessible GJ phenolics, ~24 mM
monosaccharides), spiked with d7-glu (6mM), and applied to the apical surface of Caco-2
monolayers. A matching phenolic-free control was prepared by solubilizing glucose and
fructose (24mM total) with d7-glu (6mM each) in blank AQ digesta diluted 2:7 with PBS.
Treatments were replicated in quadruplicate. Transport of d7-glu was followed as
described previously.
In a second experiment, 100% GJ was co-digested with a test meal consisting of a
starch/nonfat dry milk model meal. The model meal was prepared by mixing corn starch
and non-fat dry milk (NFDM) in double-distilled water (10% v/v each). The mixture was
then heated (95°C, 30 min) and cooled slowly to 4°C. The resulting product was blended
and an aliquot (5g) was combined with 2.5 or 5g of 100% GJ (Concord or SO2 Niagara,
2013 harvest) or sugar-matched control beverage (50:50 Glucose:Fructose; 16° Brix)
prior to introduction to the oral phase of digestion. Starting materials (GJ plus model
meal) and final AQ digesta were collected and stored (-80°C). Bioaccessibility of
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phenolics was determined by comparing individual phenolic content of AQ digesta
relative to starting material. The extent of starch digestion was determined by
comparison of initial glucose content in starting material to that in final AQ digesta.
Percent inhibition of starch digestion by GJ was determined by comparing release of
glucose from starch during digestion of model meal with grape juice relative to phenolicfree control. Following digestion, the ability of co-digested GJ to further inhibit glucose
transport was determined by diluting AQ digesta 2:7 with PBS (pH 5.5) containing 6mM
d7-glu (delivering ~5 to 16 µM total bioaccessible phenolics, determined using FolinCiocalteu assay [30]) and applying to the apical surface of Caco-2 monolayers. Feeding
material containing AQ from high and low level GJ samples contained ~12mM and 6mM
glucose and fructose total, respectively. Matching phenolic-free controls were prepared.
Treatments were replicated in quadruplicate. Transport of d7-glu (6mM) was tracked and
compared to control matched for sugar content.

2.4

Data Analysis

Data for polyphenol, anthocyanin, (d7)-glu and (d7)-fru content of GJ samples, AQ
digesta and basolateral material are expressed as mean ± SEM. Relative (%)
bioaccessibility is defined as the percent of polyphenol recovered in final digesta from
that in starting material. Absolute bioaccessibility (μM) is the amount of phenolic
available in AQ digesta relative to that present in starting material, calculated by
multiplying % bioaccessibility by concentration (μM) of phenolic in starting material.
Percent (%) glucose release from corn starch by α-amylase was calculated as the fraction
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of glucose released compared to negative control. Glucose transport is expressed as
concentration (μM) of d7-glu appearing in the basolateral compartment over time.
Percent (%) glucose transport was then calculated on the basis of initial d7-glu content in
the apical compartment at time 0. In order to facilitate comparison between treatments
and control for variability between individual replicates, percent (%) glucose transport
was normalized using the d7-glu transport from control. Differences in phenolic profile,
bioaccessibility data, enzyme inhibitory activity and glucose transport for each GJ or GJ
extract were performed using JMP (SAS Institute, Cary, NC), and evaluated using
ANOVA followed by a Tukey’s test or t-test. All significant differences testing used α<
0.05.

2.5

2.5.1

Results

Phenolic and Anthocyanin Profiles of 100% Grape Juice

Phenolic content including anthocyanins and non anthocyaninin phenolics (Table
2-2) in Niagara and Concord GJ were comparable to that reported previously [5,36].
Several phenolic species previously reported in these native American grape varieties
were observed including phenolic acids, flavonoids, stilbenes and anthocyanins. Concord
GJ had higher levels of total phenolics compared to Niagara GJ for both 2013 and 2014
harvest juices. Further, GJ produced from 2014 harvest grapes had higher (p<0.05) levels
of caftaric acid, epicatechin, quercetin, quercetin-3-O-glucoside and specific
anthocyanins compared to that from 2013 harvest grapes. Overall, phenolic acids,
quercetin, and resveratrol were the most prominent phenolics observed in all samples,
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Table 2-2: Content (µM) of individual non-anthocyanin phenolics and anthocyanins in 3 types of grape juices over 2 harvest years.1,2,3,4

1

2
3
4
5
6

1

Values represent mean ± standard error of mean from a triplicate analysis

2

NC = Non Detected

3

Presence of different letter between values indicates significant differences in concentration of phenolic class between grape juices (p<0.05)

4

Cyanidin-3-O-p-coumaroyl-5-O-diglucoside and delphinidin-3-O-p-coumaroyl glucoside were present in Niagara juices at 0.9±0.01 to 1.9±0.1 and 3.7±0.1 to 4.1±0.1 µM, respectively.
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with levels up to 1134 µM. Use of SO2 during Niagara GJ processing did result in higher
phenolics levels in finished juice compared to untreated juice (p<0.05).
Anthocyanins were present in GJ at lower levels compared to other phenolics
(Table 2-2). Consistent with a report by Wang et al. [37], cyanidin and delphinidin
derivatives were primary contributors to total anthocyanin content in Concord GJs.
Concord GJ contained 80.8 to 102.6 µM total anthocyanins compared to 3856.5 to 4629.6
µM non-anthocyanin phenolics. Specifically, cyanidin-3,5-O-diglucoside and
delphinidin-3-O-glucoside were the most abundant anthocyanins in Concord GJ, present
at up to 24.7 and 29.0 µM, respectively. Further, cyanidin-3-O-p-coumaroyl-5-Odiglucoside and delphinidin-3-O-p-coumaroylglucoside were the only anthocyanins
detected and tentatively identified in Niagara GJ and only at low levels (0.9 to 1.9 and 3.7
to 4.1 µM, respectively).

2.5.2

Modulation of α-Amylase and α-Glucosidase Activity by Grape Juice Phenolic
Extracts
The ability of GJ phenolic extracts (50 to 500μM) to inhibit α-amylase and α-

glucosidase were determined in vitro. Only results from higher level phenolics
experiments (300 and 500µM) are shown (Table 2-3) as no activity was observed at less
than 300µM (data not shown). For both assays, the positive control (acarbose) decreased
α-amylase and α-glucosidase activity significantly (p<0.05) with complete inhibition of
α-amylase activity observed at 300µM. α-Glucosidase inhibition was observed by
300µM and 500µM acarbose at 88.9 and 92.4%, respectively.
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Table 2-3: Inhibition (%) of α-amylase and glucosidase activity by grape juice
phenolic extracts1,2,3,4.
Inhibitor concentration (μM
Percent (%) inhibition
GAE)5
Inhibitor
α-amylase
α-glucosidase
Negative Control
0
0
0
500
103.2 ± 5.1
92.4 ± 1.2
300
102.0 ± 6.1
88.9 ± 0.9
Acarbose (Positive
Control)
5
30.5 ± 2.9
6.2 ± 0.8
3
17.6 ± 5.1
2.3 ± 0.5
a,b*
500
7.9 ± 4.5
10.0 ± 4.2ab*
Niagara, 2013
300
4.5 ± 2.2b,c*
6.6 ± 2.9ab*
500
9.4 ± 3.3a*
11.5 ± 3.1a*
SO2 Niagara, 2013
300
-3.9 ± 2.0f
7.1 ± 2.6ab*
500
8.7 ± 4.3a*
9.2 ± 0.8ab*
Concord 2013
300
-3.4 ± 2.0f
5.4 ± 2.1b*
500
0.7 ± 1.7d,e
6.2 ± 3.4ab*
Niagara, 2014
300
-1.9 ± 2.6e,f
3.8 ± 2.0b
500
9.2 ± 3.9a*
7.1 ± 2.7ab*
SO2 Niagara, 2014
300
0.5 ± 1.0d,e
4.2 ± 2.1b
500
3.4 ± 1.4c,d*
9.3 ± 3.2ab*
Concord 2014
300
-1.2 ± 2.1e,f
4.9 ± 1.2b
1

Experiments represent average of n=3 replicates;
Preliminary dose finding experiments conducted with range of 10-1000μM of phenolic extracts;
3
Presence of different letter between values indicates significant differences in percent inhibition
between GJ extracts (p<0.05);
4
Presence of asterisk following values indicates significant differences in percent inhibition by
inhibitor compared to negative control (p<0.05);
5
Total phenolics in digesta determined using Folin-Ciocalteu Assay and expressed as gallic acid
equivalents (GAE); HPAEC-ECD and inhibition of α-glucosidase by glucose oxidase-peroxidase
assay.
2
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GJ phenolic extracts demonstrated only modest inhibitory capacity for α-amylase
and α-glucosidase (Table 2-3). At 500 µM, GJ phenolic extracts only modestly decreased
α-amylase activity compared to phenolic-free control, with 2013 extracts (7.9 to 9.4%
inhibition) generally having greater (p<0.05) impact compared to 2014 extracts (0.7 to
9.2% inhibition). α-Amylase inhibition at lower GJ phenolic levels was not observed.
Conversely, all GJ extracts exhibited modest α-glucosidase inhibitory capacity at both
300 and 500 µM. 2013 harvest GJ extracts had similar inhibitory capacity for αglucosidase (5.4 to 11.5% inhibition) compared to 2014 extracts (3.8 to 9.3% inhibition).

2.5.3

Modulation of glucose transport across Caco-2 intestinal cells by grape juice
phenolic extracts

Previous studies have shown that various plant-derived phenolic extracts have
ability to decrease basolateral glucose transport [18–20]. To determine if GJ phenolics
exhibit similar activity, their ability to modulate intestinal glucose and fructose transport
was assessed using a three-compartment Caco-2 human intestinal cell model. GJ extracts
containing between 10 and 100 µM total phenolics were able to reduce transport of d7fru and d7-glu compared to control, with effect generally being increased with increased
phenolic concentration (Figure 2-1; Table A-1). Inhibition was similar across all GJ
extracts and was greater for d7-fru compared to d7-glu transport, ranging from 10.9 to
41.3% and 4.7 to 35.7% inhibition for d7-fru and d7-glu transport, respectively. Overall,
extracts from Niagara GJ with and without SO2 had similar effect on transport of d7-glu
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Figure 2-1: Impact of 2013 or 2014 harvest grape juice extracts on d7-fructose (A,B) or d7-glucose (C,D) transport across Caco-2
human intestinal cell monolayer. Data is represented as concentration of deuterated sugar in basolateral compartment at 60 min. Data
represent mean ± SEM for n=4 replicate wells at each time point. Presence of different letter between values indicates significant
differences in glucose transport between treatments within each concentration (p<0.05).
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and d7-fru and generally exhibited a greater ability to inhibit transport relative to
Concord GJ extracts.

2.5.4

Influence of bioaccessible phenolics from 100% grape juice phenolics on

carbohydrate digestion and glucose transport when co-digested with starch rich
model test meal
In order to better understand the extent to which inhibition of starch digestion and
glucose transport from GJ extracts translates to 100% GJ and whole food systems,
Niagara and Concord GJs were subjected to an in vitro gastrointestinal digestion model
with and without a starch based model meal. Bioaccessibility of GJ phenolics from each
juice was determined to evaluate differences in delivery of phenolics to the upper GI tract
from AQ digesta based on grape variety (Concord, Niagara), harvest year (2013, 2014),
and SO2 treatment (Table 2-4). Impact of bioaccessible phenolics on intestinal transport
of glucose was then assessed (Figure 2-2). Additionally, the impact of co-digestion of GJ
with a starch rich model meal on bioaccessibility of phenolics from GJ, starch digestion,
and intestinal transport of glucose from AQ digesta was assessed (Tables 2-5 and 2-6;
Figure 2-3 and Table A-2).
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Table 2-4 Relative (%) and absolute (µM or nM) bioaccessibility of phenolics for 3 types of grape juices over 2 harvest years.1,2,3,4,5
100% Juice:
Grape, harvest year
Niagara, 2013
SO2 Niagara, 2013
Concord, 2013
Niagara, 2014
SO2 Niagara, 2014
Concord, 2014
100% Juice:
Grape, harvest year
Concord, 2013
Concord, 2014
100% Juice:
Grape, harvest year
Niagara, 2013
SO2 Niagara, 2013
Concord, 2013
Niagara, 2014
SO2 Niagara, 2014
Concord, 2014
100% Juice:
Grape, harvest year
Concord, 2013
Concord, 2014

Non-anthocyanin Phenolic Relative Bioaccessibility (%)
Caftaric
Quercetin 3,4Gallic Acid Caffeic Acid
Epicatechin
Quercetin Isorhamnetin
Acid
diglucoside
a
b
ab
e
a
32.0±9.2
24.8±2.6
39.5±0.6
NC
16.9±6.8
8.4±0.8a
20.9±0.8a
a
a,b
b
a
a
a
31.7±4.4
36.1±4.2
32.7±1.7
27.4±3.0
21.7±8.5
7.6±0.5
18.5±1.9a
a
b
b
c
a
b
29.6±6.6
29.1±3.6
32.2±1.6
18.5±1.4
15.7±7.4
2.6±0.5
7.6±0.4b
a
b
a
d
a
b
29.7±5.8
27.5±2.0
56.0±15.0
11.8±2.0
13.8±4.6
2.1±0.2
7.6±0.2b
a
a
b
a,b
a
b
22.0±1.5
44.7±8.0
31.6±3.2
24.3±2.1
16.7±8.8
1.7±0.3
4.1±0.4c
a
b
b
b,c
a
b
29.2±2.5
28.7±5.7
30.3±5.2
21.3±1.3
12.2±5.0
1.8±0.5
3.3±0.3c
Anthocyanin Relative Bioaccessibility (%)
Cyanidin-3,5Peonidin-3,5Delphinidin-3Delphinidin-3-ODelphinidin-3-O-pO-diglucoside O-diglucoside
O-glucoside
acetyl glucoside
coumaroyl glucoside
18.0±0.9a
25.7±1.5a
12.0±1.1a
6.3±1.8a
10.1±0.8a
b
b
b
b
13.1±1.2
18.7±1.1
8.1±1.3
3.7±0.9
6.3±0.6b
Non-anthocyanin Phenolic Absolute Bioaccessibility (µM)
Caftaric
Quercetin 3,4Gallic Acid Caffeic Acid
Epicatechin
Quercetin Isorhamnetin
Acid
diglucoside
b
b
e
a
91.0±20.0
47.5±6.2
53.4±0.6
NC
8.2±3.4
46.5±3.7a
21.2±0.7b
c
b
d
c
a
a
36.3±5.6
103.6±8.8
100.9±5.2
13.7±1.3
9.2±3.7
50.3±5.6
23.7±1.1a
a
a
b
b
a
b
139.0±25.9
179.1±22.3
214.3±8.8
50.7±7.1
14.3±6.9
25.9±4.7
19.9±0.7b
b,c
b
e
c
a
b
68.7±10.6
64.8±6.3
53.3±15.2
9.5±0.9
7.8±3.4
14.0±1.2
8.0±0.1c
c
a
c
a
a
b
37.0±6.2
177.6±37.1
169.2±7.2
96.8±10.5
10.5±4.4
17.8±2.6
8.7±0.2c
a
a
a
a
a
b
152.4±14.2
202.5±37.4
241.1±35.8
91.5±3.7
11.5±4.6
20.3±5.1
8.9±0.5c
Anthocyanin Absolute Bioaccessibility (nM)
Cyanidin-3,5Peonidin-3,5Delphinidin-3Delphinidin-3-ODelphinidin-3-O-pO-diglucoside O-diglucoside
O-glucoside
acetyl glucoside
coumaroyl glucoside
16.2±1.0a
5.1±0.4a
10.1±0.4a
0.9±0.2a
2.8±0.2a
b
b
a
a
13.4±1.5
3.9±0.2
9.8±1.7
1.0±0.2
1.8±0.3b

Piceid

Resveratrol
a

22.1±1.2
10.3±0.3c,d
14.8±2.0b
12.6±0.1b,c
8.9±1.3c,d
8.1±1.2d

18.7±1.9b
17.5±1.6b
26.6±1.7a
14.6±1.4b
16.8±2.3b
17.6±3.8b

Petunidin-3O-glucoside
23.0±1.9a
19.9±2.9a

Malvidin-3O-glucoside
37.2±1.7a
30.0±4.8b

Piceid
c

8.2±0.4
24.2±1.6a
14.1±1.9b
7.8±0.2c
19.2±2.6a,b
15.3±2.2b
Petunidin-3O-glucoside
5.7±0.2a
5.6±1.4a

Resveratrol
57.8±4.6c,d
102.7±14.0a
40.4±1.8c,d
66.1±6.9b,c
86.1±11.6a,b
38.6±7.7d
Malvidin-3O-glucoside
6.2±0.3a
6.4±1.4a

1

Values represent mean ± standard error of mean from a triplicate analysis;
NC = Non Detected;
3
Presence of different letter between values indicates significant differences in concentration of phenolic class between grape juices (p<0.05);
4
Quercetin-3-O-glucoside bioaccessibility from Concord grape juices was between 7.2±2.7 to 8.1±3.5%. Delphinidin-3-O-p-coumaroyl glucoside bioaccessibility from
Niagara juices and Concord juices was between 8.4±0.5 to 24.3±1.0% and 6.3±0.6 to 10.1±0.8%, respectively;
5
Phenolics in GJs and digesta determined using LC-MS.
2
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Figure 2-2: Impact of 2013 and 2014 100% grape juice aqueous digesta (AQ) on d7glucose transport across Caco-2 human intestinal cell monolayers over 60 min. Data
represent mean ± SEM for n=4 replicate wells. Asterisk indicates significant difference in
basolateral glucose concentration (mM) compared to control (p < 0.05).
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Table 2-5: Glucose transport by Caco-2 small intestinal epithelial cells co-treated with
d7-Glu (6 mM) and aqueous digesta (AQ) or matched phenolic-free control.1,2,3,4

Treatment
Without Model Test Meal
Control (24mM glucose/fructose)
Niagara, 2013 AQ
SO2 Niagara, 2013 AQ
Concord, 2013 AQ
Niagara, 2014 AQ
SO2 Niagara, 2014 AQ
Concord 2014 AQ
With Model Test Meal
1:1 Control (12mM glu/fru)
1:2 Control (6mM glu/fru)
1:1 Concord 2013
1:1 SO2 Niagara 2013
1:2 Concord, 2013
1:2 SO2 Niagara 2013
1

Phenolic
Concentration
[μM]5

Percent
d7-Glu
Transport6

Percent (%) d7-Glu
transported over 60
min relative to
Control7

0
27.1
37.8
56.3
20.8
39.4
53.7

2.4±0.1a
1.3±0.1b
1.4±0.3b
1.4±0.2b
1.4±0.3b
1.4±0.2b
1.6±0.2b

100a
54.8±5.4b
58.6±13.0b
59.2±7.3b
58.2±10.4b
60.1±9.0b
65.7±6.5b

0
0
16.4
7.1
10.1
4.6

1.5±0.1a
1.3±0.1a
1.1±0.2b
1.3±0.2a,b
1.3±0.1a
1.4±0.1a

100a
100a
78.6±7.7b
90.6±7.6a,b
89.5±9.5a,b
95.2±10.2a

Treatments included aqueous digesta (AQ) diluted 2:7 prior to introduction to apical
compartment of three-compartment Caco-2 cell model
2
d7-Glucose (6mM) was used as a marker for glucose transport; Diluted Concord, Niagara, and
blank digesta AQ contained 15, 12, and 12mM glucose, respectively and 12, 17, and 12mM
fructose, respectively
3
Data represent an average of n=4 wells per experiment
4
Presence of different letter between values indicates significant differences in glucose transport
between treatment and control, within experiment comparing AQ digesta from different juices or
experiment comparing AQ digesta with and without model test meal (p<0.05)
5
Total phenolics and sugars in digesta determined using LC-MS
6
Percent of d7-glucose transported from apical media to basolateral compartment
7
Amount of d7-glucose transported basolaterally over 60 minutes relative to daily control
matched for glucose/fructose and d7-glucose.
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Table 2-6. Percent decrease in release of glucose from starch-rich model meal
co-digested with grape juice compared with a sugar-matched control.1

Formulation2

Concentration of phenolics
in aqueous digesta (AQ)
fraction following digestion
(µM)3

Percent decrease in
glucose release from corn
starch by GJ phenolics
compared to phenolicfree control4

1:1 Concord:Model meal

73.7

15.0

1:2 Concord: Model meal

35.4

5.9

1:1 SO2 Niagara: Model meal

25.9

12.1

1:2 SO2 Niagara: Model meal

17.2

6.6

Figure 2-3 d7-Glucose transport across Caco-2 human intestinal cell monolayers from
AQ digesta of co-digested GJ and starch rich test meal. Data is represented as a
concentration of deuterated glucose in basolateral compartment at 60 min by treatment
compared to control over 60 minutes. Data represent mean ± SEM for n=4 replicate wells
at each time point.
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Overall, relative bioaccessibility (Table 2-4) of non-anthocyanin phenolics was
similar between Concord and Niagara GJ varieties and generally consistent with previous
reports of phenolic bioaccessibility from fruit juices [38–40]. SO2 treatment generally did
not significantly alter bioaccessibility of non-anthocyanin phenolics from Niagara GJ.
Phenolic acids were the most bioaccessible form of phenolics in GJ ranging from 22.0 to
56.0% relative bioaccessibility. Overall caftaric acid was the most bioaccessible nonanthocyanin phenolic from GJ, with bioaccessibility ranging from 30.3 to 56.0%.
Remaining phenolic acids as well as epicatechin and resveratrol were less bioaccessible
(~11.8 to 44.7%). Quercetin, isorhamnetin, and piceid generally had higher (p<0.05)
relative bioaccessibility from 2013 harvest Niagara GJ compared to 2014 harvest.
Although there were few trends for differences in relative bioaccessibility of phenolic
acids between GJs, absolute bioaccessibility (µM) of most non-anthocyanin phenolics
were significantly (p<0.05) higher from SO2 Niagara compared to non SO2 treated
Niagara GJ and phenolic acids and epicatechin were significantly higher (p<0.05) from
Concord GJ compared to Niagara GJs (Table 2-4).
Relative bioaccessibilities of individual anthocyanins from GJ were generally
lower compared to other phenolics, ranging from 3.7 to 37.2% (Table 2-4). Notably,
malvidin-3-O-glucoside had the highest bioaccessibility among anthocyanins (37.2±1.7%)
from Concord 2013 harvest GJ. Similar to the trend for phenolics, relative
bioaccessibility for anthocyanins were higher (p<0.05) from 2013 harvest compared to
2014 harvest Concord GJs. For Niagara GJs, delphinidin-3-O-p-coumaroylglucoside
bioaccessibility was significantly higher from 2013 compared to 2014 harvest GJ
(24.3±1.0% compared 9.5±0.1%). Unlike non-anthocyanin phenolics, anthocyanin
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absolute bioaccessibility from each GJ were reflective of the trends observed in relative
bioaccessibility. Notably, cyanidin-3,5-O-diglucoside had highest absolute
bioaccessibility (13.4 to 16.2 nM). Absolute bioaccessibility was low for remaining
anthocyanins ranging between 0.9 to 10.1 nM.
Following assessment of bioaccessibility, AQ fractions from final digesta of
juices and sugar-matched controls were diluted with PBS (pH 5.5, 6mM d7-glu) and
applied to the apical side of Caco-2 monolayers to determine intestinal glucose transport
from phenolic rich GJ. Apical to basolateral transport of d7-glu was assessed over 60 min.
Compared phenolic-free sugar matched control beverages, all media containing GJ AQ
digesta reduced d7-glu transport efficiency by 34.3 to 45.2% over 60 min (Table 2-5,
Figure 2-2). These results were similar to those observed from GJ extracts described
earlier (Figure 2-1) and suggests that activities observed in extract screen are preserved
through digestion.
To better understand the potential influence of macronutrients from a complex
meal on the ability of GJ to influence carbohydrate digestion and glucose transport,
Concord and SO2 Niagara GJ (2013 harvest) were co-formulated with a model test meal
(1:1 and 1:2 (wt:wt) in starting material) consisting of a corn starch and milk protein rich
model meal and digested in vitro. Co-digestion of starch-rich model meal with Concord
and SO2 Niagara GJ at both high (1:1 GJ:model meal) and low (1:2 GJ:model meal) juice
levels resulted in decreased glucose release (5.9 to 15.0% reduction) from starch
digestion relative to phenolic-free sugar matched control (Table 2-6), suggesting
bioaccessible phenolics from 100% GJ have ability to modulate glucose availability by
decreasing the digestive release of glucose from starch in the small intestine.
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To confirm that bioaccessible GJ phenolics resulting from co-digestion of GJ with
test meal maintain the ability to modulate d7-glu intestinal transport, AQ digesta fractions
from co-digestion experiments were diluted with PBS containing a final concentration of
6mM d7-glu. Despite lower phenolic concentration in test media, distinct inhibition of
glucose transport was observed (Table 2-5; Figure 2-3). Specifically, d7-glu transport
was decreased by 4.8 to 21.4%, with a significant (p<0.05) decline in glucose transport
observed for treatment with 50% Concord GJ inclusion in the model meal.

2.6

Discussion

Clinical evidence exists to support the notion that certain phenolic-rich foods and
beverages may modify glycemic parameters [22,23,41–46]. 100% GJ is a particularly
rich source of dietary phenolics, but is also naturally high in sugar (~36g sugar per
240mL serving) [9]. While it has been reported that fruit juices have similar glycemic
response to their corresponding whole fruits [10]), GJ has also been shown to have a
lower insulinemic response than corresponding grapes [21]. This may be related to the
differential profile of grape juice compared to grapes and thus a better understanding of
the interaction between GJ phenolics and the intrinsic sugar in these products is required.
This study was designed to develop insight into the ability and mechanisms by which GJ
phenolics may modulate starch digestion and absorption of glucose in the context of a
juice matrix with and without a starch rich meal.
One mechanism that has been proposed for these effects is related to phenolic
inhibition of starch digestion [47–50]. In the present study, GJ phenolic extracts (300 and
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500µM) demonstrated only modest inhibitory capacity for α -amylase and α-glucosidase
(Table 2-3). Harvest year impacted α-amylase, but not α-glucosidase activity, with 2013
extracts generally having greater impact compared to 2014 extracts. This may be related
to subtle differences in qualitative phenolic profiles from 2013 to 2014 harvest GJs as
total levels appeared similar between harvest years. Phenolic rich GJ extracts had greater
inhibitory activity toward α-glucosidase compared to α-amylase. Similar results were
previously reported for wine grape tannins, and pomace and skin extracts, showing
inhibition of α-glucosidase (~20 to 85%), with little to no detectable impact on α-amylase
activity [48,49]. Levels of phenolics required to achieve even modest inhibition were
observed to be high (>300µM). However, it is important to note that concentrations of
phenolics in the gut lumen from a serving of phenolic rich food or beverage may in fact
be quite high and approach high µM to even mM levels as previously postulated [7,51].
Therefore, results here suggesting a modest ability of GJ phenolics to inhibit αglucosidase at a 300 µM dose do support the hypothesis that consumption of GJ with
starch rich foods may have relevance to starch digestion and liberation of glucose in the
gut lumen.
A second mechanism by which phenolics may modulate glycemic response is
through alteration of glucose intestinal transport [18–20]. In the present study, GJ
extracts (10 to 100µM total phenolics) reduced intestinal glucose and fructose transport
by Caco-2 human intestinal cell monolayers compared to control. These findings are
similar to those previously reported with plant-derived phenolic extracts [18–20] (Figure
2-1; Table A-1). Overall, inhibition by GJ extracts was greater for d7-fru compared to d7glu transport, with extracts from Niagara GJ generally exhibiting greater inhibitory

77
activity relative to Concord GJ extracts. Since extracts were standardized for total
phenolics, these results suggest that the qualitative phenolic profile of Niagara GJ, which
is primarily composed of non-anthocyanin flavonoids and phenolic acids and minimal
amounts of anthocyanins (Table 2-2), may be most critical to consider in selection of
juices and therefore merits additional investigation as a targeted modifier of intestinal
glucose transport. The mechanism behind this reduction of glucose transport may be
related, in part, to the ability of GJ phenolics to inhibit expression of hexose transporters
(GLUT2 and SGLT1) or through direct inhibition of these transporters. Alzaid et al. [20]
demonstrated that GLUT2 and SGLT1 mRNA were significantly decreased compared to
baseline by up to 85 and 70%, respectively, following treatment of cells with berry
extract for over 12 hours. However although GLUT2 protein was significantly reduced
compared to control by treatment of blueberry extract for 16 hours, SGLT1 protein levels
were not affected. In a preliminary experiment, expression of GLUT2 and SGLT1 mRNA
were measured in Caco-2 monolayers exposed to 100% GJ phenolic extracts (SO2
Niagara and Concord 2013) for 4 and 24 hrs. Interestingly, GLUT2 mRNA was
significantly (p<0.05) decreased 2-fold following treatment by Concord GJ phenolic
extract, but no significant change in SGLT1 expression was observed (Figure A-1).
While these preliminary results are consistent with previous observations [18–20] they
cannot fully explain the observed effects in the present study. Previous reports have also
demonstrated that bioavailability of select polyphenols may be increased in the presence
of carbohydrates [52-54] suggesting the potential for additional interrelated mechanism
impacting the transport of both phenolics and carbohydrate. Transepithelial flux of grape
juice phenolics was not simultaneously monitored in this study, and as such it is not
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possible to speculate to these mechanisms. Further investigations are therefore warranted
to better delineate the extent to which phenolic inhibit of natural juice sugars may be
related to changes in transporter expression or function or alternative mechanisms.
Finally, in order to better understand the extent to which these effects would be
extendable to 100% GJ, Niagara and Concord GJ or matching phenolic free control were
formulated with and without a starch rich model meal and digested in vitro. Differences
observed in phenolic relative bioaccessibility from juice alone are suggestive of
variations in grape phenolic components between harvest years (Table 2-2 and 2-4). On
the other hand, SO2 treatment did not impact relative bioaccessibility of phenolics from
Niagara GJ. These results logically suggest that starting concentration of phenolics in 100%
GJ have a direct impact on concentration of phenolics available for interactions in the gut
and ultimate stability and accessibility of phenolics in the small intestine. Following
assessment of phenolic bioaccessibility, transport of glucose from AQ digesta of 100%
GJ and sugar matched controls by Caco-2 intestinal cells was assessed. All GJ AQ
digesta reduced d7-glu transport efficiency compared to phenolic-free sugar matched
control by up to 45% over 60 min (Figure 2-2; Table 2-5). These results were similar to
those observed from extract screening and suggest that reduced efficiency of intestinal
glucose transport may be a factor to consider in assessing glycemic response from GJ
relative to a phenolic free sugar sweetened beverage. Interestingly, this observation is
consistent with the glycemic response of phenolic rich apple juice that had previously
been shown to be lower relative to sugar matched controls in healthy humans [22,41].
To build on these findings with the awareness that GJ is commonly consumed
with meals, it is important to consider the consequences of co-consumed food on ability
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of GJ phenolics to modulate carbohydrate digestion and glucose transport. It is well
known that phenolics interact non-covalently with protein and carbohydrate (reviewed by
Bordenave et al. [55] and Jakobek et al. [56]). These interactions in the context of a coconsumed meal may result in changes to the activity of phenolics relative to endpoints
critical to glycemic response, namely carbohydrate digestion and glucose transport.
Therefore, digestion of carbohydrate from a starch and protein-rich test meal coformulated with GJ compared to phenolic-free control was determined. Although the
level of GJ phenolics in AQ digesta resulting from co-digestion of GJ with test meal was
lower compared to level of phenolics from GJ extracts used in enzyme inhibition assays
(Tables 2-3 and 2-5), results for inhibition of starch digestion were in fact similar.
Therefore, it appears bioaccessible phenolics in the context of a complex meal still have
the ability to impact digestion of carbohydrates derived from the meal. The extent to
which this may be due to the proximity of phenolics and macronutrients in the meal and
specific interactions that may develop through preparation and/or digestion remains to be
explored.
Modifying glucose transport by GJ in the context of a digested meal was also
determined. The effect of AQ digesta from GJ containing meals demonstrated only
modest inhibitory effects (Figure 2-3) which reach significance only for 100% Concord
GJ. While in contrast with extract screening that found Niagara phenolics to be more
effective, this observation was not totally unexpected as the phenolic concentrations
resulting from digestion of mixed meals were lower than extract and juice experiments,
especially for Niagara (Table 2-5). Considering that in humans concentrations in the gut
lumen may reach high µM to mM levels [12] from typical food doses and gut dilution,
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responses within a meal such as those observed with berries by Törrönen et al. [57] may
be expected. While requiring additional clinical insights as to the direction and extent of
this effect in vivo are required, current results, while in vitro, do reflect the modest but
important changes in glycemic response observed in recent clinical trials involving
phenolic-rich foods and beverages [22,23,41–46]. This is relevant considering that
moderate post-prandial hyperglycemia blood glucose levels (148 to 199mg/dL) have been
shown to be indicative to development of negative health effects including
atherosclerosis and endothelial damage [58]. This range represents a ~6% increase
compared to recommended <140mg/dL post-prandial (2hr) blood glucose target [59],
suggesting that even subtle improvements to post-prandial blood glucose level may
prevent development of negative health outcomes. Therefore while subtle, the current
observations that 100% GJ may impact both carbohydrate digestion and glucose transport
both from juice and in the context of a model meal suggest that the benefits of 100% GJ
may be extendable beyond the glucose derived from the juice to the response of a full
meal and thus may have positive impacts to health.

2.7

Conclusions

Although high in natural sugar, 100% Concord or Niagara GJ remains a rich
source of dietary phenolics that have been reported to modify glycemic parameters
through alteration of carbohydrate digestion and glucose transport. Results of the current
study are in general agreement with previous studies reporting the ability of phenolics to
decrease α-glucosidase activity [48,49] and also indicate that 100% GJ phenolics have the
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ability to decrease glucose transport even following simulated oral gastric and small
intestinal digestions. Further, results suggest that 100% GJ when placed in the context of
a meal maintains the ability to decrease intestinal starch digestion and subsequent glucose
transport in a fashion consistent with promotion of healthy glucose homeostasis. Further
clinical assessments of 100% GJ in the context of glycemic response are warranted to
clarify the impact of both intrinsic fruit sugar in juice and the potential impact fruit
phenolics on glycemic response from a meal.
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CHAPTER 3. PHENOLICS FROM PIGMENTED POTATOES AND THEIR CHIPS
IMPACT INTESTINAL GLUCOSE TRANSPORT AND MODIFY GLYCEMIC
RESPONSE IN HUMANS

3.1

Abstract:

Potatoes are an important dietary source of phenolic compounds. Beneficial effects
of some phenolic compounds in modulation of carbohydrate digestion and glycemic
response have been reported, however the effects of phenolics from potatoes and
processed potato products on these endpoints are not well known. The objectives of this
study were to characterize the phenolic profile of fresh potatoes (purple, red, or white
fleshed; 2 varieties each) and potato chips and to examine the potential for potato
phenolic extracts (PPE) to modulate in vitro starch digestion and intestinal glucose
transport in a Caco-2 human intestinal cell model. Following in vitro assessment, a pilot
clinical study (n=11) assessed differences in glycemic response and gastric emptying
between chips from pigmented and white potatoes. PPEs were rich in anthocyanins (~98,
11 and ND mg/100 g dw) and chlorogenic acids (~519, 425 and 157 mg/100 g dw) for
purple, red and white varieties, respectively. While no significant effects were observed
on starch digestion by -amylase and α-glucosidases, PPEs (from whole potato and peel)
significantly (p<0.05) decreased the rate of glucose transport, measured following
transport of 1,2,3,4,5,6,6-d7 -glucose (d7-glu) across Caco-2 human intestinal cell
monolayers, by 4.5-83.9%. Further, consistent with in vitro results, consumption of
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purple potato chips significantly (p<0.05) (albeit moderately) decreased blood glucose at
60 minutes post consumption compared to white chips without any significant changes in
gastric emptying. These results suggest that potato phenolics may play a role in
modulation of glycemic response and these effects may be translatable to finished
consumer products such as potato chips.

3.2

Introduction:

Potatoes can be converted to numerous food products that play a role in delivering
nutrients to consumers around the world [1]. Globally, potatoes are the third highest
consumed food crop [2] and are considered a staple in the US diet. As a vegetable,
potatoes are low in fat but high in carbohydrate (as starch) and modestly high in fiber,
depending on method of preparation. Additionally, potatoes have appreciable levels of
select micronutrients including vitamin C, potassium and magnesium [3,4]. In addition to
traditional nutrients, potatoes are also a rich dietary source of dietary phytochemicals
including phenolics (phenolic acids, anthocyanins, and flavan-3-ols), tocochromanols
(tocopherols and tocotrienols), and carotenoids (lutein, zeaxanthin and -carotene) [5-7].
While carotenoids and anthocyanins predominate in yellow/orange and red/purple potato
cultivars, respectively, phenolic acids and chlorogenic acid derivatives are widely
distributed in most commonly consumed potato cultivars. Concentrations can vary widely
across cultivars, but high values (473 to 1833 mg chlorogenic acid per 100g) are
commonly reported in raw tubers [5-7,8]. An average serving of potatoes can provide up
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to 20 mg of phenolics [9], making them one of the most important dietary sources of
phenolics in the US diet [10].
Despite these positive attributes, the high inherent starch content, and added fat
and sodium commonly present in potato dishes and snacks, have been implicated in
obesity and diabetes risk [11,12]. However, data on glycemic response from potato
products is mixed (reviewed by Ek et al. [13]). As commonly prepared (boiled, baked,
fried etc.) potatoes are considered to be a medium to high glycemic index (GI) food
[3,14]. Still, consumer perception often reverts to the notion that potatoes are exclusively
a high glycemic food. In this context, interest in understanding factors that can be
leveraged to modify the glycemic response of potato products has grown.
Many efforts have focused on modifying the type and extent of processing to
impact the glycemic response to potato products [14-16]. Process modification can be
leveraged to alter the structure of potato starch and by extension digestibility. This
includes conversion of rapidly digestible starch in cooked potatoes to slowly digestible or
resistant starch by processing techniques including microwave heating and frying [17,18].
In addition to processing efforts, polyphenols from multiple dietary sources of phenolics
including fruits, vegetables and cereals have been shown to modulate carbohydrate
digestion leading to reduced glycemic response (reviewed by Williamson et al. [31] and
Hanhineva et al. [19]). Phenolic acids, flavonoids and chlorogenic acids, commonly
found in potatoes, have all demonstrated in vitro and in vivo activities consistent with
modulation of glycemic response. This includes altering glucose release in the gut
through interactions with starch and digestive enzymes [20,21]. A recent report from
Ramdath et al. [22] found an inverse correlation between polyphenol content of potatoes
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and glycemic index (GI) in microwaved potato cubes. Specifically, highly pigmented
potatoes, rich in anthocyanins as well as chlorogenic acids, tended to elicit reduced blood
glucose responses and GI values compared to white or yellow varieties. This effect, while
not reaching statistical significance, was attributed, in part, to polyphenol inhibition of
intestinal α-glucosidase enzymes in the gut and, by extension, glucose generation in the
GI tract. The significance of these results remains unclear. Further, considering the
documented ability of certain phenolics to modify glucose intestinal transport [23,24] it
remains to be determined if enzyme inhibition is the only mechanism responsible for this
modest effect. Additionally, it is critical to understand if this effect holds for commonly
consumed snack foods, such as chips, that undergo more extensive processing that may
impact phenolic profiles. Leveraging these findings to broader consumer potato products,
including snacks, requires additional insights into the recovery of bioactive polyphenols
through processing and the ability of these phenolics to contribute to mechanisms related
to glycemic response including both digestive enzyme inhibition and glucose transport.
The specific objectives of this study were therefore to (1) characterize the phenolic
composition from fresh and processed potato chips made from distinct varieties of
colored potatoes; (2) examine the potential for potato phenolics to modulate carbohydrate
digestion in vitro and glucose transport in a Caco-2 human intestinal cell model; and (3)
to assess if these factors translate to acute changes in the glycemic response to potato
chips with different phenolic profiles in humans.
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3.3

3.3.1

Experimental

Chemicals, solutions and standards

Sigma Aldrich (St. Louis, MO) was the supplier of solvents including hexane,
acetonitrile, methanol, water, formic acid and ammonium formate; Folin-Ciocalteau
reagent, gallic acid, and sodium acetate for the Folin-Ciocalteau assay; reagents for
enzyme inhibition assays including dimethylsulfoxide (DMSO), acarbose, phosphoric
acid, α-amylase (A3176), rat intestinal α-glucosidase, NaCl, glucose oxidase-peroxidase,
maltose, maltotriose, maltotetrose, maltopentose, and epigallocatechin gallate (EGCG);
cell culture reagents including 4-(2-hydroxylethyl)-1-piperazineethanes (HEPES), bovine
serum albumin (free fatty acid free) (FFA), and glucose-free DMEM; as well as and Dglucose-1,2,3,4,5,6,6-d7 (d7-glucose). Waxy corn starch for enzyme assays was
purchased from Tate and Lyle (London, UK). The glucosidase assay was completed
using a Megazyme glucose assay kit. Caco-2 cells and Dulbecco’s Modified Eagles
Medium (DMEM), non-essential amino acids (NEAA), penicillin/streptomycin
(pen/strep), and phosphate buffered saline (PBS) used for cell culture maintenance were
purchased from Lonza (Walkersville, MD). NaHCO3, monosodium phosphate, and
disodium phosphate were obtained from J.T. Baker (Center Valley, PA). Fetal bovine
serum (FBS) (Atlanta Biologicals), gentamycin (J.R. Scientific), and trypsin (Thermo
Scientific, Waltham MA) were also used for maintenance of cell culture. Glucose and
fructose were purchased from Research Products International Corps (Mt. Prospect IL).
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3.3.2

Samples

Potato raw materials and industrial products used in this study were provided by
PepsiCo Inc. and included six cultivars/samples of fresh potatoes and six finished
chipped products made from the same lot of potatoes in a commercial chipping and
frying operation. Cultivars included: 2 purple, 2 red, a white and a yellow. Fresh potatoes
were manually separated into flesh and peel fractions, sliced, freeze dried and ground to a
fine powder prior to freezing at -80°C until extraction. Potato chips were prepared
following common commercial frying conditions. Finished chips were stored frozen
until use.

3.3.3 Polyphenol Phenolic Extraction
Powdered whole potato (~400mg), flesh (~400mg), peel (~200mg) and ground
potato chips (~700mg) were defatted with hexane prior to phenolic extraction. Samples
were then extracted two times with methanol:water:formic acid (85:15:0.5). The first
extraction was performed at room temperature followed by a second extraction achieved
by addition of formic acid (2%) in water and heat treatment (60°C, 15 min) to facilitate
gelatinization of the starch and enhanced phenolics extraction. Extracts were combined,
dried under nitrogen, and standardized to 5 mL in 2% formic acid in water. Resolubilized
extracts (PPEs) were then frozen at -80°C until analysis. Total phenolic content of an
aliquot of each sample was measured using a modified Folin Ciocalteau assay as
described by Waterhouse [25] and corrected for vitamin C and sugar following
methodology by Georgé [26]. Remaining PPE was used for phenolic analysis by LC-MS.
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Extraction recovery, determined by a spike addition of ethyl-gallate (120 µmol per
sample) as an internal standard to potato powder prior to extraction, ranged between 80
and 115%.

3.3.4

Analysis of polyphenol and anthocyanin-rich fractions by LC-MS

Phenolic compounds from potatoes and potato products were characterized by
LC-MS using methods adapted from Song et al. [27]. Phenolic acids were detected in
negative mode electrospray ionization (ESI). Single ion responses (SIRs) were set to m/z
353 and 179 for chlorogenic and caffeic acids, respectively. Identification and
quantitation of chlorogenic acids were acheived using standards 5-O-caffeoylquinic (5CQA) and 4-O-caffeoylquinic (4-CQA) acids and by comparison with previous literature
[28,29,30]. Positive mode ESI was used to detect anthocyanins as anthocyanidin ions
with SIRs set to m/z 272, 287, 301, 303, 317, and 331 for pelargonidin, cyanidin,
peonidin, delphinidin, petunidin, and malvidin aglycone fragments respectively. All
anthocyanins were quantified using cyanidin-3-glucoside as an external standard. Peak
areas for each individual anthocyanidin SIR were summed to obtain a total content
expressed for each anthocyanidin subclass.

3.3.5

Potato phenolic effect on carbohydrate digestion and intestinal transport

3.3.5.1 Inhibition of pancreatic α-amylase and α-glucosidase
Release of sugars from starch by pancreatic α-amylase was completed using high
performance anion exchange chromatography coupled with an electrochemical detector
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(HPAEC-ECD). Briefly, PPEs were dissolved in DMSO (~3mM). Then, a waxy
cornstarch solution (1g/50 mL) was prepared in 20mM sodium phosphate buffer and
boiled to achieve gelatinization (20 min). Corn starch solutions were combined with
potato phenolics (delivering 10-300μM of total polyphenols) and pancreatic α-amylase (1
mL, 37°C, 10 U/mL in phosphate buffer 20 mM, pH 6.9, containing 6.7 mM NaCl).
Phenolic concentrations were chosen to emulate levels that may be possible in the gut
lumen following consumption of phenolic rich foods [31]. Samples were incubated for
10min after which the reaction was terminated by boiling. Samples were diluted 10x in
water prior to quantification of maltose and maltotriose by HPAEC-ECD as described by
Lee et al. [32]. Percent inhibition of α-amylase by potato polyphenols was calculated
relative to a negative control (no PPE) and compared to a positive control acarbose and a
phenolic control epigallocatechin gallate (EGCG) which has been previously reported to
inhibit starch digestion [33].
Inhibition of glucosidases by potato phenolics was assessed using a Megazyme
glucose assay kit. Rat intestinal α-glucosidase solution (2 g/20 mL, 10 µL) was mixed
with inhibitor (10 µL, 10-300 µM). Sodium phosphate (0.1 M, pH 6.8, 70 µL) was added
to the enzyme-inhibitor solution and the mixture was vortexed (30 min). Maltose solution
(10 µL, 100 mg/mL) was then added. The reaction mixture was incubated at 37°C for 90
min. Enzyme inactivation was completed by placing the samples in a boiling water bath.
Samples were then centrifuged and supernatants were collected and diluted 10x. The
glucose content was determined by combining sample (13 μL) with glucose oxidaseperoxidase reagent (300 μL) and obtaining absorbance at 510 nm using a Molecular
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Devices Spectra Max 190 96-well plate reader to calculate percent inhibition of αglucosidase.

3.3.5.2 Glucose transport in Caco-2 human intestinal cell monolayers
The ability of potato phenolics to inhibit transport of glucose across the intestinal
epithelium was assessed using a three-compartment Caco-2 human intestinal cell culture
model. Caco-2 (TC7) cells were maintained using protocols described previously [34].
Cells were grown, and differentiated in 6 well Transwell® inserts (Corning® Transwell®
polyester membrane, 24 mm diameter, pore size 0.4 μm). All experiments used
differentiated monolayers (transepithelial electrical resistance (TEER) > 250 Ω) at
passages 85-95, with uptake/accumulation studies conducted 21-24 days post-confluency.
Cells were incubated in glucose-free DMEM for 2 hours preceding treatment. Test media
was prepared by solubilizing glucose (6 mM), d7-glu (2 mM), and PPEs (25-100 μM
total phenolics) in PBS pH 5.5 prior to introduction to the apical surface of cell
monolayers. At predetermined time intervals (0, 15, 30, 60 min), basolateral media (150
μL) was collected and replaced with fresh PBS. After 60 min, apical media was collected
and cells were washed twice with 0.1% FFA bovine serum albumin in PBS followed by
ice cold PBS prior to collection by scraping and then frozen until analysis. Treatments
were replicated in quadruplicate.
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3.3.5.3 Analysis of d7-glu concentration in basolateral media by LC-MS
Basolateral media was filtered through a 0.45 μm PTFE filter prior to analysis for
d7-glucose by LC-TOF-MS. An aliquot (10 µL) was then injected onto an Agilent 1100
Series HPLC system equipped with a Waters Micromass LCT Premier. Separation was
achieved using a Varian Polaris C18-amide column (2.0 mm id x 150 mm, 3.0 μm
particle size) heated to 30°C under isocratic conditions with flow rate of 0.3 mL/min and
solvent mixture of 8 mM ammonium formate in 87:30 acetonitrile:water (pH 9.8). MS
conditions adapted from Ikegami et al. [35] were as follows: ionization mode: ESI (-);
capillary and cone voltage: 3200 and 20 V, respectively; source temp: 100°C; desolvation
temp: 350°C; nitrogen gas flow rates for desolvation and cone gas: 350 and 50 L/hr,
respectively. d7-Glu was quantified using the extracted ion response at m/z 222 for the
d7-glucose chlorine adduct.

3.3.6

Clinical assessment of glycemic response and gastric emptying from phenolic rich
potato chips

3.3.6.1 Participants
All study procedures were approved by the Purdue University Committee on the
Use of Human Research Subjects and informed consent was obtained from all
participants. Participants had BMI between 18.5 to 25 kg/m2, were 18 to 50 years old,
and had stable weight (+/- 2.5kg) for 3 months. Subjects were excluded if they had
history of gastrointestinal disease, hypertension, diabetes, bariatric surgery, acute or
chronic disease, smoked, consumed >30 units of alcohol/week, were peri- or post-
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menopausal women, were following a weight reduction program within the last 3 months,
or had baseline blood glucose greater than 126 mg/dL.
A total of 12 healthy adult subjects (6 male and 6 female) were recruited from the
greater Lafayette, IN area using posted flyers. One female participant did not complete
the study and therefore was excluded from analysis. Average age and BMI of the
participants were 25 (range 19-33) and 23 kg/m2 (range 20.1-29.1), respectively.

3.3.6.2 Test foods
Commercial potato chips produced from commercial White 1, Purple 1 and Red 1
potatoes were obtained from PepsiCo as described above. Salted wheat crackers were
obtained from a local market (West Lafayette, Indiana). Product composition is provided
in Table 3-3. Fat content of samples was determined gravimetrically. Fat was extracted
from chips and crackers (2g) using hexane. Supernatants resulting from 2 rounds of
extractions were combined and dried under nitrogen. Weight of remaining fat residue was
recorded. Total carbohydrate was determined using a Megazyme kit (Total starch assay,
amyloglucosidase/α-amylase method) according to manufacturer’s instructions. Total
protein analysis was performed commercially using Leco combustion analysis (A & L
Great Lakes Laboratories, Inc., Fort Wayne, IN, USA).
On test days, the potato chips were portioned to deliver 50 g of available
carbohydrate and served with a sugar-free fruit punch flavored beverage (240 mL)
containing [13C]octanoic acid (0.1g). Participants consumed both food and beverage
within 10 min.
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3.3.6.3 Study Design.
A randomized crossover study design was used where subjects were randomly
assigned to one of four groups for intervention, each lasting one day with a one week
free-living period between interventions. Subjects were asked to consume one potato
chip product made from either White 1, Purple 1 or Red 1 potatoes. A plain salted wheat
cracker was a control treatment. Treatments could not be blinded due to the different
colors of the chips. Participants reported to the laboratory after a 10 hour overnight fast.
An initial capillary blood sample was collected by finger stick and fasting blood glucose
was measured immediately using a commercial blood glucose meter (One Touch Ultra
blood glucose meter). Following this, participants ingested either potato chips or cracker
control (50 g available carbohydrate load) with an energy-free beverage containing 100
mg [13C] labeled-octanoic acid as a marker to measure the rate of gastric emptying. No
other food or drink was allowed during the remainder of the test session. Following
ingestion, capillary blood samples were collected at 10, 20, 30, 60 and 120 min for
immediate glucose assessment. Breath samples were collected every 15 min for 4 h. The
rate at which the test materials were emptied from the stomach was determined using a
13

CO2 Urea Breath Analyzer POCone (Otsuka Electronics Co, Ltd, Osaka, Japan).

3.3.7 Data Analysis
Data for the polyphenol and anthocyanin content of potato samples and for in
vitro digestive glucose release and transport assays are all expressed as mean ± SEM
from a minimum of triplicate experiments. Percent (%) glucose release from cornstarch
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by α-amylase was calculated as the fraction of glucose released compared to the negative
control. Glucose transport is expressed as amount (μmol) of d7-glucose transported
across the Caco-2 monolayers to the basolateral compartment. Percent (%) glucose
transport was then calculated on the basis of initial d7-glucose content in the apical
compartment at time 0. Rate (μmol/min) of d7-glucose transport was calculated by linear
regression. To facilitate comparison between treatments and control for variability
between individual replicates, percent (%) glucose transport was normalized with total
transport of control d7-glucose samples at 60 min.
Blood glucose concentrations (mM) were baseline corrected. Incremental area
under the cuve (AUC) for blood glucose response following chip consumption was
calculated for each potato tested by each participant using the trapezoidal method.
Percent dose 13C recovered per hour (PDR) and cumulative PDR (CPDR) was calculated
(Braden et al. [36]). Parameters related to gastric emptying rate (lag phase, ½ emptying
time, and gastric emptying coefficient) were determined using methods by Maes et al.
[37]. Analysis by one-way ANOVA was performed using SAS 9.3 (SAS Institute, Cary,
NC) for phenolic profile data for each potato, with differences evaluated by Bonferroni’s
post hoc test. Differences in enzyme inhibitory activity, glucose release and intestinal
transport, blood glucose response, and gastric emptying parameters were performed using
JMP (SAS Institute, Cary, NC), and evaluated using ANOVA followed by a Tukey’s test
or t-test. Significance was based on α< 0.05.
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3.4

3.4.1

Results

Phenolic and anthocyanin profiles of six potato varieties

Two main phenolic classes were observed in the six tested potato varieties
including phenolic acids and anthocyanins. Caffeic acid was one of the main phenolic
acid species in potatoes, but only in modest concentrations ranging from 1.8±0.3 to
14.7±1.6 mg/100g dry weight (d.w.) whole potato (Table 3-1). Chlorogenic acid
derivatives were the most abundant phenolic compounds in potato samples ranging in
content from 43.0±19.1 to 503.8±15.0 mg/100g d.w. Main chlorogenic acid species
included 3-O-, 4-O-, and 5-O-caffeoylquinic acids. 5-O-caffeoylquinic acid was highest
in whole potatoes (ranging from 21.4±5.0 to 312.1±14.4 mg/100 g d.w.) followed by 3-O
and 4-O-caffeoylquinic acid (10.6±6.3 to 107.9±8.9 and 7.4±5.1 to 80.5±2.3 mg/100 g
d.w., respectively). Red 2 was highest in total chlorogenic acid content, whereas Yellow
1 and White 1 both had lower total concentrations (36.8±19.0 to 104.2±14.5 mg/100g
d.w.). In pigmented cultivars total monomeric anthocyanin content ranged from 91.6±5.5
to 147.6±0.3 mg/100g d.w. Red 2 had the highest anthocyanin content (147.6mg/100g
d.w.) and remaining red and purple cultivars contained between ~90-100mg of
anthocyanins per 100g d.w. Petunidin derivatives predominated in purple potatoes
(79.4±13.8 to 83.3±21.2 mg/100g d.w. whole potato) whereas pelargonidin derivatives
predominated in red potatoes (87.9±5.3 to 140.6±0.6 mg/100g d.w. whole potato).
Petunidin, malvidin, and delphinidin derivatives were not detected in red potato and
pelargonidin derivatives were not detected in purple potato.
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Overall, potato peels had significantly (p<0.05) higher concentrations of
phenolics relative to flesh and whole potato across varieties with up to 310.1±62.3 and
1167.8±146.1 mg/100 g d.w of total monomeric anthocyanins and chlorogenic acids,
respectively in peel; 132.9±4.2 and 420.6±25.2 mg/100 g d.w. of total monomeric
anthocyanins and chlorogenic acids, respectively in flesh; and up to 99.3±20.59 and
508.7±77.0 mg/100 g d.w. of total monomeric anthocyanins and chlorogenic acids,
respectively, in whole potato (Table 3-1).
To understand the impact of processing of potatoes into chips on phenolic content,
raw potato flesh content was compared to that after chipping and frying (Figure 3-1).
Phenolic levels in finished chips ranged from 13.4±0.8 to 362.1±9.2 mg/100g d.w. and
31.7±6.09 to 78.4±31.23 mg/100g d.w. for total chlorogenic acids and total monomeric
anthocyanins, respectively. While the general trend suggested that levels of phenolics in
finished chips were lower relative to fresh potato flesh, this effect was not significant
with the exception of Red 1 (p<0.05) for both total chlorogenic acids and monomeric
anthocyanins and Red 2 (P<0.05) for total monomeric anthocyanins.
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Table 3-1: Content of individual phenolic species (mg/100g d.w.), total phenolics (mg GAE/g d.w.) and total monomeric anthocyanins
(mg Cyn3Glu/g d.w.) in flesh, peel, whole potato, and chipped potato for 6 varieties of potatoes.1,2,3
Phenolic Acids
Caffeic Acid

3-O-CQA4

4-O- CQA

5-O- CQA

Purple 2

Flesh
Peel

ND
60.7±6.6

79.5±7.5
256.9±31.4

73.6±3.6
253.9±9.6

267.5±27.6
657.0±114.1

Total
Chlorogenic Acid
Isomers5
420.6±25.2
1167.8±146.1

3.3±0.4

107.9±8.9

80.5±2.3

312.1±14.4

500.5±15.0

Purple 1

Whole
Flesh
Peel

ND
264.7±5.8

49.2±9.2
179.5±10.2

44.9±3.0
195.7±18.7

215.8±7.8
669.1±33.0

309.9±6.0
1044.2±60.5

14.7±1.6

69.5±4.0

63.9±1.8

263.6±25.8

396.9±27.8

ND
114.3±10.9

60.1±21.3
97.8±25.4

47.1±3.2
109.5±23.1

233.1±21.5
442.1±37.9

340.4±39.3
649.5±62.9

4.6±2.5
ND

51.4±23.0
43.2±15.3

64.2±6.3
54.0±6.3

232.0±42.6
257.7±42.6

347.6±70.7
354.9±63.7

147.3±6.7
5.1±1.6
ND

120.8±40.3
90.7±26.4
7.2±7.2

127.6±17.7
85.5±11.5
13.9±12.9

603.6±49.3
327.4±39.3
33.9±17.4

851.9±103.8
503.6±77.0
55.0±36.9

Peel
Whole
Flesh

193.0±5.7
6.2±1.8

77.5±4.0
11.9±7.9

142.8±11.8
7.4±5.1

231.4±8.8
21.4±5.0

451.8±18.6
36.8±19.0

ND

3.7±3.7

9.6±2.1

52.7±3.7

66.0±8.4

Peel

84.3±7.8

56.8±12.8

81.9±12.7

189.3±16.7

328.0±28.4

Whole

1.8±0.3

10.6±6.3

16.1±3.2

77.5±6.3

104.2±14.5

Whole
Flesh
Red 1

Peel
Whole
Flesh

Red 2

Peel
Whole
Flesh

Yellow 1

White 1
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Table 3-1: Continued

Purple 2

Purple 1

Red 1

Red 2

Yellow 1

White 1

Total
Delphinidins

Total
Malvidins

Total
Cyanidins

Flesh

3.3±0.8

7.8±1.2

1.3±1.1

Peel

8.9±1.2

48.8±11.1

Whole

3.4±0.4

Flesh

Anthocyanins
Total
Petunidins

Total
Peonidins

Total
Pelargonidins

Total
Anthocyanins5

48.87±17.0

1.6±0.5

ND

62.8±16.1

5.3±0.3

240.05±48.6

7.1±1.3

ND

310.1±62.3

9.3±1.2

1.0±0.1

83.32±21.2

2.2±0.6

ND

99.3±20.6

4.6±0.5

4.3±0.9

1.3±0.3

53.83±11.4

1.8±0.2

ND

65.0±12.8

Peel

15.9±4.0

25.5±6.9

10.5±1.2

191.45±44.4

7.8±1.3

ND

250.6±57.5

Whole

5.5±0.5

7.7±1.3

1.6±0.1

79.41±13.8

2.6±0.3

ND

96.5±15.8

Flesh

ND

ND

2.2±1.1

ND

0.9±0.5

82.2±6.5

85.0±5.8

Peel

ND

ND

23.8±1.3

ND

8.1±0.8

249.7±10.5

285.5±12.9

Whole

ND

ND

2.5±0.1

ND

1.7±0.1

87.9±5.3

91.6±5.5

Flesh

ND

ND

5.8±0.0

ND

0.2±0.0

126.8±4.1

132.9±4.2

Peel

ND

ND

7.1±0.5

ND

4.8±0.5

332.6±29.4

344.4±30.4

Whole

ND

ND

6.9±0.3

ND

0.1±0.0

140.6±0.6

147.6±0.3

Flesh

ND

ND

ND

ND

ND

ND

ND

Peel

ND

ND

ND

ND

ND

ND

ND

Whole

ND

ND

ND

ND

ND

ND

ND

Flesh

ND

ND

ND

ND

ND

ND

ND

Peel

ND

ND

ND

ND

ND

ND

ND

Whole

ND

ND

ND

ND

ND

ND

ND

1

Values represent mean ± standard error of mean from a triplicate analysis
ND = Non Detected
3
Presence of different letter between values indicates significant differences in concentration of phenolic class between potato component within variety (p<0.05)
4
CQA= Caffeoylquinic Acid
5
Total chlorogenic acid isomers and total anthocyanins by HPLC-MS
2
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3.4.2

Modulation of α-amylase and glucosidase activity by PPE

The ability of potato phenolics to inhibit starch digestive enzymes was assessed in vitro.
Release of sugars (maltose, maltotriose, maltotetrose, and maltopentose) from corn starch
by α-amylase with and without the presence of PPE (10-300 M) was quantified using
HPAEC-ECD. Inhibition of glucosidase was determined using the glucose oxidaseperoxidase assay. Activity of PPEs was compared to positive control phenolic EGCG
(300 μM) and acarbose (3 and 300 μM). For all assays, the positive control decreased αamylase and glucosidase activity compared to negative control (Table 3-2). However,
PPEs at the highest concentration (300 M) did not significantly inhibit α-amylase
activity in vitro. PPEs did exert a modest inhibitory effect on glucosidase activity,
decreasing activity by 3.6-7.7% at the highest concentration assessed (300 M), with
Purple 2, Purple 1 and White 1 extracts significantly (p<0.05) decreasing activity
compared to negative control.
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Figure 3-1: Phenolic profiles of potato flesh and chips. (A) Total chlorogenic isomer
content (mg/100g dry weight) in flesh and chips and (B) total monomeric anthocyanin
content (mg/100g dry weight) in flesh and chips for each variety. Data represent mean ±
SEM for 4 replicate extractions and analysis by LC-MS with values representing the sum
of individual chlorogenic acid isomers and individual anthocyanin species. Presence of
different letter between values indicates significant differences between potato
component/product within variety (p<0.05)
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3.4.3

Modulation of glucose transport across Caco-2 intestinal epithelial cells by PPEs
Phenolic extracts from both whole potato and peel significantly (p<0.05) reduced

the rate of glucose transport through highly differentiated Caco-2 human intestinal cell
monolayers (Table B-1; Figures 3-2 & 3-3). Specifically, exposure to extracts from whole
Red 1 followed by White 1 potatoes resulted in greatest reduction in rate of d7-glu
transport compared to d7-glu control from 3.0 to 0.5 and 1.1 µmol d7-glu per min,
respectively. Remaining varieties decreased transport by 0.2 to 1.5 μmol d7-glu per min.
On the other hand, peel PPEs had only a modest impact with the rate of glucose transport
decreasing from 1.0 mol d7-glu per min to between 0.5 and 0.7 mol d7-glu per min for
potato peel extracts. This almost 50% reduction in transport rate was less than that
observed for whole potatoes. However, it is important to note that these assays were run
on separate days and variation in control response (1.0 versus 3.0 mol/min) may have
also played a role in this observation. Total % d7-glucose transport over 60 min
normalized to control accounted for these day to day differences. These normalized data
support the notion that while peel PPEs decreased total glucose transport it was much
more modest than that observed for whole potato extracts, with peel and whole PPE
achieving between ~16-53% and 49-98% inhibition, respectively.
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Table 3-2: Percent inhibition of α-amylase and glucosidase activity by whole potato
phenolic extracts.1,2,3
Percent (%) inhibition
Sample Description

Treatment
α-amylase

glucosidase

- Control

Control (no inhibitor)

0a

0a

Phenolic Control

EGCG

2.0±4.0a

53.4±0.6b

+ Control (High Dose)

Acarbose

97.5±1.0b

91.3±0.1c

+ Control (Low Dose)

Acarbose (3 µM)

14.4±3.2a

ND

Potato

Purple 2

-6.0±4.2a

7.7±2.0d

Potato

Purple 1

-8.4±7.6a

7.0±3.7d

Potato

Red 1

-8.1±5.2a

6.3±1.0a,d

Potato

Red 2

-7.5±6.0a

4.2±5.0a,d

Potato

Yellow 1

1.3±11.4a

3.6±0.1a,d

Potato

White 1

-5.3±7.0a

8.5±2.4d

1

Experiments represent average of n=3 replicates.
Preliminary dose finding experiments conducted with range of 100-1000µM of phenolic extracts
3
Unless otherwise noted, treatment concentration is 300µM
4
ND- not determined
2
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Figure 3-2: Impact of whole potato extracts from (A) Purple 2, and (B) Purple 1, C) Red
1, D) Red 2, E) Yellow 1, and F) White 1 on glucose transport in Caco-2 human
intestinal cell monolayers. Each data point is represented as a ratio of total glucose
transport by control over 60 minutes. Data represent mean ± SEM for n=4 replicate wells
at each time point.
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Figure 3-3: Impact of potato peel extracts from (A) Purple 2, and (B) Purple 1, C) Red 1,
D) Red 2, E) Yellow 1, and F) White 1 on glucose transport in Caco-2 human intestinal
cell monolayers. Each data point is represented as a ratio of total glucose transport by
control over 60 minutes. Data represent mean ± SEM for n=4 replicate wells at each time
point.
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3.4.4

Modulation of glycemic response by phenolic rich potato chips

The ability of phenolics to modify the post-prandial blood glucose concentration
from potato chips was assessed in healthy humans. Commercially available wheat based
salted crackers were used as a positive control and compared to blood glucose AUC and
blood glucose concentrations at stipulated time points for white, purple and red potato
chips with differing phenolic profiles. Macronutrient profiles were similar between chips
but differed significantly in fat content compared to the salted cracker control (Table 3-3).
Total fat, carbohydrate, and protein content ranged between 8.5 to 10, 13.8 to 15.8, and
1.7 to 2.0 g/28g serving of chips, respectively. White chips had significantly (p<0.05)
higher carbohydrate content and significantly (p<0.05) lower fat and phenolic
concentrations per serving compared to pigmented chips (Tables 3-3, B-2). In regards to
phenolics, Red chips contained significantly (p<0.05) higher anthocyanin concentrations
compared to Purple chips (1886.7±46.7 compared to 621.0±10.3 nmol/28g serving).
However, Purple chips had higher total phenolic concentrations (including anthocyanins)
compared to Red chips (82.3±1.4 compared to 65.3±4.2 μmol/28g serving) (Table 3-3).
Participants (6 males, 5 females) involved in the clinical study included Caucasian
(n=7), Hispanic (n=4) and Asian/Pacific (n=1) backgrounds with ages ranging from 19 to
33 years with a mean BMI of 23.2±0.7 kg m-2 and normal fasting blood glucose
concentrations (4.4±0.1 mM). The mean blood glucose AUC was significantly lower
following consumption of white, red, and purple chips (99.8±14.1, 93.5±14.4,
76.0±14.1mM) compared to crackers (181.0mM±28.9mM). Similarly, postprandial blood
glucose concentrations were lower than control (salted wheat cracker) at each time point
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Table 3-3: Macronutrient content in 3 types of potato chips and crackers.1,2,3

Product

Fat
(g/28g
serving)

Carbohydrate
(g/28g
serving)

Protein
(g/28g
serving)

Cracker
White
Purple
Red

2.2±0.2d
8.5±0.1c
9.6±0.1b
10.1±0.04a

20.1±1.1a
15.8±0.7b
13.3±0.9c
13.8±0.6c

2.8±0.01a
1.9±0.03c
2.0±0.04b
1.7±0.01d

Total
phenolics
(µmol/28g
serving)
ND
16.8±0.3c
82.3±1.4a
65.3±4.2b

Total
anthocyanins
(nmol/28g
serving)
ND
ND
621.0±10.3b
1886.7±46.7a

1

Values represent mean ± standard error of mean from a triplicate analysis
ND = Non Detected
3
Presence of different letter between values indicates significant differences in macronutrient content or
concentration of phenolics between potato chips and crackers (p<0.05)
2

with blood glucose concentrations from 20 to 60 minutes being significantly (p<0.05)
lower for chips compared to crackers (0.3 to 1.2 and 1.8 to 2.3mM, respectively). Gastric
half-emptying time (hrs) and lag phase (hrs) were significantly longer (p<0.05) for each
chip compared to cracker control (Table 3-4).
There were no significant differences of total blood glucose AUC or incremental
blood glucose AUC (iAUC) between 0 to 30 mins or 30 to 120 minutes among the chips
(Table 3-4). However, there was a trend for lower blood glucose total AUC and iAUC
(30 to 60 mins) for purple potato chips compared to white and red potato chips. Blood
glucose curves for each potato chip had distinct patterns, indicating potential for subtle
differences in rates of carbohydrate digestion or glucose absorption (Figure 3-4). Peak
blood glucose concentrations were similar for all chips (1.0 to 1.2 mM) but differed in
time with Red and Purple chips displaying delayed responses. Specifically, blood
glucose concentrations peaked (Cmax= 1.2 mM) at ~20 minutes for white potato chips,
compared to ~30 minutes for pigmented potato chips (Cmax= 1.2 and 1.0 mM for red and
purple chips, respectively). Between 30 and 60 minutes, blood glucose concentrations for
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Table 3-4: Clinical parameters for each chip and cracker control.1,2

Cracker

Half
emptying
time (hr)3,4
1.5±0.1b

White 1

2.1±0.2a

2.1±0.2a

26.5±5.5b

85.9±11.3b

99.8±14.1b

Purple 1

2.0±0.2a

2.0±0.2a

25.2±3.7b

62.2±12.6b

76.0±14.1b

Red 1

2.1±0.2a

2.1±0.2a

24.5±2.6b

80.3±14.0b

93.5±14.4b

Sample

1

Lag phase
(hr)3

IAUC
(0-30 min)5

IAUC
(30-60 min)5

Total AUC
(0-120 min)5

1.5±0.1b

44.9±5.8a

159.2±27.1a

181.0±28.9a

Values represent mean ± standard error of mean from n=11 participants
Presence of different letter between values indicates significant differences gastric emptying parameters
between potato chips and crackers (p<0.05)
3
Half emptying time and lag phase were calculated using regression estimated constants in mathematical
formula from which a cumulative percentage dosage of 13C retained (CPDR) curve was fitted (Maes et al.
1994)38
4
Gastric half-emptying time (G1/2) determined excluding outliers (confirmed using Q-test). Without
correction, G1/2 was 6.1±4.0, 3.4±0.8, and 9.1±5.6 hrs for White 1, Purple 1, and Red 1 potato chips,
respectively.
5
Incremental AUC for blood glucose response following chip consumption was baseline corrected and
calculated for each potato tested by each participant using the trapezoidal method. Blood glucose data for
Participant 1 were outliers (confirmed using Q-test) and was therefore discluded from analyses.
2
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Figure 3-4: Baseline normalized blood glucose concentration (mM) following
consumption of either pigmented (red-Mountain Rose, purple-Purple Majesty) potato
chips, white potato chips and, in top figure, crackers. Data represent as blood glucose
concentration (mM) mean ± SEM for n=11 participants at each time point. Presence of
single asterisk and double asterisk indicate significant (p<0.05) difference in blood
glucose concentration following consumption of crackers compared to potatoes or
pigmented potato compared to white potato, respectively, within each timepoint.
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purple chips declined at a faster rate compared to red and white potato chips, and
maintained a significantly (p<0.05) lower blood glucose concentration at 60 min
compared to white chips. There were no significant differences in markers of gastric
emptying time including percentage dose of 13C recovered (PDR), cumulative percentage
dose of 13C recovered (CPDR), half-emptying time, lag phase, or gastric emptying
coefficient between the three chips (Tables B-3 and B-4, and Table 3-4).

3.5

Discussion

There is significant interest in understanding the potential for phenolics to modify
glycemic characteristics of consumer products including potatoes. Previous
investigations have reported the ability of plant phenolics, as extracts or individual
compounds, to modify both starch digestion and glucose intestinal transport in model
systems [19-24,33,38]. Results from in vivo studies suggest that these mechanisms may
translate to modified glycemic responses following consumption of phenolic-rich foods.
For example, plasma glucose concentrations 3 hrs post-consumption were lower for
volunteers that consumed both clear and cloudy apple juice (400 mL) rich in phenolics
compared to that of those that consumed phenolic-free drinks matched for sugar content
[39]. In another study, consumption of polyphenol-rich dark chocolate (20g daily, 500
mg total polyphenols) for 4 weeks significantly decreased fasting blood glucose levels
compared to low-phenolic placebo dark chocolate [40]. Additionally, interest in the
association between phenolic content of potatoes and GI has grown. Recent research
reported a significant inverse association between polyphenol content and GI of
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microwaved red and purple potatoes, and associated this effect with the inhibition of
starch digestion, specifically through inhibition of α-glucosidase [22]. In another study,
consumption of anthocyanin rich purple potatoes for 4 weeks did not impact fasting
blood glucose [41]. To better understand the impacts of consumer relevant pigmented
potato products on the acute glycemic response, we assessed the recovery of phenolics
through processing of potato chips from six phenolic-rich cultivars and determined the
ability of potato phenolics to mitigate starch digestion and rate of glucose transport across
Caco-2 human intestinal cells. We then completed a pilot study assessing the impact of
potato phytochemicals on the post-prandial glycemic response.
Consistent with previous reports, chlorogenic acids were the most abundant phenolic
species in all potato varieties [5-8]. Also in agreement with recent studies, pigmented
varieties contained higher chlorogenic acid concentrations compared to non-pigmented
white/yellow potatoes [22,42]. Here, levels of total anthocyanin pigments and individual
anthocyanin classes in red and purple potatoes were similar to those reported by Giusti et
al. [42], with petunidin and pelargonidin derivatives being dominant anthocyanins in
purple and red potatoes, respectively (Table 3-1). Bioactive compounds including
phenolic acids are commonly reported to be more concentrated in potato peel compared
to flesh [6,43,44]. It was therefore expected that peels would have a greater phenolic
content compared to potato flesh and whole potato for all six varieties. Total chlorogenic
acid and anthocyanin content were both generally 2-5x more concentrated in peel
compared to flesh on a dry weight basis (Table 3-1). This trend was most pronounced for
Yellow 1, which contained about 8x more total chlorogenic acids in the peel compared to
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flesh. These results are consistent with previous reports that potato peeling may
significantly reduce phenolic content especially for white and yellow varieties [6,43,44].
Potato chips are a snack food produced by high temperature frying. It is
commonly reported that phenolics in fruits and vegetables degrade with increased
temperature following first order kinetics, typical of Arrhenius behavior [27,44].
Therefore, it was anticipated that frying would be detrimental to phenolic profiles of
finished potato chips. Interestingly, no significant difference in chlorogenic acid or
anthocyanin content (mg/100g dry weight) was observed between raw potato flesh and
final chipped and fried potato (Figure 3-1), with the exception of red varietals including
Red 1 and Red 2. While commonly assumed to be extremely heat labile, phenolic
stability observed during the chipping process is generally in agreement with previous
studies reporting general stability for phenolics [45-47]. A possible reason for
preservation of phenolics following chipping and frying despite phenolic susceptibility to
degradation by high temperatures is that chipped potatoes are held at high temperatures
for a relatively short amount of time during the frying process, between 3 and 20 min
(Pedreschi et al. [48]). Further, the frying process is a dehydration process that results in
a low to intermediate moisture product that may be more favorable to stability against
oxidative reactions [49]. The apparent stability of anthocyanins and phenolics to chip
frying suggests that finished chip products would generally preserve phenolics from fresh
potatoes and therefore make them available to impact potential consumer health
outcomes.
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Considerable evidence exists that phenolics interact non-covalently with proteins,
including digestive enzymes [50-54]. However, in the present study only minor inhibition
of starch digestive enzymes, specifically α-glucosidases, was observed. One possibility
for this discrepancy with previous studies may stem from the nature of the assay for
amylase inhibition. Colorimetric methods such as the Red Starch method and the
dinitrosalicylic acid (DNS) method are commonly used for measurement of α-amylase
activity [51,52,55]. These indirect methods may be affected by background colors of
extracts and may result in over or under representation of inhibitory activity. In the
present study, HPAEC-ECD was utilized to quantify products of amylase digestion
directly and overall potato phenolics were not found to impact starch digestion by αamylase. On the other hand, α-glucosidase activity was significantly, but modestly,
decreased compared to control. However, the inhibitory effect observed in the present
study was only ~4 to 9% compared to ~30 to 40% inhibition by potato phenolics reported
by Ramdath et al. [22]. These results suggest that while variation may exist in potatoes,
observed correlations between phenolic profiles and glycemic response may not be
exclusively due to alteration of starch digestion in the GI, but also by another mechanism
including modulation of intestinal transport of glucose generated through digestion.
To address this, we investigated whether potato phenolics, when present at
physiologically relevant concentrations in the gut lumen (25-100 M), can modulate
glucose transport in a Caco-2 human intestinal cell model. Phenolic extracts obtained
from various plant extracts have previously demonstrated the ability to decrease glucose
transport across highly differentiated Caco-2 cell monolayers [23,24,38]. Results from
Caco-2 experiments suggest that PPEs from whole potatoes of all varieties decreased the
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rate of glucose transport and total glucose transport from apical to basolateral
compartments after 60 minutes compared to control media. Similar effects were observed
for peel PPEs, but this effect was modest compared to that observed for whole potato
extracts. Together, standardization of PPEs to deliver between 25 and 100 M and the
qualitative similarity between peel and whole potato (peel plus flesh) phenolic profile
would suggest a similar level of inhibition between extracts. The greater effect of whole
potato PPEs suggests that other factors from flesh beyond the phenolics assayed in this
study may be may be responsible, in part, for the observed inhibitory effects in glucose
transport by Caco-2 cells.
To determine if results from in vitro enzyme and Caco-2 models are predictive of
clinical responses, a clinical assessment of post-prandial blood glucose concentrations
and gastric emptying following consumption of potato chips produced from Purple, Red,
and White potato varieties was completed. Blood glucose concentrations at each time
point, and therefore mean blood glucose AUC, were significantly lower following
consumption of White, Red, and Purple chips compared to crackers. Further, gastric halfemptying time (hrs) and lag phase (hrs) were significantly longer for each chip compared
to cracker control. Increased fat content has been shown to decrease gastric emptying and
the blood glucose response [55]. Therefore, these results were expected as chips have
higher fat content compared to crackers.
We hypothesized blood glucose concentrations following consumption of
pigmented potato chips would be lower compared to white potato chips. Consistent with
pre-clinical enzymatic and Caco-2 cell culture assays completed here, effects of potato
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variety on glucose transport were modest. Still, among chips, results demonstrated that
blood glucose concentrations at 60 minutes post-consumption were significantly lower
for Purple chips compared to White chips. Further, glucose concentrations were slightly
increased from 60 to 120 minutes for Purple chips. This delay in response may be a result
of delayed carbohydrate digestion or glucose uptake. Alternatively, Red chips did not
differ compared to White chips. Considering that gastric emptying parameters were not
significantly different between varieties, these results support the notion that observed
effects are most likely associated with the inhibition of starch digestion and/or glucose
transport by potato phenolics rather than to rate of gastric emptying (Table 3-4).
Observations for phenolic-rich potato snack products produced using Purple Majesty,
Mountain Rose, and white potatoes are similar for those observed for baked potatoes of
the same varieties [22]. Similar to our results, the AUC blood glucose response and mean
glycemic index were not significantly different between potatoes. However, polyphenol
content did correlate inversely with the GI of potatoes. Taken together, it appears that
increased phenolic content in pigmented potatoes may slow intestinal glucose transport
compared to non-pigmented varieties. Ultimately, these results indicate pre-clinical in
vitro assays may also be valuable as tools for prediction of in vivo outcomes.

3.6

Conclusions

Potatoes contain appreciable concentrations of phenolics including chlorogenic
acids and anthocyanins, especially in pigmented varieties, which are well recovered
through chip processing. When present at physiologically relevant concentrations, potato
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phenolics modulated starch digestion to a limited extent and intestinal absorption of
glucose to a greater extent. Overall these results are in agreement with the observations
of changes in glycemic response from similar potatoes observed by Ramdath et al. [22].
These effects may be attributed to a combination of modest phenolic inhibition of the αglucosidases and perhaps more significant modulation of intestinal glucose transport.
The long term impact of such subtle changes in blood glucose by phenolic rich products
merits further evaluation.
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CHAPTER 4. CONCLUSIONS & FUTURE DIRECTIONS

4.1

Conclusions

Interest in the mechanisms through which phenolic-rich foods may positively
impact glycemic end-points has been driven by existing research connecting consumption
of phenolic-rich fruits and vegetables with a decrease in those endpoints. Several studies
have reported that phenolics may modulate glucose homeostasis through two key actions:
(1) inhibition of carbohydrate digestion and (2) modification of intestinal glucose
transport. Although several studies have observed inhibition of α-glucosidase enzymes
and, to a lesser extent, α-amylase activity, only few studies have evaluated the impact of
phenolic-rich extracts on glucose transport across the intestinal epithelium. Most of these
studies to date have relied on purified extracts or phenolics rather than complex foods and
beverages that have been associated with the actual benefits. Therefore, it remains
unclear if these mechanisms are translatable to the broader food matrices these phenolics
are included in.
The impact of phenolics from within the food matrix on starch digestibility and
intestinal glucose transport has not been clearly assessed. Considering that the food
matrix is very impactful to the digestive stability and bioaccessibility of phenolics, it
would not be surprising to see similar impacts to activities in the gut. Further, since
phenolic-rich foods are consumed as a snack or a meal mechanistic information
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supporting the bioactivity of bioaccessible phenolics from a fresh food must be placed in
the broader context of a meal. In the present series of studies, in vitro models and test
foods were leveraged to address these factors in a fashion that closely mimics in vivo
patterns. These experiments were then translated, in part, to a clinical paradigm.
The objective of the first study was to determine the ability of intrinsic phenolics from
100% Niagara or Concord grape juice (GJ) formulated with and without presence of a
starch-rich model meal to mitigate starch digestion and intestinal glucose transport
relative to a phenolic-free, sugar sweetened beverage. In this study, three juices were
sourced from Welch’s including Concord, Niagara and SO2 treated Niagara. All GJs
maintained similar levels of natural sugar (~16°Brix as glucose and fructose) and samples
were taken from 2 different harvest years (2013, 2014). Phenolic content,
bioaccessibility and glycemic modifying activities were assessed. Juices were rich in
phenolic acids and flavonoids, especially caftaric acid, caffeic acid, and quercetin. In
addition, Concord GJ was high in anthocyanins, primarily as cyanidin derivatives. While
phenolic levels were similar between juices, Concord GJ did contain the highest level of
phenolics. SO2 Niagara GJ contained higher levels of non-anthocyanin phenolics
compared to Niagara GJ, confirming that the addition of SO2 stabilized phenolic through
processing and storage.
Extracts of GJs were initially screened for their ability to inhibit α-amylase and αglucosidase activity and intestinal glucose transport across Caco-2 intestinal cell
monolayers. There is an abundance of information regarding the ability of plant-derived
phenolics to inhibit α-amylase and α-glucosidase activity in vitro [1–8]. Studies
completing α-glucosidase and α-amylase inhibition assays in parallel commonly observe
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significant inhibition of α-glucosidase and low or no phenolic inhibitory activity toward
α-amylase [3,5,4] . Similarly, results here showed GJ extracts (300 and 500 μM total
phenolics) significantly decrease α-glucosidase activity, but have little to no impact on αamylase activity. Although extent of enzyme inhibition was similar between varieties,
2013 harvest extracts generally decreased enzyme activity to a greater extent compared to
2014 harvest. Therefore, it can be hypothesized that variation in environmental
conditions between harvest years may have impact on phenolic profile and therefore alter
ability of plant-derived phenolics to inhibit α-amylase and α-glucosidase activity.
Although there is limited information for impacts of phenolics on in vitro
intestinal glucose transport, results from the current studies are in agreement with
existing evidence [9–11]. Specifically, each GJ extract (10 to 100 μM total phenolics)
decreased glucose transport compared to phenolic free control in an apparent dosedependent manner. Neither variety nor SO2 addition significantly impacted activity.
Collectively, results suggest that GJ phenolics in extract form have the ability to
decrease carbohydrate digestion and glucose transport in our model systems. To extend
these findings to whole juice matrices and to better understand the extent to which these
activities could be extended to more complex meals, further experiments were conducted.
100% Concord and Niagara GJs were formulated with and without starch-rich model
meals at different ratios and compared to phenolic free sugar matched control beverages.
Samples were digested using a three stage in vitro digestion model and the extent of
carbohydrate digestion and ultimate impact of aqueous digesta (AQ) containing
bioaccessible phenolics on glucose transport were assessed. Each GJ AQ decreased in
vitro digestion of starch leading to a similar release of glucose. These effects were
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consistent with the inhibitory activities observed through screening of GJ extracts.
Further, AQ digesta from GJ and GJ co-digested with a starch-rich model meal decreased
glucose transport compared to phenolic-free controls. As expected, phenolic impacts on
carbohydrate digestion and glucose transport were modest ranging from 3.8 to 11.5 and
4.8 to 21.4% inhibition, respectively. These results are nonetheless relevant considering
that only a ~6% increase in blood glucose level compared to normoglycemic postprandial blood glucose target may result in negative health effects, suggesting that even
subtle improvements to post-prandial blood glucose level may prevent development of
negative health outcomes (Hanefeld et al. 1999). Taken together, results from the first
study suggest that bioaccessible GJ phenolics may modulate glucose homeostasis by
reducing extent of carbohydrate digestion and intestinal glucose transport in the context
of foods containing high levels of intrinsic sugars and starch-rich foods. Further,
consumption of 100% GJ may result in decreased post-prandial glycemic response
compared with a sugar-sweetened beverage.
Although results from the first study are promising, in vivo data was not collected to
complement the in vitro data obtained. Clinical studies are critical components of
advancing the science of phenolics and providing a path to translate basic science to
consumer guidance and products that have physiological relevance. With this in mind, a
second series of studies were undertaken to parallel the juice work with phenolic rich
starch foods (potatoes) that included both preclinical and clinical components.
Potatoes are high-yielding and disease resistant vegetables, and are therefore an
important staple crop in the US. Importantly, potatoes are low in fat and high in fiber and
micronutrients including vitamin C, potassium and magnesium [12]. Additionally,
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potatoes contain high levels of dietary phenolics, primarily phenolic acids, anthocyanins
and flavan-3-ols, providing up to 20 mg of phenolics per serving [13–17]. Although
potatoes are important sources of nutritive and non-nutritive dietary compounds,
consumers are less aware of nutritional benefits of potatoes compared to their medium- to
high- glycemic status [18,19]. Therefore, more information on processing and breeding
conditions that may result in potato products with modified glycemic response is needed.
Six varieties of potatoes were received from PepsiCo including red, purple, and
white potatoes (2 varieties each). In the first set of experiments, a screening approach
similar to that conducted with juice samples was performed to assess the potential for
phenolics within potato matrices to modify starch digestive enzymes and glucose
intestinal transport in vitro. Phenolic profiles of potatoes and their processed products
(chips) were analyzed to determine if it may be possible that these activities can be
extended to phenolics in products that undergo chipping and frying process.
Consistent with literature, all potato varieties were rich in chlorogenic acids and
red and purple potatoes contained anthocyanins, with red potatoes containing high levels
of pelargonidins and purple potatoes containing high levels of petunidins [14–16,20,21].
As expected, phenolics were more concentrated in potato skin compared to flesh
[14,22,23]. However surprisingly, processing potatoes into potato chips did not
significantly alter phenolic content in finished product, with the exception of chlorogenic
acids from red potatoes. Previous work has shown that phenolics degrade at high
temperatures following first order kinetics, typical of Arrhenius behavior [23,24].
However, high recovery of potato phenolics through frying has been previously observed
[25] and suggest that a well-controlled process may allow for high recovery and delivery
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of phenolics in convenient and well accepted consumer snack form. This observed
stability may be due, in part, to the lower moisture content of chips compared to fresh
potatoes, resulting in improved phenolic stability to frying [26]. Results from enzyme
inhibition assays suggested whole potato extracts from each variety moderately decreased
α-glucosidase activity, however no effects were observed for α-amylase inhibition. This
is consistent with observations with grape phenolics. However, the inhibitory effect
achieved by potato phenolics in the present study was lower compared to that recorded
previously, reaching only ~4-9% inhibition compared to ~30-40% [27].
On the other hand, potato phenolics (25 to 100 µM) effectively inhibited glucose
transport by 16 to 98% compared to control. Interestingly, whole potato extracts had
increased ability to modulate glucose transport compared to potato peel extracts,
indicating there may be additional compounds present in whole potato that possess
glucose transport inhibitory activity that were not assayed in the current model. On the
other hand, there was no clear trend indicating the phenolic profile of a specific potato
variety has an enhanced influence on glucose transport compared to another.
Following completion of in vitro assays, a clinical assessment of three distinct
potato chip products containing different qualitative and quantitative phenolic profiles
was undertaken. Participants (n=11; randomized cross-over design) were recruited to
compare postprandial blood glucose levels at 10, 20, 30, 60, and 120 mins following
acute consumption of pigmented potato chips compared to white potato chips (50g
available carbohydrate each). Gastric emptying data was also obtained simultaneously. At
60 minutes, blood glucose levels were significantly lower for purple potato chips
compared to white potato chips. In addition, there was a trend for decreased postprandial
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blood glucose AUC (0 to 120 mins and 30 to 120 mins) following consumption of purple
compared to white potato chips. Gastric emptying rate was not different between
treatments suggesting differences in blood glucose levels are likely attributed to altered
carbohydrate digestion or intestinal glucose transport rather than to differences in gastric
emptying.
Each blood glucose curve had a unique shape, suggesting that each potato chip
influences carbohydrate digestion or glucose uptake at diverse rate or extent. Peak blood
glucose levels for Purple and Red potato chips were delayed compared to White potato
chips, peaking at 30 minutes. Further, Red potato chip peak blood glucose concentration
was higher compared to Purple potato chips. Interestingly, Purple potato chip blood
glucose level declined from 30 to 60 minutes, and then slowly increased over the next
hour. Results indicate delayed postprandial carbohydrate digestion or absorption
following consumption of pigmented potato chips compared to white potato chips.
Observations for phenolic-rich potato snack products produced using Purple Majesty,
Mountain Rose, and white potatoes are similar for those observed for baked potatoes of
the same varieties [27]. Similar to our results, while AUC for blood glucose response was
not significantly different between baked Purple Majesty, Mountain Rose, and white
potatoes, polyphenol content did correlate inversely with potato GI.
Overall, results from these studies suggest that consumption of phenolic-rich
foods and drinks may modestly impact blood glucose levels through their ability to
modify starch digestion and glucose transport. Moreover, favorable effects appear to be
maintained in the presence of a complex, starch-rich meal. The main effects also appear
to be through inhibition of α-glucosidase activity, but not α-amylase activity, and through
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modification of intestinal glucose transport. Importantly, results indicating phenolic
modulation of carbohydrate digestion and glucose absorption obtained using the coupled
in vitro digestion/Caco-2 model were somewhat predictive of clinical outcomes in a study
using a finished consumer good as the phenolic-rich source. Therefore, while modest, it
appears that phenolic rich foods may in fact be responsible for improved control of blood
glucose from a food and these effects may be translatable to a broader meal. These data
suggest that strategies can be implemented to leverage these activities and generate
improved glycemic profiles for starch/sugar rich foods.

4.2

Future Directions

While results from the present study and previous studies show phenolic-rich
apple, baked pigmented potatoes, and pigmented potato chips moderately alter postprandial glycemic response compared to low phenolic matched controls, they may be
underpowered (n=9 to 11). Similar studies investigating hypoglycemic effects of
phenolic-rich foods should use these pilot studies to determine statistical power for larger
scale clinical trials. In addition to impacts on post-prandial glycemic response,
information must be obtained concerning the influence chronic consumption of phenolicrich foods may have on resting blood glucose levels. Thus far, lowered resting blood
glucose levels following consumption of Concord GJ was observed as a secondary
outcome from a study completed by Dohadwala et al. [28].
In addition to specific study designs and outcomes that require implementation, a
larger variety of phenolic-rich foods need to be evaluated to better understand the extent
to which various phenolic classes and food matrix components impact hypoglycemic
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effects. For example specific fruits, vegetables, and herbs generally differ with regards to
the dominant phenolic class. Colored fruits and vegetables contain high anthocyanin
levels; tea, apples and cocoa are rich in flavan-3-ols; parsley, celery, and millet contain
flavones; onions and kale are the richest sources of flavonols; and oranges and grapefruit
are rich in flavanones [17,29–31]. It will be important to determine which phenolic
classes, and therefore which specific foods, may have greatest influence on blood glucose
levels.
Although it is important to obtain information about influences of specific
phenolic-rich foods on glycemic response, these individual foods are commonly
consumed as part of a meal. Evidence exist suggesting phenolics interact with food
matrix carbohydrates and protein (reviewed by Bordenave et al. [31]). Importantly, these
interactions alter the availability and bioactivity of phenolics in the gut. Therefore, pilot
clinical studies should be completed to validate in vitro results and to provide information
as to what degree various types of meal patterns alter glycemic effects of phenolic-rich
foods. Larger clinical studies must then be planned accordingly to achieve results with
increased power.
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Appendix A

Supplementary Material for Chapter 2

Table A-1: Glucose transport by Caco-2 small intestinal epithelial cells co-treated with sugar solution (Glu and Fru (9mM each), d7Glu and d7-Fru (3mM each) and phenolic extract from grape juice or phenolic-free control.1,2,3
Treatment

Phenolic
Concentration
[μM GAE]4

Percent (%) d7-Fru Transport

Percent (%) d7-Glu Transport

Percent (%) d7-Fru
Transported over 60 min
Relative to Control

Percent (%) d7-Glu
Transported over 60 min
Relative to Control

Control (24mM Glucose/Fructose)

0

2.8±0.2a

3.4±0.3a

100a

100a

Niagara, 2013 extract

SO2 Niagara, 2013 extract

Concord 2013 extract

Niagara, 2014 extract

SO2 Niagara, 2014 extract

a,b

10

2.5±0.2

50

2.0±0.1c
b,c

2.8±0.2

a,b

2.4±0.04b
b

89.5±5.8

a,b

72.0±2.0c

71.5±1.0b,c

b,c

66.5±4.0c

100

2.1±0.1

2.3±0.1

10

2.5±0.1a,b

3.0±0.2a,b

88.3 ±4.6a

88.3 ±3.0a

50

1.9±0.1b

2.8±0.1b,c

68.3 ±3.0b

83.0 ±2.7a,b

b

c

73.9±4.0

82.3±5.9a,b

70.3 ±3.9b

100

2.0±0.1a

2.4±0.1

10

2.1±0.2b

2.9±0.2a

74.8±6.1b

84.6±4.7a

50

b

2.2±0.1

3.1±0.2

a

b

89.2 ±5.8a

100

2.0±0.2b

2.8±0.2a

69.1±6.4b

82.3±6.0a

10

2.3±0.1a,b

3.0±0.1a

85.55±5.4a,b

95.3±2.6a

50

a,b

2.1±0.2

3.0±0.2

a

100

1.6±0.3b

2.4±0.4a

58.7 ±12.4b

77.8 ±12.4a

a

a,b

89.7±1.6a,b

76.7±7.3b,c

86.0±6.0a,b

a,b

10

2.3±0.1

50

2.0±0.2b,c

2.7±0.2a

78.9±6.3
87.1±2.7

a,b

95.2±6.8a

64.3±9.1b

a

94.2±5.9a

50
2.2±0.1a
2.8±0.1a
81.7±5.6a
a
a
100
2.2±0.2
2.7±0.2
81.9±8.4a
1
d7-Glucose and d7-fructose (3mM) were used as markers for glucose transport.
2
Data represent an average of n=4 wells per experiment.
3
Presence of different letter between values indicates significant differences in glucose transport within treatment and compared to control (p<0.05).
4
Total phenolics in digesta determined using Folin-Ciocalteu assay, reported as gallic acid equivalents (GAE).

89.0±2.4a
85.8±7.0a

10
Concord, 2014 extract

1.6±0.1

a

2.4±0.1

2.0±0.3

b

77.9 ±3.9

c

100

c

2.8±0.1

70.5 ±4.8

b

2.9±0.2

a

59.6±3.6

89.1 ±5.4
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Table A-2: Relative (%) bioaccessibility of marker phenolics and anthocyanins in Concord, 2013 grape juice co-digested with a model
meal.1,2
Phenolic Bioaccessibility (%)
Gallic Acid

Caffeic Acid

Caftaric
Acid

Epicatechin

Quercetin 3O-glucoside

Quercetin-3,4diglucoside

Quercetin

Isorhamnetin

Piceid

Resveratrol

41.8±2.3a

63.1±6.3a

40.3±3.1a

8.8±1.3b

4.6±0.9a

2.2±0.1b

4.0±0.1b

5.7±0.4a

0.8±0.1c

1.5±0.2c

1:2 Concord:Model
meal
1:2 Concord: Model
meal
1:2 Concord:Water

19.5±1.4c

31.1±2.9c

14.7±1.7b

4.1±0.2c

1.3±0.1b

0.4±0.1d

2.0±0.2d

5.1±1.4a

0.5±0.05d

0.8±0.1d

33.8±1.2b

47.1±1.4b

15.5±0.5b

17.1±0.3a

5.1±0.2a

5.0±0.02a

6.7±0.1a

2.5±0.1b

1.9±0.04a

3.5±0.1a

1:2 Concord:Water

16.0±0.6c

21.7±0.9c

5.6±0.4c

7.5±0.2b

1.3±0.02b

1.5±0.1c

4.3±0.2c

1.0±0.02b

1.2±0.04b

1.9±0.2b

Anthocyanin Bioaccessibility (%)
Cyanidin-3,5-Odiglucoside
1:2 Concord: Model
meal
1:3 Concord: Model
meal
1:2 Concord:Water
1:2 Concord:Water

Delphinidin-3-Oglucoside

b

20.3±1.2

11.4±1.1c

10.7±1.1c

30.1±1.8a
14.9±0.4b,c

17.9±1.4

b

Peonidin-3,5-Odiglucoside

a

Petunidin-3-Oglucoside

Malvidin-3-O-glucoside

19.1±4.2

19.7±4.6

b

31.3±2.4b

4.9±0.3d

11.4±1.7a,b

12.8±1.3b

16.4±1.2c

39.6±0.5a

27.7±1.6a

15.4±0.9a,b

39.5±1.4a

46.1±3.1a

22.6±0.1b

12.4±0.8c

6.7±0.3b

18.5±0.6b

23.8±0.2b,c

21.2±1.7

b

Delphinidin-3-O-pcoumaroylglucoside

1

Values represent mean ± standard error of mean from a triplicate analysis
Presence of different letter between values indicates significant differences in concentration of phenolic class between grape juices (p<0.05)
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Modulation of Caco-2 glucose/fructose transporter gene expression by GJ phenolic
extracts
Cells and experimental conditions for gene expression experiment were maintained
and executed according to glucose transport experiments, with minor modifications. Test
media was prepared by solubilizing glucose and fructose (12mM each) and GJ phenolic
extracts in PBS pH 5.5 (delivering 50 µM total phenolics). Test media was applied to the
apical surface of cell monolayers and cells were incubated for 4 or 24 hours. Cells were
collected with RNAlater (Sigma-Aldrich) and frozen until analysis. Treatments were
replicated in quadruplicate.
Characterization of mRNA expression and anthocyanin-rich fractions by LC-MS
Total RNA was isolated from the cultured cells using TRIzol® (Invitrogen™ Life
Technologies, Paisley, UK) according to the manufacturer's instructions. RNA
concentration was measured using wavelength of 260 and 280 using a NanoDrop 2000
UV-Vis Spectrophotometer (Thermo Scientific.) Following first strand cDNA synthesis,
expression levels of glucose transporter mRNA and GAPDH mRNA (used as a
housekeeping gene) were analysed by real-time quantitative PCR using an ABI Prism
7700HT Sequence Detection System and a Power SYBR® Green PCR master mix kit
(Applied Biosystems™ Cheshire, UK). The primer sequences used for each gene are
given in Supplemental Table 3. cDNA was then synthesized from 150 ng RNA using MMuLV reverse transcriptase (BioLabs, Ipswich, MA). Real-time q-RT-PCR was
performed using a CFX Connect Real-Time PCR Detection System (BioRad). The
expressions of SGLT1 and GLUT2 were evaluated and the expression of housekeeping
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gene β-actin was assessed. The primer sequences used for each gene are given in
Appendix Table A3.

Table A-3: Forward and reverse PCR primer sequences utilized for gene expression
analysis
by PCR1.
mRNA target

Oligonucleotides (5’ → 3’)
F: TGGCAATCACTGCCCTTTA

SGLT1
R: TGCAAGGTGTCCGTGTAAAT
F: GTCCAGAAAGCCCCAGATACC
GLUT2
R: GTGACATCCTCAGTTCCTCTTAG
Β-actin

F: TCCTATGTGGGTGACGAGGC
R: CATGGCTGGGGTGTTGAAGG

1

F indicates forward primer, R indicates reverse primer.
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Figure A-1: Impact grape juice phenolic extract (50μM) treatment (4 or 24 hours) has on
Caco-2 expression of SGLT1 or GLUT2 compared to phenolic-free control. Data is
represented as protein expression compared to control β-actin. Data represent mean ±
SEM for n=4 replicate wells. Presence of different letter between values indicates
significant differences in protein expression between treatments within each time point
(p<0.05).
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Appendix B

Supplemental Material for Chapter 3

Table B-1: Glucose transport by Caco-2 small intestinal epithelial cells treated with 6mM glucose (control) or co-treated with 6mM
glucose and phenolic extract from whole potato and potato peel.1,2
Whole potato

Sample
Control (6mM
Glucose)
Purple 2

Purple 1

Red 1

Red 2

Yellow 1

White 1

Potato Peel

Phenolic
Concentration
[µM]

Rate of d7Glucose
Transport
(mmol/min)

Percent d7Glucose
Transport3

Percent (%) d7-Glu
transported over 60
min relative to
Control4

Rate of d7Glucose Transport
(mmol/min)

Percent d7Glucose
Transport3

Percent (%) d7-Glu
transported over 60
min relative to
Control4

0

2.98

6.1±0.2a

100a

0.97

2.9±0.09a

100a

25
50
100

1.94
1.95
1.64

4.5±0.1c
4.4±0.2c
3.7±0.0b

62.8±0.02b
64.3±0.04b
53.4±0.02b

0.74
0.60
0.51

2.3±0.07c
1.8±0.06b,c
1.5±0.06b

74.7±0.03d
59.3±0.03c
48.5±0.02b

25
50
100

2.21
1.00
0.81

4.9±0.09c
2.1±0.08b
1.9±0.07b

117.8 ±0.05c
55.6 ±0.10b
46.6 ±0.08b

0.63
0.68
0.64

1.7±0.16b
2.0±0.07c
1.8±0.05b,c

70.2 ±0.07b
79.3 ±0.04b
74.5 ±0.03b

25
50
100

1.46
0.47
0.51

4.3±0.7c
1.3±0.04b
1.4±0.06b

50.0±0.10c
15.9 ±0.01b
16.4±0.01b

0.81
0.70
0.70

2.3±0.41a
2.3±0.13a,b
1.9±0.07b

93.2±0.17a,b
81.0 ±0.05b
81.2±0.04b

25
50
100

1.63
1.04
1.00

3.3±0.5a
2.1±0.1b
2.4±0.2b

78.3±0.14c
51.8±0.04b
50.3 ±0.04b

1.08
1.12
1.05

3.1±0.58a
3.1±0.05a
3.0±0.08a

97.9±0.18a
95.10.04a
88.2 ±0.04a

25
50
100

0.66
0.54
0.55

7.7±0.5c
6.1±0.2b
5.9±0.2b

54.0±0.03c
44.2±0.02b
43.5±0.02b

0.96
0.82
0.69

2.9±0.07a
2.3±0.04c
1.8±0.16b

96.5±0.03a
78.9±0.02b
64.8±0.06b

25
50
100

1.43
1.10
1.09

4.4±0.2b
3.4±0.2c
3.6±0.1b,c

45.7 ±0.03c
35.6±0.02b
36.2±0.02b,c

0.78
0.80
0.70

2.1±0.01a,b
2.4±0.08c
2.0±0.03b

75.7 ±0.03b,c
80.1±0.04c
67.6±0.03b

1

d7-Glucose (2mM) was used as a marker for glucose transport.
Data represent an average of n=4 wells per experiment.
3
Percent of d7-glucose transported from apical media to basolateral compartment.
4
Amount of glucose transported basolaterally over 60 minutes relative to daily control matched for glucose (6mM) and d7-glucose (2mM).
2
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Table B-2: Content of individual phenolics (µmol/28g serving) and anthocyanins (nmol/28g serving) in 3 types of potato chips.1,2,3
Phenolic Content (µmol/28g serving)
Potato Variety

3-O-CQA

4-O-CQA

4.1±0.03

c

3.9±0.01

c

Purple 1

13.8±0.2

a

11.1±0.2

a

Red 1

9.9±0.5b

White 1

8.2±0.6b

5-O-CQA
5.8±0.2

Caffeic Acid

b

37.4±0.7

3.0±0.1

a

c

16.8±0.3c

a

82.3±1.4a

14.7±0.8b

65.3±4.2b

19.9±0.5

32.6±2.4a

Total Phenolics

Anthocyanin Content (nmol/28g serving)
Potato Variety

Total
Cyanidins

Total Peonidins

Total
Delphinidins

Total Petunidins

Total Malvidins

Total
Pelargonidins

Total
Anthocyanins

Purple 1

NC

16.6±0.04b

164.0±4.0a

265.1±12.0a

125.9±4.1a

49.4±1.0b

621.0±10.3b

Red 1

470.9±6.4a

20.7±1.4a

77.8±0.8b

ND

74.3±1.7b

1243.1±37.8a

1886.7±46.7a

1

Values represent mean ± standard error of mean from a triplicate analysis
ND = Non Detected
3
Presence of different letter between values indicates significant differences in concentration of phenolic class between potato chips (p<0.05)
2
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Table B-3: Percent (%) dose 13C recovered at every 15 minute sampling interval, up to 240 minutes.1,2
Percent Dose Retained (%) (sampling interval (min))
Sample

15min

30min

45min

60min

75min

90min

105min

120min

Cracker

24.2±4.4 a

29.9±2.6 a

26.4±2.2 a

24.1±1.8 a

21.2±1.5 a

18.9±1.4 a

16.6±1.3 a

14.3±1.2 a

White 1

19.7±3.6 a,b

22.6±2.9 a,b

21.0±2..7 a,b

20.3±2.4 a,b

18.0±2.2 a,b

16.6±2.1 a,b

15.5±2.0 a

14.3±1.9 a

Purple 1

15.6±3.5 a,b

20.4±2.9 b

19.0±2.5 b

17.0±2.2 b

15.8±1.9 b

14.5±1.7 a,b

13.4±1.5 a

12.9±1.4 a

Red 1

13.0±3.6 b

18.5±2.5 b

16.8±2.2 b

15.1±2.0 b

14.0±1.8 b

13.3±1.6 b

12.1±1.5 a

11.0±1.3 a

Percent Dose Retained (%) (sampling interval (min))
Sample

135min

150min

165min

180min

195min

210min

225min

240min

Cracker

12.5±1.0 a

11.4±1.1 a

9.9±0.9 a

8.8±0.9 a

7.5±0.9 a

6.5±0.7 b

5.8±0.7 b

4.7±0.6 b

White 1

13.5±1.7 a

12.9±1.7 a

12.1±1.6 a

11.4±1.5 a

10.4±1.5 a

10.0±1.4 a

8.9±1.3 a

8.3±1.3 a

Purple 1

12.3±1.3 a

11.4±1.3 a

11.5±1.2 a

10.8±1.0 a

10.5±1.0 a

10.3±0.9 a

9.1±0.9 a

8.7±0.8 a

Red 1

10.3±1.3 a

10.1±1.3 a

9.6±1.0 a

9.3±1.0 a

8.2±0.9 a

8.2±0.9 a,b

7.6±1.0 a,b

7.1±1.0 a,b

1

1

Values represent mean ± standard error of mean from n=11 participants
Presence of different letter between values indicates significant differences in concentration of phenolic class between potato chips and crackers (p<0.05)
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Table B-4: Cumulative Percent (%) dose 13C recovered at every 15 minute sampling interval, up to 240 minutes.1,2
Cumulative Dose Retained (%) (sampling interval (min)
Sample

15min

30min

45min

60min

75min

90min

105min

120min

Cracker

3.0±0.6a

9.8±1.4 a

16.8±1.9 a

23.1±2.4 a

28.8±2.7 a

33.8±3.0 a

38.2±3.3 a

42.1±3.6 a

White 1

2.5±0.4a,b

7.8±1.2 a,b

13.2±1.8 a,b

18.4±2.4 a,b

23.2±2.9 a,b

27.5±3.4 a,b

31.5±3.9 a,b

35.2±4.3 a,b

Purple 1

1.9±0.4 a,b

6.4±1.2a, b

11.4±1.8 b

15.9±2.3 b

20.0±2.8 b

23.8±3.1 b

27.2±3.5 b

30.5±3.8 b

Red 1

1.6±0.5 b

5.6±1.1 b

10.0±1.5 b

14.0±2.0 b

17.6±2.4 b

21.0±2.8 b

24.2±3.1 b

27.1±3.4 b

Cumulative Dose Retained (%) (sampling interval (min)
Sample

135min

150min

165min

180min

195min

210min

225min

240min

Cracker

45.5±3.8 a

48.5±4.0 a

51.1±4.1 a

53.5±4.3 a

55.5±4.5 a

57.2±4.6 a

58.8±4.8 a

60.1±4.9 a

White 1

38.7±4.7 a,b

42.0±5.1 a,b

45.1±5.5 a,b

48.1±5.8 a,b

50.8±6.1 a,b

53.3±6.4 a,b

55.7±6.6 a,b

57.9±6.9 a

Purple 1

33.7±4.0 b

36.7±4.2 a,b

39.5±4.4 a,b

42.3±4.6 a,b

45.0±4.8 a,b

47.6±4.9 a,b

50.0±5.1 a,b

52.2±5.3 a

Red 1

29.7±3.7 b

32.3±4.0 b

34.8±4.2 b

37.1±4.4 b

39.3±4.5 b

41.4±4.7 b

43.3±4.9 b

45.2±5.0 a

Values represent mean ± standard error of mean from n=11 participants
Presence of different letter between values indicates significant differences in concentration of phenolic class between potato chips and crackers (p<0.05)
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IRB Narratives for Chapter 3
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Institutional Review Board
1. Project Title:

Post-prandial glucose response from phytochemical rich potato

products
2.
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3.
4.

Anticipated Funding Source: Internal and/or Pepsico Global
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5. Co-investigators and key personnel [See Education Policy for Conducting Human
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Consultants [See Education Policy for Conducting Human Subjects Research]:
Name and Title Department, Building, Phone, FAX, E-mail address
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application and to promptly report to the Institutional Review Board any proposed
changes and/or unanticipated problems involving risks to subjects or others participating
in the approved project in accordance with the HRPP Guideline 207 Researcher
Responsibilities, Purdue Research Foundation-Purdue University Statement of
Principles and the Confidentiality Statement. The principal investigator has received a
copy of the Federal-Wide Assurance (FWA) and has access to copies of 45 CFR 46 and
the Belmont Report. The principal investigator agrees to inform the Institutional

_

Page
146

147
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terminate University association.
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8.
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APPLICATION TO USE HUMAN RESEARCH SUBJECTS
9. This project will be conducted at the following location(s): (please indicate city &
state)
Purdue West Lafayette Campus
=
Purdue Regional Campus (Specify):
Other (Specify):
10.
If this project will involve potentially vulnerable subject populations, please
check all that apply.
Minors under age 18
Pregnant Women
Fetus/fetal tissue
Prisoners Or Incarcerated Individuals
University Students (PSYC Dept. subject pool ___)
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Economically/Educationally Disadvantaged Persons
Mentally/Emotionally/Developmentally Disabled Persons
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Intervention(s) that include medical or psychological treatment
11.

Indicate the anticipated maximum number of subjects to be enrolled in this protocol as
justified by the hypothesis and study procedures: 12

12.

This project involves the use of an Investigational New Drug (IND) or an Approved
Drug For An Unapproved Use.
YES
NO
Drug name, IND number and company:

13.

This project involves the use of an Investigational Medical Device or an Approved
Medical Device For An Unapproved Use.
YES
NO
Device name, IDE number and company:

14.

The project involves the use of Radiation or Radioisotopes:
YES
NO

15.

Does this project call for: (check-mark all that apply to this study)
Subject Compensation? Please indicate the maximum payment amount to
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Purdue’s Human Subjects Payment Policy
Participant Payment Disclosure
Form
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More Than Minimal Risk?
Waiver of Informed Consent?
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Extra Costs To Subjects?
The Use of Blood?

16.

Total Amount of Blood
<5mL
Over Time Period (days) 35 days
The Use of rDNA or Biohazardous materials?
The Use of Human Tissue or Cell Lines?
The Use of Other Fluids that Could Mask the Presence of Blood (Including Urine
and Feces)?
The Use of Protected Health Information (Obtained from Healthcare Practitioners
or Institutions)?
The Use of academic records?
Does investigator or key personnel have a potential financial or other conflict of interest
in this study?
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APPLICATION NARRATIVE
A.

PROPOSED RESEARCH RATIONALE
Potatoes are a rich source of phenolic compounds that have been hypothesized to
have the ability to modulate carbohydrate digestion and metabolism leading to
reduced glycemic response. An inverse correlation between polyphenol content of
potatoes and glycemic index (GI) has been observed with select boiled purple and
red potatoes rich in phenolic antioxidant pigments (anthocyanins). In alignment
with these finding, we have shown through a series of preliminary studies that
potato phenolics may have a more pronounced effect on glucose intestinal transport
as compared to starch digestion. This effect was more pronounced for extracts
generated from anthocyanin rich purple and red potatoes relative to white potatoes.
These preliminary results suggest that a reduced post-prandial glycemic response
might be expected from certain types of potato products and that phenolic
antioxidants may play a critical role in predicting the physiological response from
potato products.
To better understand how potato product characteristics, specifically phenolic
antioxidant content and profile, may alter post-prandial glycemic response, the
proposed study will focus on assessment of glycemic response from consumer
relevant products (chips) produced from commercially available antioxidant rich
potato cultivars (Purple Majesty and Mountain Rose). We will test the hypothesis
that chipped potato products with a higher content of phenolics and specifically
anthocyanins (red and purple pigments) will have a reduced glycemic response.
Specifically, we will assess modified glycemic response from a serving of chipped
potato products through capillary glucose monitoring. Glycemic profiles will be
related to gastric emptying rate through a 13C breath test and phenolic content.
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B.

SPECIFIC PROCEDURES TO BE FOLLOWED
General Protocol:
Potential participants will respond to public advertisements (attached) and will also
be asked to complete a questionnaire on the Laboratory for Sensory and Ingestive
Studies website (IRB approval#504002017). Those meeting initial screening
criteria will be required to sign the consent form (attached).
The entire study will consist of four five-hour sessions with a one week washout
period between each treatment, where subjects will consume one of three
commercial potato chip products or a white bread control. Participants will report
to the laboratory after a ten hour overnight fast. Initially a capillary blood sample
will be collected from a blood drop (~1-10uL) collected by finger tip stick.
Samples will be collected by clinical staff Judy George or Robin Rhine who are
trained in collection and processing of such samples. Following this, the participant
will ingest either 100g of potato chips or a white bread control along with a calorie
free beverage containing 100 mg [13C] labeled-octanoic acid as a marker that will
be detected through breath samples to measure the rate of gastric emptying.
Octanoic acid is a generally recognized as safe (GRAS) food substance (21 CFR
184.1025), and is a food additive permitted for direct addition to food for human
consumption. Further, in 21 CFR 172.860, it is stated that “Octanoic acid is a food
additive permitted for direct addition to food for human consumption, as long as 1)
the quantity of the substance added to food does not exceed the amount reasonably
required to accomplish its intended physical, nutritive, or other technical effect in
food, and 2) any substance intended for use in or on food is of appropriate food
grade and is prepared and handled as a food ingredient”. [13C]-labeled octanoic acid
is a commercially available standard tracer used (100 mg) in human breath tests to
measure gastric emptying rates. [1, 2] Breath samples will be collected in 300 ml
bags every 15 min for four h from the time they finish consuming the potato chip.
Subjects will be instructed to consume all of the potato given to them. No other
food or drink will be allowed during the remainder of the test session.
Additional capillary blood samples will be collected at 10, 20, 30, 60 and 120
minutes for glucose assessment. The total amount of blood collected will not exceed
5mL during the course of the study.
The rate at which the test materials are emptied from the stomach will be
determined using a 13CO2 Urea Breath Analyzer POCone (Otsuka Electronics Co,
Ltd, Osaka, Japan). We have previous experience with both breath test methods
(IRB Protocols # 1102010450, 04/09/2011 and # 1104010761, 05/24/2011). The
Hamaker group has previous experience using the [13C] octanoic acid breath test
method for gastric emptying assessment (IRB Protocols # 1102010450, 04/09/2011
and # 1104010761, 05/24/2011).
Study Samples:
Test foods will consist of commercial potato made from different potato cultivars or
white bread control. Chips will have a defined composition of potatoes and oil and
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will provide a natural range of polyphenolic compounds estimated to be 20-300
mg/100g.
Data collection:
In addition to descriptive information (gender, height, weight, age, BMI), blood
glucose response, [13C] breath recovery, gastric emptying time, and breath hydrogen
recoveries will be determined

C.

SUBJECTS TO BE INCLUDED
Twelve healthy adult subjects (6 M and 6F) will be recruited to participate in this
study. Other inclusion and exclusion criteria include:
Inclusion Criteria:
BMI 18.5 - 25 kg/m2
18-50 years
Stable weight for the past 3 months i.e. +/- 2.5 kg
Exclusion Criteria:
Gastrointestinal disease
Smokers
Peri- or post-menopausal women
Following a weight reduction program or having followed one during the last 3
months
Acute or chronic disease
Alcohol consumption > 30 units/week
Hypertension
Diabetes
Previous bariatric surgery
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D.

RECRUITMENT OF SUBJECTS AND OBTAINING INFORMED
CONSENT
Subjects will be recruited using flyers posted around campus. Interested individuals
will be prescreened in person for verification of qualifying physical criteria. These
individuals will be given an overview of the study and the test procedures for breath
collection and blood sampling. Informed consent forms will be signed by qualified
subjects who choose to participate in the study. Individuals that are found not to
meet the requirements of the study during the prescreening process will not be
allowed to participate and will not receive compensation.

E.

PROCEDURES FOR PAYMENT OF SUBJECTS
Subjects will receive compensation for their time and compliance with test
procedures. Subjects will be paid at a rate of approximately $10/hr for their time
and commitment to the study. We plan on paying each subject $250 in full after
completion of the study. All subjects will fill out and sign a payment log with the

_

Page
151

152
Department of Food Science business office. Subjects who do not complete all five
treatment sessions will receive a prorated payment. Non-resident subjects will be
required to complete additional payment procedures via the Purdue Glacier system.
F.

CONFIDENTIALITY
The records of subjects’ self-reported prescreening information and their progress
in the study will be kept in a confidential file in a locked filing cabinet in a secure
location on the Purdue Campus. A copy of the subject consent form, prescreening
information, and their progress will be retained for at least three years after
termination of the study and will be accessible to the principal investigator and
researcher. At that time, they will be destroyed. The confidentiality of any computer
record will also be carefully guarded by never including subjects’ names on any
data file. The information will be stored electronically on a password-protected
computer file. No information by which subject can be identified, such as names,
will be published. Names of subjects on all records will be de-identified by
replacing names with numerical codes.
In the case that subjects’ information can be beneficial in further research purposes,
subjects will be notified and their permission to use the current study’s information
will be requested.

G.

POTENTIAL RISKS TO SUBJECTS
There is a minor risk associated with all research. The standard for minimal risk is
that found in everyday life. In addition there is minor risk of a breach of
confidentiality pertaining to the information gathered from the subjects. However,
all information and records of subjects will be locked in a secure location on the
Purdue campus, and safeguards are in place for data security as described in Section
F. Any record saved electronically will not contain names of subjects and the
computer will require secure passwords to log in and gain access to the files.
Additionally, there is slight risk of infection at the sites of blood collection and
transient discomfort with the finger stick required to obtain a blood sample.

H. BENEFITS TO BE GAINED BY THE INDIVIDUAL AND/OR SOCIETY
There are no direct benefits to the subjects from their participation in this study.
The results of this study will help us to understand the effects of slow release of
glucose in the body and the role food derived phenolic compounds may play in
modulating this response. This may help to decrease the risk of chronic diseases
like diabetes.

I.
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INVESTIGATOR’S EVALUATION OF THE RISK-BENEFIT RATIO
The risk associated with participation are comparable to those associated with a
routine blood test. While there are no direct benefits to participants, the findings
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should provide insight into how dietary phenolics may help to modulate blood
glucose response and risk for diabetes and obesity.
J.

WRITTEN INFORMED CONSENT FORM
The approved copy of the Consent Form will be stamped with the IRB’s approval
and returned to us for use. This approved consent form will be given to the subjects
to read and understand the purpose of the study before signing it. Only the subjects
that want to participate will sign and date the form.

K.

SUPPORTING DOCUMENTS
●
●
●

Recruitment flyer
Medical History Questionnaire
Written consent form

Reference:
1. "Octanoic Acid | C8H16O2 - PubChem." Octanoic Acid | C8H16O2 - PubChem.
N.p., n.d. Web. 05 Mar. 2015.
2. Perri, F., M. R. Pastore, and V. Annese. "13C-octanoic acid breath test for
measuring gastric emptying of solids." Eur Rev Med Pharmacol Sci 9.5 Suppl 1
(2005): 3-8.
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Appendix E

Screening Form for Chapter 3

Screening Sheet Potato Study
Criteria:
BMI: 18.5-25
Age: 18-50
Non Smoker

Name: _____________________

Participant Number:

_________
Gender: _________
DOB: __________

Age: ________

Email: _____________________________
Smoker Status: _____________
Race: __________
Height: _________
Weight: ________
Tanita:
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Appendix F

Consent Form for Chapter 3

RESEARCH PARTICIPANT CONSENT
FORM
Glucose response from antioxidant rich
potato chips Principal Investigator: Mario
G. Ferruzzi, PhD. R.D. Department of
Food Science, Nelson Hall
Pur
due
Universi
ty West
Lafayett
e, IN
47907
(765) 494-0625

What is the purpose of this study?
There is considerable interest in how antioxidants in fruits and
vegetables may help control blood glucose and provide health benefits
(e.g., reduced risk of diabetes, obesity and cardiovascular disease).
Potatoes are a rich source of both carbohydrate (as starch) and
antioxidant compounds. While assumed to be high in glycemic
response, the antioxidants in potatoes may modify the ability of the
body to digest the starch and ultimately slow the absorption of the
glucose. Considering there are several varieties of potatoes with higher
levels of antioxidants, there are questions about whether use of these
high antioxidant potatoes in production of common snack foods, such
as chips, can improve the glycemic response of potato snacks. It is also
possible that the higher antioxidants may slow rate at which foods are
digested. The influence of each of these factors will be explored.
What will I do if I choose to be in this study?
To confirm your eligibility for this study, you must first read this
consent form and ask any questions you may have about
participation.You will report to the Laboratory for the Study of
Sensory and Ingestive Studies in Stone Hall after a 10 hour fast on five
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separate occasions. A blood sample (one drop) will be collected by
finger prick (a small lancet will be inserted into a finger) and you will
ingest a sample consisting of potato chips or white bread along with a
calorie free beverage. Another blood sample will then be collected by
finger prick. Additional blood samples will be collected at 10, 20, 30,
60, and 120 minutes. You will also be
asked to rate the palatability of the sample and your mood over the day.
Testing will be conducted one week apart.

How long will I be in the study?
This study will require five visits, about 5 hours per visit, over a five week period.
What.are the possible risks or discomforts?
. All research has risk. This research has minimal risk, defined as the risk found
in everyday life. The food samples you will be asked to consume are made of
commercially available ingredients and pose no foreseeable risk. The calorie
free beverage wil1 contain labeled octanoic acid, This ingredient is an approved
food additive that carries no risk at the levels used in this test. All blood will
be collected by an experienced technician, but the procedure may result in
soreness at the site of collection (finger tips) and/or, infection. The total
amount of blood collected over all of the test sessions will be less than the
amount normally taken during a routine blood test. To minimize any potential
complications associated
with the blood collection, you must not have donated blood in the past 3 months
nor plan to donate during the upcoming 3 months.

There is a minor risk associated with a breach of confidentiality pertaining to
the information gathered from the subjects. However all information and
records of subjects will be locked in a secure location on the Purdue campus
and safeguards are in place to ensure safety of record. Any record saved
electronically will also not contain names of subjects and the computer will
require password security to log in and gain access to that information.

Are there any potential benefits?
You will receive no foreseeable direct benefits from my participation. The
knowledge gained may provide insights for improving dietary
recommendations intended to reduce the frequency and complications of heart
disease and cancers.
Will I receive payment or other incentive?
You will receive a payment of $250.00 as compensation for any inconvenience my
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participation may have caused. Participants need to complete a payment log with
the Department of Food Science Business Office in order to receive payment, and
some personal information will be required including, name, address and social
security number. Non-resident subjects will be required to complete additional
payment procedures via the Purdue Glacier system. If you withdraw or are
withdrawn from the study, you will receive a pro-rated payment.

Are there costs to me for participation?
There are no cost to participate in this study

What happens if I become in jured or illbecause I took part in this study?

If you feel you have been injured due to participation in this study, please
contact Clinical Study Coordinator Judy George (765-494-6192; george
j@purdue.edu) or Study PI Mario Perruzzi (765-494-0625;
mferruzz@purdue.edu). Purdue University
will not provide medical treatment or financial compensation if you are injured or
become ill as a result of participating in this research project. This does not waive
any of your legal rights nor release any claim you might have based on negligence.

Conflict of Interest Disclosure
The following disclosure( s) is(are) made to give you an opportunity to decide if
this(these) relationship(s) will affect your willingness to participate in the research
study.

• This study is supported, in part, by an unrestricted grant from PepsiCo, Inc.
Will information about me and my participation be kept confidential?
The project's research records may be reviewed by the study sponsor/funding
agency (PepsiCo Inc.), Food and Drug Administration (if FDA regulated), Office
for Human Research Protections (if federally funded) and by departments at
Purdue University responsible for regulatory and research oversight. You
understand that the record of your progress in the study will be kept in a
confidential file in a locked filing cabinet in a secure location on the Purdue
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Campus. A copy of this consent form and the record of my progress will be
retained for three years after termination of the study. At that time, they will be
destroyed. The confidentiality of any computer record will also be carefully
guarded by never including my name on any data file. The information will be
stored electronically on a password-protected computer file. No information by
which you can be identified will be published. However, you understand that it
will be necessary to provide your name, social security number and address to the
University business office to process any compensation payments. In addition,
research records may be inspected by the Purdue University Institutional Review
Board or its designees, and (as allowable by law) state or federal agencies
including the National Institutes of Health.
In the case that subjects' information can be beneficial for further research
purposes, subjects will be notified and their permission to use the current
study's information will be requested.

Please check one of the following boxes:

DYes, you have my permission to use the current study's information for
future research purposes.
DNo, you do not my permission to use the current study's information for
future research purposes.
What are my rights if I take part in this study?
Your participation in this study is voluntary. You may choose not to participate or,
if you agree to participate, you can withdraw your participation at any time without
penalty or loss of benefits to which you are otherwise entitled.
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Who can I contact if l have questions about the study?

If you have questions, comments or concerns about this research project, you can
talk to one of the researchers. Please contact Mario Ferruzzi (765-494-0625).

If you have questions about your rights while taking part in the study or have
concerns about the treatment of research participants, please call the Human
Research Protection Program at (765) 494-5942, email (irb@purdue.edu)or write to:
Human Research Protection Program - Purdue
University Ernest C. Young Hall, Room 1032
155 S. Grant St.
West Lafayette, IN 47907-2114

Documentation of Informed Consent

You have had the opportunity to read this consent form and have the research study
explained. You have had the opportunity to ask questions about the research study,
and your questions have been answered. You are prepared to participate in the
research study described above. You will be offered a copy of this consent form after
you sign it.

Date

Participant's Signature

Participant's Name

Date

Researcher's Signature
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Appendix G

Characterization of Orange Pomace as a Source of Bioactive Compounds
for Modification of Intestinal Glucose Uptake
Sydney Moser1, Bruce Hamaker2, Mario G. Ferruzzi1

1

Departments of Food Science and Nutrition Science, Purdue University, 47907
Department of Food Science and Whistler Center for Carbohydrate Research, Purdue University

2

Objectives

The overall objective of this study was to determine if orange pomace could be
leveraged as a source of bioaccessible phenolics capable of modulating intestinal glucose
uptake. The specific objectives of this portion of the study were three-fold. The first was
to characterize the phenolic composition of orange pomace generated from orange juice
processing and of orange juice products formulated with pomace. The second objective
was to determine the bioaccessibility of phenolics from orange samples provided by
Pepsico R&D and the final objective was to examine the potential for bioaccessible
orange pomace phenolics and fibers to modulate kinetics of intestinal glucose
uptake/transport in a Caco-2 human intestinal cell model.

Experimental

Samples

Orange fruit and industrial products used in this study were provided by Pepsico
R&D Global and included 2 fruit samples (Valencia and Navel) and 9 finished orange
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juice products (Valencia or Navel orange juice OJ)) formulated with citrus fiber or
pomace (Table 1). Each sample was extracted and polyphenol profiles were obtained
(Objective 1). The ability of phenolic extracts to inhibit glucose uptake was then
evaluated (Objective 2).

Table 1: Orange fruit and orange juice (OJ) sample description and codes received from
Pepsi R&D Global.1

1

Sample

Sample Description

Valencia fruit

Orange Fruit Valencia

Navel fruit

Orange Fruit Navel

Navel OJ

A7 OJ

Navel OJ P1%

A7 OJ w/ pomace (1% fiber)

Navel OJ CF1%

A7 OJ w/ Citri-Fi (1% fiber)

Navel OJ CF2.8%

A7 OJ w/ Citri-Fi (2.8% fiber)

Valencia OJ

Valencia OJ

Valencia OJ P1%

Valencia OJ w/ pomace (1% fiber)

Valencia OJ P2.8%

Valencia OJ w/ pomace (2.8% fiber)

Valencia OJ CF1%

Valencia OJ w/ Citri-Fi (1% fiber)

Valencia OJ CF2.8%
Fiber in final product

Valencia OJ w/ Citri-Fi (2.8% fiber)

Polyphenol extraction and analysis by LC-MS (Objective 1):

Extraction of starting material and digesta using microwave-assisted extraction

Orange phenolics were extracted using a microwave assisted extraction adapted
from Proestos et al. [1]. Briefly, extraction solvent (60% acetone in water, 8 mL) was
added to starting material or digestion fractions (2 mL) in a 15 mL conical. Samples
were vortexed (5 sec) and transferred to MarsXPRESS vessels and extracted with
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magnetic stirring using a Mars Xpress microwave. The parameters for irradiation were as
follows: power- 750W; 45 seconds power on, 30 sec power off, 15 sec power on. The
extract was then centrifuged (4500 rpm, 20 min, 4⁰C). The supernatant was recovered
and diluted 1:1 with 0.4% formic acid in water and filtered (0.2µm) for injection on
HPLC.

Analysis of polyphenols by LC-MS

Phenolic compounds from orange juice products were characterized by HPLC
using methods adapted from those described by Song et al. [2]. Aliquots of starting
material and digesta extractions were centrifuged (14krpm, 5min) and diluted 1:1 with
mobile phase in preparation LC-MS and aliquots of aqueous digesta were direct injected.
All samples were analyzed using a Waters 2695 Alliance system using a Waters XBridge C18 column (2.5 µm, 100 x 2.0 mm i.d.) and a binary mobile phase consisting of
2.0% formic acid (v/v) in ddH2O (Reservoir A) and 0.1% formic acid (v/v) in acetonitrile
(Reservoir B).Initial conditions of 95:5 A/B was followed by a linear gradient to 65:35
A/B (0-15 min), 30:70 A/B (15-17 min), 95:5 A/B (17-19 min), and 95:5 A/B (19-23
min). Following separation the column effluent was introduced by negative mode
electrospray ionization (ESI) into a Waters Micromass ZQ MSD. MS conditions were as
follows: ionization mode: ESI-; capillary voltage: 3.00kV; cone voltage: 40V; extractor
voltage: 5V; RF lens: 0V; source temp: 150°C; desolvation temp: 250°C; desolvation gas
flow: 400L/hr; and cone gas flow: 60L/hr. Following initial screening, key mass spectra
single ion responses (609, 463, 593, 579, 301, 271, 287, and 317) were collected for
detection and quantification of individual orange juice polyphenols.
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Table 2: Single ion responses for identification and quantification of phenolic
compounds.
Single Ion Response [m/z]

Flavonoid Compound

609

Hesperedin

463

Quercetin-Glucoside

593

Didymin

579

Narirutin

301

Hesperetin

271

Naringenin

287

Eriodictyol

317

Myricetin

Polyphenol stability/bioaccessibility from model orange juice beverages (Objective 2)

Phenolic bioaccessibility from orange products was determined using a three
stage in vitro digestion as described by Thakkar et al. [3] and modified by Kean et al. [4].
This method simulates oral, gastric and small intestinal digestion in sequence is order to
assess the release and stability of bioactive compounds, including phenolics, from foods
and beverages. Oral phase digestive solution was prepared by addition of KCl, Na3PO4,
Na2SO4, NaCl, and NaHCO3 for final concentrations of 242.78, 10.83, 8.03, 10.20, and
40.33 mmol/L, respectively. Aliquots of formulated orange juice beverages (~20 g) were
mixed with oral phase solution in a 50 mL centrifuge tube. The reaction tube was
vortexed, blanketed with nitrogen, and incubated in a covered shaking water bath (37°C,
85 opm, 10 min). Samples were then brought to 30 mL with saline solution (0.9% NaCl).
The gastric phase was then initiated by addition of 2 mL porcine pepsin solution (20
mg/mL in 0.1 M HCl) and adjustment of the reaction pH to 3.0 ± 0.1 with 1.0 M HCl.
After addition of 0.9% saline solution to 40 mL total volume, samples were blanketed
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with nitrogen and incubated in a covered shaking water bath (37°C, 85 opm, 1 hr).
Following incubation, the small intestinal phase was initiated by addition of 1.0 M
NaHCO3 to adjust the pH of gastric digesta to 6.5 ± 0.1. A cocktail of small intestinal
enzymes (2 mL, 30 mg/mL pancreatin, 15 mg/mL lipase in 0.1 M NaHCO3) and porcine
bile salts (3 mL, 120 mg/mL bile extract in 0.1 M NaHCO3) were added to the solution.
Samples were then brought to a final volume of 50 mL with 0.9% saline solution,
blanketed with nitrogen and incubated in a covered shaking water bath (37°C, 85 opm, 2
hrs). After completion of the small intestinal phase, samples were centrifuged (10,400 x
g, 4°C, 1 hr) and filtered using a 0.2μm filter. Aliquots of undigested beverage starting
material (SM), and centrifuged aqueous small intestinal digesta (AQ) were collected and
applied to glucose transport studies (below) or acidified with aqueous acetic acid (1%
total in sample) and stored frozen at -80°C until analysis by HPLC (outlined above).

Glucose Transport by Caco-2 Small Intestinal Epithelial Cells (Objective 3)

Caco-2 glucose transport model

The potential for bioaccessible orange phenolics to inhibit intestinal glucose
transport was investigated using the Caco-2 human intestinal cell culture model using the
method of Manzano and Williamson [5] with modification applying d7-glucose as the
labeled tracer for transport studies. Caco-2 (HTB-37) cells were maintained in DMEM
supplemented with 10% v/v fetal bovine serum, 1% v/v nonessential amino acids, 1% v/v
HEPES, 1% v/v penicillin/streptomycin and 0.1% v/v gentamicin. Cells were incubated
at 37°C in an incubator under a 5% CO2/95% air atmosphere at constant humidity.
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Culture medium was changed every two days. Cells seeded (0.212x106 cells/cm2 were
grown and differentiated in 6 well insert plates (Corning® Transwell® polyester
membrane, 24mm diameter, pore size 0.4μm) under a humidified atmosphere of air/CO2
(95:5) at 37°C. All experiments used differentiated monolayers (electrical resistance > 500
Ω cm2) at passages 85-95, with uptake/accumulation studies conducted 20-22 days postconfluency. Cells were incubated in glucose-free DMEM for 2 hours preceding
treatment. Test media was prepared by diluting aqueous digesta 1:2 with d7-glucose
solubilized in PBS pH 5.5 for final glucose and d7-glucose concentrations of 11-13 mM
and 2mM, respectively, prior to introduction to the apical surface of cell monolayers.
Matching controls were prepared by diluting blank digesta 1:2 with glucose, fructose, and
d7-glucose solubilized in PBS pH 5.5 for final glucose, fructose, and d7-glucose
concentrations of 6 mM, 6 mM and 2 mM, respectively. At predetermined time intervals
(0, 15, 30, 60 min), basolateral media (150μL) was collected. After 60 min, apical media
was collected and cells were washed twice with 0.1% fatty acid free PBS. Membranes
were then washed with ice cold PBS to stop glucose transport, and cells were collected
and frozen until analysis.

Analysis of glucose concentration in basolateral media by LC-MS
Basolateral media was filtered through a 0.45 μm PTFE filter prior to analysis.
10μL of sample was injected on a Waters 1100 Series HPLC system equipped with a
Waters MicromassLCT PremierMS. Separation was achieved using a Varian Polaris
C18-amide column (2.0 mm id x 150 mm, 3.0μM particle size) heated to 30°C under
isocratic conditions with flow rate of 0.3 mL/min and solvent mixture of 50:50 ofddH2O.
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MS conditions adapted from Ikegami et al. [6] were as follows: ionization mode: ESI (-);
mass: 222m/z; capillary voltage: 3.2 kV; cone voltage: 20 V; source temp: 100°C;
desolvation temp: 350°C; desolvation gas flow: 350 L/hr; and cone gas flow: 50 L/hr.

Data Analysis

Data for polyphenol content of orange samples and for glucose samples are
expressed as mean ± SEM from a minimum of n=3-4 replicates. Glucose transport is
expressed as concentration (μM) of glucose in basolateral compartment, percent (%)
glucose transport, rate (μmol/min) of glucose transport, and percent (%) glucose transport
relative to control. Relative bioaccessibility (%) is defined as the percent of polyphenol
recovered in final digesta from that in starting material. Absolute bioaccessibility
(μmol/reaction) is the amount of phenolic available in digesta per gram starting material,
calculated by multiplying relative bioaccessibility by grams of starting material.
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Results

Figure 1: Levels of polyphenols in (a) starting material, (b) digesta, and (c) aqueous
digesta of Valencia orange juice beverages formulated with varying types and amounts of
fiber and from orange fruit and puree.
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Figure 2: Levels of polyphenols in (a) starting material, (b) digesta, and (c) aqueous
digesta of Navel orange juice beverages formulated with varying types and amounts of
fiber and from orange fruit and puree.
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Table 3. Concentration (μmol/100g) of polyphenols from raw material of Valencia orange juice beverages formulated with varying
types and amounts of fiber, and from orange fruit and orange puree.
Sample

Hesperedin

Quercetinglucoside

Didymin

Didymin

Narirutin

Valencia
Fruit
Valencia
OJ
Valencia
OJ P1%
Valencia
OJ P2.8%
Valencia
OJ CF1%
Valencia
OJ
CF2.8%

32.9 ± 1.3a

0.9 ± 0.03a

2.9±0.1a

2.0±0.1a

4.5±0.1a

27.8±0.2b

0.2±0.01c

1.5±0.02c

0.8±0.02c,d

25.5±0.3c

0.2±0.01c

1.6±0.04c

23.3±0.2d

0.2±0.01c

28.9±0.4b
34.3±0.1a

Hesperetin

Naringenin

Eriodictyol

Myricetin

Total

11.7±0.1a,b

34.7±0.4a

2.0±0.04a

1.6±0.1a

93.2±2.0a

1.3±0.01c,d

11.2±0.1b

13.2±0.1c,d

1.2±0.01c

1.0±0.01c,d

58.1±0.4c

0.8±0.04d

1.4±0.04c,d

9.3±0.4d

12.6±0.6d

1.1±0.1c

1.0±0.1c

53.4±1.5d

1.3±0.04d

0.6±0.01e

1.3±0.03d

9.3±0.1d

11.1±0.3e

0.9±0.02d

0.8±0.02d

48.8±0.7e

0.2±0.01c

1.5±0.1c

0.9±0.03c

1.5±0.1c

10.6±0.1c

14.3±0.8c

1.2±0.04c

1.0±0.1c

60.1±1.6c

0.4±0.01b

1.8±0.1b

1.2±0.03b

2.1±0.04b

11.8±0.1a

18.3±0.4b

1.4±0.01b

1.2±0.02b

72.4±0.6b

Table 4. Concentration (μmol/100g) of polyphenols from raw material of Navel orange juice beverages formulated with varying types
and amounts of fiber, and from orange fruit and orange puree.
Sample

Hesperedin

Quercetinglucoside

Didymin

Didymin

Narirutin

Navel
Fruit

35.3±5.8a,b

0.3±0.02c

3.1±0.1a

2.6±0.5a

5.6±0.4a

Navel OJ

30.5±0.3a,b

0.2±0.01c

1.6±0.01d

1.0±0.02b

Navel OJ
P1%
Navel OJ
CF1%
Navel OJ
CF2.8%

27.1±0.3b

0.3±0.01b,c

1.7±0.1c,d

32.2±0.4a,b

0.3±0.01b

36.8±1.8a

0.4±0.01a

Hesperetin

Naringenin

Eriodictyoll

Myricetin

Total

11.5±1.1a,b

36.4±1.6a

1.5±0.1a

1.0±0.1b

97.4±9.5a

1.8±0.02c

10.8±0.3b,c

16.2±0.2c,d

1.2±0.02b,c

0.8±0.01d

64.2±0.6c

0.9±0.04b

1.7±0.04c

9.7±0.3c

15.7±0.3d

1.2±0.01c

0.9±0.02c

59.2±1.1c

1.8±0.01c

1.1±0.02b

2.0±0.02b,c

11.5±0.1a,b

18.2±0.1c

1.3±0.03b

0.9±0.02c

69.4±0.6b,c

2.0±0.04b

1.3±0.02b

2.4±0.02b

12.9±0.1a

22.1±0.4b

1.6±0.01a

1.2±0.02a

80.6±1.5b
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Table 5. Relative (%) bioaccessibility of polyphenols from Valencia orange juice beverages formulated with varying types and
amounts of fiber, ad from orange fruit and orange puree.
Sample

Hesperedin

Quercetinglucoside

Didymin

Didymin

Narirutin

Hesperetin

Naringenin

Eriodictyol

Myricetin

Valencia Fruit

24.1±0.6a,b

48.9±3.4b

51.5±1.0b,c

39.9±2.8a

40.1±0.9d

19.1±0.7b

30.6±0.8b

40.5±0.6b

48.3±2.1b

Valencia OJ

20.6±1.8b,c

22.8±2.9c

57.0±5.1b

30.7±2.1b,c

65.8±5.4a

5.8±0.5c

6.8±0.6c

12.4±0.9c

22.4±2.5c

Valencia OJ
P1%
Valencia OJ
P2.8%
Valencia OJ
CF1%
Valencia OJ
CF2.8%

22.1±1.6b

21.0±2.2c

43.3±1.9d,e

38.9±4.9a,b

52.5±2.7b,c

6.5±0.5c

6.5±0.4c

12.4±0.9c

19.7±1.8c,d

27.8±1.8a

64.5±3.6a

78.4±2.3a

37.8±2.7a,b,c

58.0±2.1a,b

25.1±1.4a

47.4±1.5a

45.8±0.7a

60.3±3.2a

17.2±1.0c,d

21.5±0.2c

45.6±2.0c,d

29.8±1.6c

52.3±1.7b,c

5.2±0.3c

6.0±0.3c

12.8±0.7c

19.1±1.0c,d

14.7±0.3d

19.5±1.4c

35.6±0.8e

31.9±1.6a,b,c

44.4±0.8c,d

5.2±0.1c

5.3±0.1c

11.4±0.2c

13.4±0.5d

Table 6. Relative (%) bioaccessibility of polyphenols from Naval orange juice beverages formulated with varying types and amounts
of fiber, and from orange fruit and orange puree.
Hesperedin

Quercetinglucoside

Didymin

Didymin

Narirutin

Hesperetin

Naringenin

Eriodictyol

Myricetin

Navel
Fruit

22.6±2.5a

58.4±3.7a

53.3±0.5a

32.1±4.5a,b

37.4±2.0b

21.8±2.0a

32.5±0.9a

44.0±0.4a

55.7±1.0a

Navel OJ

14.7±1.2c

20.1±1.4b

53.9±4.8a

24.4±1.8b

57.6±4.7a

4.5±0.3b

5.7±0.6b,c

11.5±1.0c

22.6±1.7b

Navel OJ
P1%
Navel OJ
CF1%
Navel OJ
CF2.8%

19.6±0.5a,b

22.7±1.3b

56.1±3.9a

34.8±1.4a

61.1±0.9a

5.8±0.3b

6.3±0.4b

14.5±0.9b

22.8±1.8b

16.8±0.6b,c

19.3±1.0b

54.3±2.2a

27.2±0.8b

56.2±0.6a

5.0±0.3b

5.8±0.3b

11.9±0.3c

21.0±0.3b

12.7±1.4c

11.4±1.3c

33.0±4.0b

25.7±1.5b

40.2±3.5b

4.0±0.2b

4.0±0.1c

7.3±0.6d

11.9±1.3c

Sample
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Table 7. Absolute (μmol/100g) bioaccessibility of polyphenols from aqueous digesta of Valencia orange juice beverages formulated
with varying types and amounts of fiber, and from orange fruit and orange puree.
Sample

Hesperedin

Quercetinglucoside

Didymin

Didymin

Narirutin

Hesperetin

Naringenin

Eriodictyol

Myricetin

Valencia
Fruit
Valencia
OJ
Valencia
OJ P1%
Valencia
OJ P2.8%
Valencia
OJ CF1%
Valencia
OJ
CF2.8%

19.1±0.3a

1.0±0.1a

3.6±0.1a

1.9±0.1a

4.4±0.1a

5.3±0.2a

25.5±0.9a

1.9±0.1a

1.9±0.1a

64.5±1.5a

13.7±1.1b,c

0.1±0.01c

2.0±0.2b

0.6±0.03c,d

2.1±0.2b

1.6±0.1b

2.1±0.2c

0.3±0.03c,d

0.5±0.1c

23.2±1.8c

13.5±0.8b,c

0.1±0.01c

1.6±0.04c

0.7±0.1c

1.8±0.1c

1.4±0.1b

2.0±0.04c

0.3±0.01d

0.5±0.02c

21.9±1.1c

15.6±0.9b

0.3±0.01b

2.4±0.1b

0.5±0.03d

1.8±0.04c

5.6±0.3a

12.6±0.1b

1.0±0.01b

1.2±0.04b

40.9±1.3b

11.9±0.6c

0.1±0.01c

1.6±0.2c

0.7±0.03c,d

1.9±0.1b,c

1.3±0.1b

2.1±0.1c

0.4±0.02c,d

0.5±0.04c

20.5±0.9c

12.1±0.2c

0.2±0.01c

1.5±0.01c

0.9±0.02b

2.2±0.1b

1.5±0.02b

2.3±0.01c

0.4±0.01c

0.4±0.01c

21.5±0.2c

Total

Table 8. Absolute (μmol/100g) bioaccessibility of polyphenols from aqueous digesta of Naval orange juice beverages formulated with
varying types and amounts of fiber, and from orange fruit and orange puree.
Sample

Hesperedin

Quercetinglucoside

Didymin

Didymin

Navel
Fruit

18.5±1.2a

0.4±0.01a

4.0±0.1a

Navel OJ

10.8±1.0b

0.1±0.01b

Navel OJ
P1%
Navel OJ
CF1%
Navel OJ
CF2.8%

12.8±0.5b

Narirutin

Hesperetin

Naringenin

Eriodictyol

Myricetin

Total

1.9±0.9a

5.0±0.1a

5.9±0.3a

28.3±0.6a

1.6±0.1a

1.4±0.04a

67.0±2.1a

2.1±0.2b,c

0.6±0.1b

2.4±0.2b

1.2±0.1b

2.2±0.2b

0.3±0.03b,c

0.4±0.04b,c

20.2±1.8b

0.1±0.01b

2.3±0.2b

0.7±0.01b

2.5±0.1b

1.3±0.1b

2.4±0.2b

0.4±0.03b

0.5±0.05b

23.1±0.9b

13.0±0.6b

0.1±0.01b

2.3±0.1b

0.7±0.01b

2.7±0.1b

1.4±0.1b

2.5±0.1b

0.4±0.01b,c

0.5±0.02b

23.7±0.9b

11.1±1.0b

0.1±0.02b

1.6±0.2c

0.8±0.1b

2.3±0.2b

1.2±0.1b

2.1±0.1b

0.3±0.02c

0.3±0.04c

19.9±1.7b
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Figure 3. Glucose transport by Caco-2 small intestinal epithelial cells treated with
glucose (control) or co-treated with glucose and (a) Valencia or (b) Navel orange juice
digesta. d7-glucose was used as a marker for glucose transport.
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Table 9. Glucose transport by Caco-2 small intestinal epithelial cells treated with glucose
(control) or co-treated with glucose and orange juice digesta. d7-Glucose was used as a
marker for glucose transport.
Sample

Phenolic
Concentration
[μM]

Relative (%) d7-Glucose
Transport Compared to
Daily Glucose Control

Control
(6mM Glucose)
Valencia Fruit

35.9

±

2.5

51.2±8.9c,d

Valencia OJ

12.9

±

3.0

31.6±1.7 e

Valencia OJ P1%
Valencia OJ P2.8%

12.2

±

1.8

64.4±2.7 b

22.7

±

2.1

45.3±3.1 d

Valencia OJ CF1%

11.4

±

1.6

44.3±1.8 d

Valencia OJ CF2.8%
Navel Fruit

11.9

±

0.3

57.9±2.6 b,c

37.2

±

3.4

36.6±3.1 d

Navel OJ

11.2

±

3.0

65.9±2.1 b,c

Navel OJ P1%

12.8

±

1.5

53.1±8.4 c,d

Navel OJ CF1%

13.2

±

1.6

80.0±4.7 b

Navel OJ CF2.8%

11.1

±

2.9

50.9±3.3 c,d

1

100±3.1a

0

Total phenolics determined using HPLC-MS
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Results

Starting SM phenolic profiles of eleven orange juice samples

Several phenolic species including flavanones, flavones, flavonols, and their
glycosides were observed in SM of the eleven orange products screened (Figures 1 and 2;
Tables 1, 3, and 4). Flavanones hesperedin and naringenin were the most prominent
flavonoids observed in SM of orange products. Hesperedin levels ranged between 23.3 to
34.3 μmol/100g and 27.1 to 36.8 μmol/100g in Valencia and Navel SM, respectively.
Naringenin levels ranged between 11.1 to 34.7 μmol/100g and 15.7 to 36.4 μmol/100g in
Valencia and Navel SM, respectively. All remaining flavanones and flavones were
present in orange products between 0.2 to 12.9 μmol/100g. Finally, quercetin-glucoside
(a flavonol derivative) was present at low levels (0.2 to 0.4 μmol/100g) in all orange
products except Valencia fruit (0.9±0.03 μmol/100g).
Levels of each flavonoid were compared between orange products (Tables 3 and
4). Overall, Navel SM had higher level of most flavonoids compared to Valencia SM,
with the exception of quercetin-glucoside in Navel fruit and eriodictyol in Navel OJ
without added fiber. When comparing flavonoid levels within variety, Valencia fruit SM
had significantly higher (p<0.05) levels of flavonoids compared to all Valencia OJ, with
exception of hesperedin and hesperetin, which were at similar levels compared to
Valencia OJ containing Citri-Fi (2.8%) (34.3±0.1 and 11.8±0.1 μmol/100g, respectively).
On the other hand, Navel fruit had significantly higher (p<0.05) levels of didymin
species, narirutin, naringenin, eriodictyol, and myricetin compared to Navel OJ, but
levels of remaining flavonoids were generally not different. Addition of Citri-Fi to 2.8%
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in Valencia and Navel OJ resulted in significantly increased (p>0.05) levels of most
flavonoids compared to remaining beverage formulations, with levels being similar to
those from whole fruit. No further notable trends with regards to addition of fiber to OJ
formulations were observed.
In vitro bioaccessibility of flavonoids from orange juice

Valencia and Navel fruits and formulated OJ beverages were subjected to a threestage in vitro digestion model. Relative (%) bioaccessibility (%BA; Tables 5 and 6) and
absolute bioaccessibility (Tables 7 and 8) of flavonoids from each type of orange product
were calculated to determine impacts of orange variety or presence of added fiber
(pomace or Citri-Fi) on bioaccessibility of flavonoids from orange fruit or OJ. %BA of
individual phenolics ranged from 4.0 to 78.4% (Tables 5 and 6). Hesperedin, hesperetin,
naringenin, eriodictyol, and myricetin %BA was significantly higher (p<0.05) from
Valencia and Navel fruits compared to all OJ beverages. %BA from fruits ranged from
19.1 to 44.0% compared to 4.0 to 22.8% from juices, with the exception of Valencia OJ
with pomace (2.8%). Most flavonoids were significantly more (p<0.05) bioaccessible
from Valencia OJ with pomace (2.8%) (25.1 to 78.4% BA) compared to Valencia fruit
and remaining OJs. Due to their high levels in starting material, absolute BA of
hesperedin and naringenin from orange samples were much higher compared to other
flavonoids, ranging from 2.1 to 28.3 μmol/100g compared to 0.1 to 5.9 μmol/100g
(Tables 7 and 8).
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Modulation of glucose transport across Caco-2 intestinal epithelial cells by OJ digesta

To determine the impact of bioaccessible phenolics on glucose transport, Caco-2
cells were treated with diluted AQ digesta resulting from in vitro digestion of orange
fruits and OJs (11.1 to 37.2 total phenolics; 11-13mM glucose plus fructose) spiked with
d7-glucose (2mM). All digesta resulting from in vitro digestion of fruit and fruit juices,
significantly (p<0.05) decreased d7-glucose transport over 60 min relative to matching
phenolic-free controls by 20.0 to 68.4% (Figure 3, Table 9) . Valencia OJ without added
fiber decreased glucose transport significantly (p<0.05) compared to Valencia fruit and
Valencia OJ with added fibers, decreasing transport by 68.4±1.7% compared to 35.6 to
55.7%. Navel whole fruit digesta decreased glucose transport compared with control to a
significantly greater extent (p<0.05) compared to digesta from Navel OJ without added
fiber and Navel juice with Citri-Fi (1%), decreasing transport by 63.4±3.1% compared to
34.1±2.1 and 20.0±4.7%, respectively. Further, addition of Citri-Fi for 2.8% total fiber in
Navel OJ decreased glucose transport to a significantly (p<0.05) greater extent compared
to addition of Citri-fi for 1% total fiber by 49.1±3.3 compared to 20.0±4.7%.

Discussion

Health professionals have been urging consumers to avoid consuming foods that
are high in sugars and simple carbohydrates with the concern being the increased rate at
which glucose from such foods reaches high concentration in blood, termed
hyperglycemia. Importantly, hyperglycemia is one of the main contributors to obesity and
diabetes. As beverages high in sugar elicit an elevated glycemic response, they have been
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the target of much scrutiny [7,8]. Although 100% fruit juices are considered sugary
beverages, a recent meta-analysis suggests that, unlike sugar-sweetened beverages, fruit
beverages may not have a negative impact on glucose control in adults [9]. In support,
results from recent clinical studies showed consumption of phenolic-rich 100% fruit
beverages resulted in lower blood glucose levels compared to matching sugar sweetened
beverages [10–12].
Previous research has demonstrated the ability of plant phenolics to mitigate
starch digestion and intestinal glucose transport [5,13–19]. Further, recent studies
indicate effects observed in vitro may translate to lowered glycemic response following
phenolic-rich fruit beverage compared to a sugar sweetened beverage in vivo. Glycemic
response was lower for volunteers that consumed apple juice (400 mL) compared to that
of those that consumed phenolic-free beverages matched for sugar content, indicating that
phenolic components in apple juice may decrease intestinal glucose uptake [10]. Further,
a study was conducted to determine impacts due of fiber addition to apple juice on
glucose response in men. The fibers (mixture of xanthan gum with konjac-mannan or
guar gum) were added to ~0.25% w/w in apple beverages. Subjects consumed both fiber
formulated juices and fiber-free control juice (300 mL) separately in a randomized
crossover design. Results showed that fiber had no impact on glucose response at levels
assessed [20]. However, levels of fiber used in these formulations were low. To explore
the possibility for OJ phenolics in the context of OJ food matrix to impact glycemic
response, a coupled in vitro digestion and cell culture model was utilized to determine
impacts of bioaccessible phenolics from OJ formulated with and without added fibers on
intestinal glucose transport compared to controls matched for sugar content.
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Levels of total flavanones, the primary phenolic species in OJ, observed here (214
to 315 mg/L) is comparable to those previously reported (133-760 mg/L) [21–26].
Further, most individual flavanone levels fell within range of those previously reported,
with the exception of hesperedin and hesperetin which were present at relatively low and
high levels, respectively, (33 to 52 and 118 to 164 mg/L compared to 76 to 365 and 49
mg/L hesperedin and hesperetin).
Flavonoid bioaccessibility is required for bioactivity in the gut and, ultimately,
bioavailability and systemic bioactivity. Didymin, and narirutin were the most
bioaccessible flavonoids from Valencia and Naval OJ, with bioaccessibility ranging
between 30 and 65%. However due to high starting concentrations, hesperetin and
naringenin had considerably higher absolute bioaccessibility (up to 2.0 and 2.4 μmol/rxn
for juices and whole fruits, respectively) compared to remaining flavonoids. Results for
narirutin, hesperedin, and didymin %BA were consistent with previous reports [22,24].
However, total phenolic and hesperetin bioaccessibility were about 2x lower than
previously reported. Hesperetin levels in starting material were much higher compared to
remaining flavonoids, therefore low overall phenolic bioaccessibility compared to values
reported in literature are likely due to low bioaccessibility of hesperetin. Interestingly,
flavonoid bioaccessibility was generally higher from orange fruit than OJ.
An overview of how phenolic interaction with fiber may impact bioaccessibility
and bioavailability of phenolics has previously been reviewed [27,28]. Phenolic
hydroxide groups and phenolic rings non-covalently interact with polar groups and
hydrophobic areas on polysaccharides, respectively, primarily through hydrogen bonds,
electrostatic interaction, or van der Waals attraction. The result of such interactions may
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be protection of plant phenolics from degradative reactions during digestion and
subsequent release of intact phenolic in the duodenum resulting in increased phenolic
bioaccessibility. Conversely, failure of interaction to be released in small intestine results
in delivery of phenolics to colon for further metabolism by gut microbiota or excretion.
Here, bioaccessibility of phenolics from Navel or Valencia OJ formulated with pomace
or Citri-Fi were compared to fiber-free controls. Pomace addition to 1% in Navel, but not
Valencia OJ, resulted in increased %BA of most flavonoids compared to their respective
controls. However, addition of pomace to 2.8% in Valencia OJ resulted in increased
(p<0.05) flavonoid %BA compared to remaining Valencia OJ. On the other hand,
addition of Citri-Fi to 2.8% in Navel and Valencia formulations decreased
bioaccessibility of specific phenolics (didymin, narirutin, myrecitin). Pomace consists of
a network of fibers that has ordered, cellulosic structure [29] whereas commercial Citri-Fi
is derived from orange fibers that have been mechanically processed to have a more
porous structure with increased surface area [30]. Our results suggest that the cellulosic
structure of the fibers in pomace may allow for temporary hydrophobic binding with
phenolics followed by release in the duodenum. On the other hand, interactions with
Citri-Fi fibers may be more abundant and strong in comparison to pomace fiber due to
increased surface area resulting in more limited release of phenolics in the duodenum.
The free, bioaccessible portion of flavonoids here are in AQ, whereas intact flavonoids
found in DG are bound. Flavonoid concentration in DG from Citri-Fi fromulations was
7.14 to 9.86 μM greater compared to AQ fraction whereas that in DG from OJ formulated
with pomace or without fiber was only 1.9 to 6.9 μM higher than AQ (Figures 1 and 2).
This result suggests that phenolics may be bound to Citri-Fi to a greater extent compared
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to pomace during duodenal digestion, and therefore not part of the bioavailable fraction
in the lumen.
In addition to reports suggesting phenolics may modulate carbohydrate digestion,
recent research has shown various plant-derived phenolic extracts mitigate glucose
transport across Caco-2 intestinal cell monolayers by up to 50% [5,16]. However, there is
no information on whether the bioaccessible flavonoid fraction from phenolic-rich foods
may have an effect on intestinal glucose uptake. Therefore, we investigated the impact of
the bioaccessible (AQ) fraction obtained from in vitro digestion of each orange fruit or
OJ on glucose transport in a Caco-2 human intestinal cell model. AQ feeding material
contained between 9-40µM flavonoids. AQ fraction from every orange product, except
from Navel juice with Citri-Fi (1%) significantly (p<0.05) decreased d7-glucose transport
over 60 min relative to matching phenolic-free controls. Although Valencia and Navel
fruit AQ contained higher concentration of phenolics compared to OJ AQ, Valencia fruit
AQ did not significantly decrease (p<0.05) glucose transport compared to Valencia OJ
AQ and Navel fruit AQ decreased glucose transport to a significantly greater extent
(p<0.05) only compared to AQ from Navel OJ and Navel OJ with Citri-Fi added for 1%
total fiber in product. There are no clear trends related to effects due to addition of
specific types or amounts of fiber to OJ on its ability to impact glucose transport in vitro.

Conclusions

Orange juice contains a significant amount of flavonoids. Although high in sugar,
it has been shown that consumption of 100% juice results in decreased glycemic response
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compared to consumption of phenolic-free beverages. Our results show oranges and OJ
are particularly rich in hesperetin and naringenin. In agreement with previous reports, OJ
flavonoids are moderately bioaccessible [22,24]. Addition of fiber modulated flavonoid
bioaccessibility, with effects being dependent on fiber structure. Specifically, the ordered
cellulosic structure of pomace fiber appeared to promote flavonoid bioaccessibility
whereas porous Citri-Fi fibers appeared to reduce flavonoid bioaccessibility. Results
from the coupled in vitro digestion and Caco-2 intestinal cell model suggest that
bioaccessible OJ flavonoids decrease intestinal glucose transport, and the effect is not
affected by fiber. However, the model does not take into consideration gut transit and
gastric emptying both of which are modified by fiber and may also have an impact rate of
glucose transport. Overall these results suggest substitution of sugary beverage with OJ in
may help promote glucose homeostasis.
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